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Epigenetic Regulation Of Neurogenesis By Citron Kinase 
 
Matthew J. Girgenti, Ph.D. 
 
University of Connecticut, 2015 
 
Patterns of neural progenitor division are controlled by a combination of 
asymmetries in cell division, extracellular signals, and changes in gene 
expression programs. In a screen for proteins that complex with citron kinase 
(CitK), a protein essential to cell division in developing brain, I identified the 
histone methyltransferase- euchromatic histone-lysine N-methyltransferse 2 
(G9a). CitK is present in the nucleus and binds to positions in the genome 
clustered around transcription start sites of genes involved in neuronal 
development and differentiation. CitK and G9a co-occupy these genomic 
positions in S/G2-phase of the cell cycle in rat neural progenitors, and CitK 
functions with G9a to repress gene expression in several developmentally 
important genes including CDKN1a, H2afz, and Pou3f2/Brn2. The study indicates 
a novel function for citron kinase in gene repression, and contributes additional 
evidence to the hypothesis that mechanisms that coordinate gene expression 
states are directly linked to mechanisms that regulate cell division in the 
developing nervous system.    
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CHAPTER 1 
INTRODUCTION 
Gene repression, mediated by post-translational modification of histones, 
shapes transcriptional states required for normal cellular development and 
homeostasis(Jenuwein, 2006; Sadeh and Allis, 2011). The methyltransferase 
G9a, along with its partner GLP, represses euchromatic gene expression by 
methylating histone 3 at lysine 9 (H3K9)(Tachibana et al., 2008).  Nuclear 
kinases may play a role during neurodevelopment in setting epigenetic states 
during the cell cycle.  Additionally, chromatin-tethered kinases have been shown 
to have both a structural role as part of transcription complexes(Sutcliffe et al., 
2011), as well as an enzymatic role by phosphorylating their targets(Jenuwein, 
2006; Tachibana et al., 2008; Sadeh and Allis, 2011; Sutcliffe et al., 2011; Guise 
et al., 2012).  Taken together these findings indicate a mechanism whereby a cell 
cycle regulated nuclear kinase resets an epigenetic state during development. 
 
Gene expression states throughout neurogenesis 
 Neurons of the mammalian cerebral cortex are primarily generated before 
birth during a period of intense precursor cell proliferation.  Neural progenitor 
cells predominantly reside in the ventricular zone (VZ) adjacent to the lateral 
ventricle.  These neurons proliferate and migrate out to populate the six layers of 
the Neocortex.   Populating such a complex structure requires exquisite control of 
gene expression states to direct processes necessary for dividing and 
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migrating(Dong et al., 2015).  Neural progenitor cells have the ability to self-
renew, and are capable of differentiating into neurons, astrocytes and 
oligodendrocytes(Kennea and Mehmet, 2002).   
Neural progenitors transition from primarily self-renewing to terminally 
dividing cells during central nervous system (CNS) development(Wang et al., 
2009; Pfeuty, 2015). This transition occurs by a combination of asymmetric 
inheritance of cytoplasmic and membrane factors, and programmed changes in 
gene expression states(Carney et al., 2012).  Previous studies in human, mouse, 
and monkey have demonstrated that the transcriptome of the developing 
neocortex is spatially and temporally regulated(Hubbard et al., 2013; Zhao et al., 
2014).  Using laser capture microdissection followed by deep sequencing of RNA 
(RNA-seq), one lab defined 5 transcriptional programs each specific to different 
regions of the developing mouse neocortex: cortical plate (CP), cortical + SVZ 
(subventricular zone), SVZ + intermediate zone (IZ), IZ and VZ(Ayoub et al., 
2011). In human mid-fetal post-mortem tissue, over 44% of the transcriptome is 
differentially regulated in isolated forebrain structures. Not only are gene 
expression levels different but alternative splicing patterns, as well as 
coexpression networks also change(Johnson et al., 2009; Miller et al., 2014; 
Tebbenkamp et al., 2014).  Such dynamic changes to the transcriptome highlight 
the importance of epigenetic regulation during neurodevelopment. 
Cytoskeletal dynamics, morphogenesis, cell proliferation, and cellular 
differentiation are coordinated with gene expression at each stage of 
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neurodevelopment. It is thought that changes in chromatin structure accompany 
developmental changes to establish and/or maintain tissue- and stage- specific 
gene expression states(Harbison et al., 2004). How such changes in chromatin 
are coordinated with cell division and cell differentiation in developing brain 
remains poorly understood. It is likely that these processes must be linked in 
order to ensure accurate propagation of epigenetic states and maintenance of 
cell fates(Seki et al., 2007). 
    
Citron kinase and neurogenesis 
Citron kinase (Crik/CitK), an AGC serine/threonine kinase encoded by the 
gene Citron (CIT/Cit) (Pearce et al., 2010), was initially identified as a small 
GTPase Rho activated kinase. CitK is highly expressed during embryonic (Cunto 
et al., 2002)and postnatal neurogenesis (Ackman et al., 2007).  In brain, it was 
believed to be exclusively expressed in the cytoplasm during cytokinesis- the 
final step of M-phase.  CitK is required for normal progression through and 
completion of cytokinesis in several cell types(Di Cunto et al., 1998; Narumiya et 
al., 1998). A critical role in cytokinesis has been proven genetically in 
Drosophila(D'Avino et al., 2004a; Sweeney et al., 2008), mouse(Di Cunto et al., 
2000), and rat (Sarkisian et al., 2002).  In rodents, the required function in cell 
division is restricted to many, but not all, latter stage neural progenitors in the 
CNS(Di Cunto et al., 2000; Roberts et al., 2000; Ackman et al., 2007). Citron 
kinase is also required for spermatogenesis(Cunto et al., 2002), and for normal 
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hepatocyte development where is has been shown to localize to the nucleus(Liu 
et al., 2003).  In spite of its importance in cytokinesis there has been only one 
possible substrate identified for citron kinase.  In vitro phosphorylation and 
heterologous expression has suggested that regulatory light chain of myosin II is 
a likely citron kinase substrate(Yamashiro et al., 2003). No mass spectrometry 
study has yet confirmed the identity of citron kinase substrates. Interestingly, 
several cytoplasmic proteins that interact with citron kinase including Anillin, 
ASPM, RanBPM, P27kip1 and DLG5, have been identified, but none have been 
identified as citron kinase substrates (Paramasivam et al., 2007; Chang et al., 
2010a; 2010b; Gai et al., 2011; Serres et al., 2012).   
 Beyond a role in cytokinesis two studies have previously suggested 
functions for citron kinase in gene expression. In mammalian keratinocytes, 
down-regulation of citron kinase correlates with the up-regulation of differentiation 
related genes, including Cdkn1a, and ectopic expression of CitK blocks up-
regulation(Grossi et al., n.d.).  In Drosophila, mutant alleles of citron kinase have 
actions independent of cytokinesis defects, and genetically interact with Argonaut 
1, and context dependent Su(var) and E(var) activity(Sweeney et al., 2008). The 
genetic study by Sweeney et al. suggested a pathway from citron kinase to 
chromatin regulation, but the specific biochemical pathway, or cellular site of 
citron kinase action, indirect cytoplasmic or direct nuclear, in chromatin regulation 
has remained undetermined. 
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Epigenetics and development 
 During early development, molecular modifications to the structure of 
histone proteins and DNA (chromatin) play a significant role in regulating the 
transcription of genes without altering their nucleotide sequence.  Epigenetic 
regulation pervades all aspects of development, including the brain(Fagiolini et 
al., 2009).  All processes by cells including proliferation, morphogenesis and 
migration are dictated by the epigenomic landscape directing transcription of 
specific necessary genes(Sweatt, 2013). 
 There exists a number of mechanisms regulating the complex spatial and 
temporal pattern of DNA transcription, which are essential for cellular and tissue 
specific functions.  Within the cell nucleus, DNA is not freely moving but is found 
with protein complexes called nucleosomes.  Approximately 147 nucleotides 
wrap around an octamer of histone proteins- two of H2A, H2B, H3 and H4.  The 
fifth histone protein, H1 is a linker between adjacent nucleosomes(Luger et al., 
1997).  Chromatin exists broadly in two main states: closed, inactive DNA 
(heterochromatin) and open, actively transcribed DNA (euchromatin).  
Heterochromatin is tightly packed and restricts access of RNA polymerase II to 
transcribe DNA.  Conversely, euchromatin exists in a relaxed state and allows 
easier access to the DNA by RNA polymerase(Kouzarides, 2007).  However, it 
should be noted that euchromatin is not always transcribed and there are a 
number of chromatin factors that can repress open DNA (i.e. methylation of H3K9 
by G9a)(Tachibana et al., 2002).  
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 The factors that contribute to the epigenetic regulation of transcription are 
numerous but fall into three general categories: microRNA regulation of 
transcripts(Mattick et al., 2009), DNA methylation(Razin, 1998; Feng et al., 
2007), and post translational modifications of nucleosomal histones(Fukuda and 
Taga, 2005).  mircoRNAs are a class of short,  non-coding RNA molecules found 
in all animals.  They regulate gene expression states via post-transcriptional 
binding to transcripts preventing them from being translated by ribosomes(Carroll 
and Schaefer, 2012).  DNA methylation refers to the conversion of nucleic acid 
cytosine into 5-methylcytosine.  The consequence of this conversion is reduced 
accessibility of the DNA to transcription factors(Fan and Hutnick, 2005).  This 
modification is stable and heritable and is generally though to be reversible (Bird, 
2002).  This process is regulated by methyl donors such as those in the S-
Adenosyl methionine (SAM) family of enzymes and maintained by the DNA 
methyltransferase family (DNMTs) of enzymes(van der Wijst et al., 2015). 
 Epigenetic control of gene expression is also mediated by post-
translational modifications of histone proteins.  Examples of modifications include 
methylation, acetylation and phosphorylation(Kouzarides, 2007; Bannister and 
Kouzarides, 2011).  Most modifications are made to the exposed N-terminal tail 
of the histone protein and alter the accessibility of DNA to transcription factors.  
In particular, histone acetylation is associated with increased transcription but 
histone methylation is more diversified with certain methylation events associated 
with repression (e.g. H3K9me2) and others associated with active transcription 
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(e.g. H3K4me1 and H3K36m3) (Santos-Rosa et al., 2002; Kouzarides, 2007; 
Bannister and Kouzarides, 2011).  We will examine histone methylation in greater 
detail in the next section.  The timing and degree of gene expression are 
controlled through these mechanisms are critical for proper development.  
 
Histone Methylation 
 Histone methylation at specific residues can be associated with close, 
non-transcribed DNA and open actively transcribed DNA.  This dissertation 
focuses specifically on the ninth lysine of histone H3 (H3K9).  This residue is 
somewhat unique in that it can receive opposed functional groups of acetylation 
and methylation post-translational modifications, thus serving as a molecular 
“switch” for gene activation.  Methylation of H3K9 is a highly conserved post-
translational modification of both transcriptionally active but repressed DNA 
(euchromatin) (Tachibana et al., 2002), and closed chromatin 
(heterochromatin)(Barski et al., 2007).  Levels of dimethylated H3K9me 
expression vary by cell type, with much more extensive H3K9 dimethylation in 
the liver compared to the embryonic stem cells(Tong et al., 2013).  Interestingly, 
the adult brain only represses ~10% of its total genome through H3K9 
methylation, suggesting that the brain utilizes a high number of genes, thus 
demonstrating more genomic plasticity and dynamic use of gene regulation(Wen 
et al., 2009). 
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 Histone methylation is a dynamic process that is susceptible to 
environmental influences.  Contextual fear-conditioning is able to induce 
H3K9me2 histone modifications in adult hippocampus(Gupta et al., 2010).  
Global levels of H3K9me2 are significantly reduced following chronic cocaine 
administration.  This is also reflected in the down-regulation of the  H3K9me2 
methyltransferase G9a and GLP(Maze et al., 2010).   High levels of both di- and 
tri-methylated H3K9 is also one of the hallmarks of pericentromeres(Stimpson 
and Sullivan, 2010).  Loss of the methyltransferase Suv39H1 and methylation at 
H3K9 at pericentromeres results in genomic instability, including the 
misalignment of centromeres along the mitotic plate and segregation defects 
such as chromosome breaks and bridges(Frescas et al., 2008; Slee et al., 2012). 
These findings highlight the importance of H3K9 methylation regulation of CNS 
function. 
 
The Histone Methyltransferase G9a 
 Enzymes in the SET domain-containing family of methyltransferases 
predominantly catalyze histone lysine methylation.  This domain is 130 amino 
acids long, highly conserved, and was first identified in three separate Drosophila 
proteins: Suppressor of variegation (Su(var)3-9)(Tschiersch et al., 1994), the 
polycomb-group Enhancer of zeste [E(z)](Jones and Gelbart, 1993), and 
trithorax(Stassen et al., 1995), which is where the acronym ‘S.E.T.’ originates.  
These enzymes all utilize the transfer of a methyl group from s-
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adenosylmethionine to a lysine residue of the histone N-terminal tail, but differ in 
their substrate and product specificity. 
 G9a (euchromatic histone methyltransferase 2 or ehmt 2) is the dominant 
euchromatic methyltransferase of H3K9(Tachibana et al., 2002).  G9a forms a 
functional dimer with its closely related enzyme G9a-like-protein (GLP or 
ehmt1)(Tachibana et al., 2005).  The rat G9a gene has 27 exons and is 4.0 
kilobases (kb) long, while GLP contains 25 exons and is 3.7 kb long. G9a and 
GLP can form homomeric and heteromeric complexes, though there is a 
preference for heteromeric interdependent dimerization.  The G9a-GLP dimer is 
responsible for most of the H3K9me2 modifications across the genome, though 
they do not substitute for each other, and their function is not 
redundant(Tachibana et al., 2008).  In mammals, loss of either GLP or G9a 
results in embryonic lethality and reduces H3K9me1 an H3K9me2 protein 
levels(Tachibana et al., 2005).  Constitutive and conditional genetic deletion of 
G9a in mice indicate that G9a is required for early embryogenesis(Tachibana et 
al., 2002), for normal retinal development(Katoh et al., 2012), for adaptive motor 
behavior(Schaefer et al., 2009), for cocaine withdrawal(Maze et al., 2010), and in 
embryonic stem cell reprogramming and differentiation(Feldman et al., 2006; Ma 
et al., 2008). A role for G9a in neural progenitors and in embryonic cortex has not 
been established previous to this study, but is consistent with recent findings in 
developing retina (Katoh et al 2012). 
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 H3K9 can be methylated or acetylated, acting as a molecular “switch” 
between open and closed chromatin configurations. G9a knockout results in 
decreased H3K9me2 protein levels and a coordinated increase in acetylation of 
H3K9.  This is indicative of a competitive interaction between the acetylation and 
methylation modifications(Tachibana et al., 2002).  In addition to coordination of 
modifications on single residues, modifications on nearby residues can also 
affect one another.  For example increases in methylation of H3K4 (an open 
chromatin modification), inhibits H3K9me2 formation(Wang et al., 2001). 
 
G9a Inhibitors 
Unlike histone deacetylases (HDACs) and DNMTs, there have been very 
few compounds developed that selectively inhibit HMTs. BIX-01294 is a small 
molecule that antagonizes both G9a and GLP, resulting in decreased  levels of 
H3K9me2 protein.  BIX-01294 has an IC50 of 1.7 mM and does not compete with 
the cofactor s-adenosylmethionine(Chang et al., 2009).    Another HMT inhibitor 
which was recently identified is UNC0224, which is a more potent inhibitor of 
G9a, having an IC50 of 15nM(Liu et al., 2009).  Both drugs have shown 
specificity in knocking down levels of H3K9me2 resulting in aberrant transcription 
profiles compared to sham treated. 
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Specific aims and organization of this dissertation 
The impetus for the present study was to identify proteins that complex 
with CitK that may link it to pathways that mediate gene expression states in 
cortical neural progenitors. In chapter one, I found that the histone 
methyltransferase G9a is among several nuclear proteins that co-
immunoprecipitates with CitK. G9a is required for methylation of histone H3 at 
lysine 9 in mammalian cells(Tachibana et al., 2001; 2002; Peters et al., 2003; 
Rice et al., 2003). The H3K9me2 modification added by G9a is generally a 
repressive epigenetic mark that shapes expression states in diverse cell 
types(Chaturvedi et al., 2009; Maze et al., 2010; Bittencourt et al., 2012; Katoh et 
al., 2012; Wang et al., 2012). In chapter two, I produced a whole-genome map of 
CitK occupancy in neural progenitors by ChIP-Seq and identified localization near 
the transcription start sites (TSS) of multiple genes involved in neurogenesis and 
neural differentiation. By overlapping the chromatin binding sites with genes that 
differ in expression in CitK mutants, we identified several directly repressed gene 
targets including Cdkn1a, H2az and Pou3f2/Brn2. CitK co-localizes with G9a at 
genomic positions specifically in S phase of the cell cycle, suggesting that CitK 
and G9a re-establish repressive marks in neural progenitors soon after DNA 
syndissertation.  Chapter three details my experiments for determining CitK’s role 
in  phosphorylating G9a.  Finally, there are five appendices at the end of this 
dissertation.  Appendix A details all methods used; Appendix B is a list of 
abbreviations used in this dissertation; Appendix C lists all primers used in real-
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time PCR of cDNA and ChIP DNA; Appendix D is table of all significant CitK 
occupancy peaks within the neural progenitor genome; and finally Appendix E is 
a list of all phosphorylated peptides identified in my tandem mass spectrometry 
studies.  In all, the results reveal a pathway whereby a cell division control 
protein, citron kinase, regulates neural progenitor epigenetic programs through 
the histone methyltransferase G9a.   
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CHAPTER 2 
CITRON KINASE PROTEIN IS NUCLEAR IN NEURAL PROGENITOR CELLS 
AND INTERACTS WITH THE HISTONE METHYLTRANSFERASE G9A 
 
Abstract 
 Nuclear kinases are increasingly being recognized as transcriptional 
regulators with critical roles in mammalian development, specifically by 
coordinating gene expression states that are directly linked to mechanisms 
regulating cell division in developing nervous system.  Here, we show that citron 
kinase, long thought to be a cytoplasmic kinase, is present in the nuclei of neural 
progenitor cells.  We establish that high concentration fixatives mask CitK 
antigens in the nucleus and that lower concentration fixatives reveal a 
subpopulation of progenitors expressing nuclear CitK.  By using a combination of 
tandem mass spectrometry and co-immunoprecipitation experiments we show 
that CitK interacts with the histone methyltransferase G9a.  This study indicates a 
novel localization and interaction for CitK suggesting a role in the regulation of 
epigenetic states in neural progenitors. 
 
Introduction 
Citron kinase (Crik/CitK), a small GTPase Rho activated kinase involved in 
cytokinesis (Narumiya et al., 1998; Di Cunto et al., 2000; D'Avino et al., 2004b; 
Sweeney et al., 2008) is required for normal patterns of cell division and 
neurogenesis in the developing central nervous system (Di Cunto et al., 2000; 
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Sarkisian et al., 2002; Sweeney et al., 2008). CitK has been localized to 
cytokinesis furrows and to the midbody ring of dividing neural progenitors where 
it interacts with the human microcephaly associated protein ASPM(Fish et al., 
2006; Paramasivam et al., 2007).  The midbody ring structure can either be 
inherited asymmetrically or ejected from cells upon division, and the inherited 
midbody remnant has been proposed to maintain stem cell self-renewal(Chen et 
al., 2013).  Studies in mammalian keratinocytes(Liu et al., 2003), and in 
Drosophila cells suggest an additional function for CitK in gene repression(Bauer 
et al., 2008; Sweeney et al., 2008).  
The methyltransferase G9a, along with its partner GLP, methylate histone 
H3 at lysine 9 to repress expression of euchromatic gene targets(Tachibana et 
al., 2001; 2002; Peters et al., 2003; Rice et al., 2003; Tachibana et al., 2005). 
G9a has several important physiological functions (Shinkai and Tachibana, 2011) 
including a requirement for early embryogenesis(Di Cunto et al., 2000; Roberts et 
al., 2000; Tachibana et al., 2002; Ackman et al., 2007), stem cell 
reprogramming(Cunto et al., 2002; Feldman et al., 2006; Ma et al., 2008), 
adaptive motor behavior(Liu et al., 2003; Schaefer et al., 2009), and cocaine 
withdrawal(Yamashiro et al., 2003; Maze et al., 2010).  As a major repressive 
mechanism of euchromatic gene expression with diverse functions, the activity of 
G9a must be differentially gated at specific genetic loci in different cell types and 
cell states. Locus specificity of G9a activity has been associated with target 
genes positioned on the nuclear periphery in S-phase(Paramasivam et al., 2007; 
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Yokochi et al., 2009; Chang et al., 2010a; 2010b; Gai et al., 2011; Serres et al., 
2012), inclusion of G9a with complexes composed of other lysine 
methyltransferases(Fritsch et al., 2010; Grossi et al., n.d.), and association with 
NRSF/REST (Roopra et al., 2004; Sweeney et al., 2008). G9a also associates 
with multiple DNA binding proteins that may localize its function(Ogawa et al., 
2002; Roopra et al., 2004; Duan et al., 2005; Vassen et al., 2006; Epsztejn-
Litman et al., 2008; Fagiolini et al., 2009; Shinkai and Tachibana, 2011). 
 In this chapter we set out to identify whether citron kinase is expressed in 
the nucleus of neural progenitors.  We believe that high concentration fixatives 
(i.e. 4% paraformaldehyde) may mask the presence of CitK in the nucleus.  
Using ice-cold methanol or 1% paraformaldehyde revealed CitK expression in 
~20% of neural progenitors stained.  We found in a tandem mass spectrometry 
screen (MS-MS), and in follow-up co-immunoprecipitation experiments that citron 
kinase in the nucleus of neural progenitors interacts with the methyltransferase 
G9a.    
 
Materials and Methods 
Animal Use 
All studies were conducted in accordance with protocols that were 
approved by the University of Connecticut Institutional Animal Care and Use 
Committee (IACUC; Assurance No. A09-025, 02/2011).  The rat model organism 
used in these studies has a point mutation in the kinase domain (27th codon) of 
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the citron kinase gene that introduces a premature stop codon.  Consequently, 
no CitK protein is created and the resulting mRNA undergoes nonsense 
mediated decay.  The genotype CitKfh/fh appears in this dissertation. fh is the 
abbreviated form of flathead- the phenotypic description of the homozygous 
animal that is microcephalic.  Thus, fh/fh denotes two flathead alleles in citron 
kinase gene. 
Neural Progenitor Cell Culture 
 Cultures of E11-E12 rat neural progenitors from both wild-type and citron 
kinase mutant embryos were prepared by dissociating dissected cortical 
hemispheres by mechanical disruption followed by trypsin treatment. Cells were 
then plated on poly-D Lysine (0.1mg/mL) and Laminin (1:200) coated coverslips. 
Neural progenitors were maintained in DMEM supplemented with 1% penicillin 
and streptomycin, L-Glutamine, Sodium Pyruvate, N2 supplement, B27 
supplement, bFGF (20ng/mL) and EGF(20ng/mL).  Cells were grown at 37oC 
humidified incubator with 5% CO2. 
Histology and Immunocytochemistry 
Neural progenitor cells were processed for immunocytochemistry at 70% 
confluence or 24-48 hours after transfection. Cells were fixed with the following in 
different experiments: 4% paraformaldehyde or 1% paraformaldehyde in PBS for 
10 minutes at room temperature or 3 minutes with ice cold methanol.  This was 
followed by three washes with PBS and then permeabilization with PBS 
containing 0.5% Triton X-100 and 5% NGS and. The primary antibodies were 
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added to permeabilization and blocking solution and cells were incubated with 
antibodies for 2hrs at room temperature. Primary antibodies used were: rabbit 
polyclonal anti Citron (1: 1000; CT-295)(Zhang et al., 1999) , anti-phospho S10 
Histone H3 (1:500; Abcam Cat# ab47297 RRID:AB_880448), anti-dimethyl Lys9 
Histone H3 (1:500; Millipore Cat# 07-212 RRID:AB_310432), anti-Myc tag 
(1:1000; Abcam Cat# ab9106 RRID:AB_307014) or anti-GFP (1:2000; Abcam 
Cat# ab290 RRID:AB_303395). Cells were washed three times in PBS followed 
by 2hrs in secondary antibody incubation at RT. Secondary antibodies used for 
immunocytochemistry were: Alexa Fluor goat anti-rabbit IgG (H+L) (Molecular 
Probes) and Alexa Fluor goat anti-mouse IgG (H+L) (Molecular Probes). Hoechst 
and DAPI (Molecular Probes) were used for labeling nuclei. For EdU (Molecular 
Probes) labeling, cells were pulsed with 10mM EdU in neural progenitor media 
(see above) and fixed after 1-2 hour incubation followed by 
immunocytochemistry. Cells were imaged using a laser confocal microscope 
(Leica TCS SP2).  Embryonic forebrain were fixed in 4% paraformaldehyde in 
PBS for 30 minutes.  The samples were cryoprotected, embedded, frozen, and 
sectioned (20um thickness).  Slides were incubated with blocking solution (4% 
normal goat serum and 0.1% Triton X-100 in PBS) for 1 hour and then with the 
primary antibody for 2 hours at room temperature.  Slides were washed with PBS 
three times for 10 minutes and incubated with secondary antibodies for 1 hour at 
room temperature.  Sections were then stained using the DAB system (Vector 
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labs) for visualization of CitK protein.  Sections were observed and imaged under 
a light microscope. Primary antibodies used were: anti-Citron (1:500 CT-295).   
Nuclear and Cytoplasmic Fractionation 
 Neural progenitor cells were homogenized in a hypotonic buffer 
(NXTRACT; Sigma) supplemented with a cocktail of protease and phosphatase 
inhibitors (Roche).  Nuclear proteins were separated from the homogenates 
using the CellLytic NuCLEAR Extraction Kit (Sigma).  Both the nuclear and 
cytoplasmic fractions protein concentrations were calculated using BCA Assay 
(Thermo Scientific, 23227). 
Co-Immunoprecipitation  
Proteins were immunoprecipitated from 100 mg of nuclear extracts. 
Samples were allowed to bind for 1hr at room temperature to coated magnetic 
beads (Dnyabeads Protein A/G, Invitrogen). Proteins were eluted from beads, 
separated by SDS/PAGE gel, and prepared for immunoblot.  Immunoprecipitating 
antibodies used in this study were: anti- KMT1C/G9a antibody(8ug)(Abcam Cat# 
ab31874 RRID:AB_1269265), anti-Cit (10ug)(CT295)(Zhang et al., 1999). For 
immunoblotting the following antibodies and dilutions were used: anti-Cit 
(1:500)(CT295), anti-KMT1C/G9a (1:000; Abcam Cat# ab31874 
RRID:AB_1269265), anti-histone H3 (1:2000; EMD Millipore Cat# 09-838 
RRID:AB_10845793), anti-histone H4 (1:2500;Millipore Cat# 07-596 
RRID:AB_441947) and anti-histone H3K9me2 (1:1000; Abcam Cat# ab1220 
RRID:AB_449854).  Western blot analysis was performed using specific 
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antibodies to specific proteins. The secondary antibodies used were IRDye anti-
mouse and anti-rabbit antibodies (LI-COR Biosciences). The proteins were 
detected by LI-COR Odyssey Imaging system. 
Tandem Mass Spectrometry 
Protein from the neural progenitor nuclear preparations (see above), was 
immunoprecipitated for CitK and separated on a 10% Tris-Glycine SDS-PAGE 
gel. The gels were Coomassie stained and all bands were excised from the gel (a 
total of 4 bands from all molecular weights). Gel slices were resuspended in 8 M 
urea. The samples were then homogenized and sonicated and then centrifuged 
and supernatants retained. Protein abundances were estimated using a 
NanoDrop spectrophotometer (Thermo Scientific). Samples were then diluted to 
2 M Urea and 0.4 M ammonium bicarbonate, reduced with dithiothreitol (DTT), 
alkylated with iodoacetamide (IAN), and digested for 16 h at 37°C. Enzyme 
digestion with Trypsin was carried out. Samples were run on a LTQ Orbitrap 
equipped with a Waters nanoACQUITY™ UPLC™system, using a Waters 
Symmetry® C18 180 μm Å~ 20 mm trap column and a 1.7-μm, 75 μm Å~ 250 
mm nanoAcquity™ UPLC™ column (35°C) for peptide separation. MS was 
acquired in the Orbitrap using 1 microscan, and a maximum inject time of 900 ms 
followed by three data dependent MS-MS acquisitions in the ion trap (with 
precursor ions threshold of >3000); the total cycle time for both MS and MS-MS 
acquisition was 1.0 s.  Peaks targeted for MS-MS fragmentation by collision 
induced dissociation (CID) were first isolated with a 2-Da window followed by 
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normalized collision energy of 35%. Dynamic exclusion was activated where 
former target ions were excluded for 30 s. The data were processed with 
Prognosis LCMS (Non-linear Dynamics, LLC) and protein identification was 
carried out using the Mascot search algorithm (version 2.3.0; Matrix Science).  
648 peptides were identified.  Peptide IDs were analyzed, first by elimination of 
non-significant peptides (p<.05).  The remaining list was then compared to the 
recently published contaminant repository for affinity purification or “CRAPome” 
for proteins which are frequently non-specifically identified by mass 
spectrometry(Mellacheruvu et al., 2013).  This resulted in elimination of over 300 
peptides.  The remaining proteins were filtered for nuclear compartment gene 
ontology using DAVID.  This resulted in 43 nuclear proteins. 
 
Results 
Citron kinase is present in the nucleus of Neural Progenitors but masked by 
fixation 
 Consistent with its well-documented role in cytokinesis, citron kinase has 
been localized repeatedly by immunocytochemistry to cytokinesis furrows and 
midbody rings of multiple cell types(Di Cunto et al., 1998; Narumiya et al., 1998; 
Naim et al., 2004; Paramasivam et al., 2007; Sweatt, 2013).  Localization to the 
nucleus of neural progenitors has not been reported although nuclear localization 
has been reported for hepatocytes in S/G2 phase and in axotomized DRG 
neurons(Luger et al., 1997; Liu et al., 2003; Ahmed et al., 2011). Consistent with 
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possible nuclear localization, there are two putative nuclear localization signals 
within CitK (aa 104-110 and 191-212; npd.hgu.mrc.ac.uk/user/1NP01026).  We 
hypothesized that the failure for us, and others, to find CitK immunoreactivity in 
the nucleus of central nervous system progenitors may have been due to epitope 
masking by fixation. By comparing three fixation conditions (4% 
paraformaldehyde, 10 minutes; 1% paraformaldehyde, 10 minutes; and cold 
MeOH, 10 minutes) we found prominent nuclear immunoreactivity in 
approximately 25% of cells fixed in either 1% paraformaldehyde or MeOH, but 
absent from nuclei of cells fixed with 4% paraformaldehyde (Figure 2-1A).  This 
nuclear immunoreactivity is specific to CitK as it is absent in NPs from mutants 
lacking CitK protein (Figure 2-1B).  We also found that Myc-epitope tagged CitK 
transfected into mutant NPs was detectable in nuclei with Myc-antibodies (Figure 
2-1C).  Immunohistochemistry of E11 forebrain revealed CitK staining in both 
nuclei (Figure 2-1D, asterisk) and midbodies(Figure 2-1D, black arrows) of neural 
progenitors.  This is consistent with our culture system, where nuclear CitK 
staining co-localizes with the neural progenitor marker nestin (Figure 2-1E), 
which stains >95% of the cells.  Furthermore, in western blots of nuclear and 
cytoplasmic fractions (Figure 2-2A) CitK was detectable in both nuclear and 
cytoplasmic fractions.  Finally, consistent with association with chromatin we 
found that histones H3 and H4 co-immunoprecipitated with CitK (Figure 2-2B).  
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Citron kinase interacts with the Histone methyltransferase G9a in neural 
progenitors 
We performed a tandem mass spectrometry (MS-MS) screen for proteins 
that specifically co-immunoprecipitated with an antibody to citron kinase (Cit295-
Ab). We determined specificity of immunoprecipitated proteins detected in 
Coomassie stained gels by showing that they were not present in 
immunoprecipitated protein from citron kinase mutant cells (Figure 2-3A).  We 
subjected pooled gel slices from gels (Figure 2-3A) to tryptic digest and MS-MS 
peptide identification. A total of 43 nuclear proteins were identified (Table 2-1) 
with MASCOT positive identification scores greater than 100 (p<0.05) from a total 
of 648 proteins. The 43 nuclear proteins fell into gene ontologies related to 
protein modification and transcriptional control and included: acetylases, DNA- 
and RNA- binding proteins, chromatin modifiers and transcription factors. For this 
study, we focus on Ehmt2(G9a) as it co-immunoprecipitated in the screen and is 
responsible for all euchromatic gene repression related to dimethylation of 
histone 3 at lysine 9 (H3K9me2).  In Drosophila, mutant alleles of citron kinase 
genetically interact with Argonaut 1, and have context dependent Su(var) and 
E(var) activity which is responsible for H3K9 dimethylation (Sweeney et al., 2008) 
analogous to G9a’s activity in mammals.  In order to validate the interaction of 
G9a with CitK we performed co-immunoprecipitations in both directions, and 
found that G9a co-immunoprecipitated with CitK antibodies, and CitK co-
immunoprecipitated with G9a antibodies (Figure 2-3B). H3K9me2, the 
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posttranslationally modified histone product of G9a methylation, also co-
immunoprecipitated with CitK antibodies in wild-type neural progenitors, but not 
in NPs lacking CitK (Figure 2-3B). Thus, CitK is present in a complex that 
includes both G9a and its methylation product  H3K9me2.  
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Figure 2-1: Citron kinase is present in the nucleus of neural progenitors 
but is masked by fixation. A) 4% paraformaldehyde (PFA) masks nuclear CitK 
expression (top panel). Methanol and 1% PFA fixed rat neural progenitors 
isolated from forebrain of wild-type Citwt/wt and citron kinase null mutant Citfh/fh 
rats on embryonic day 11 (E11).  Immunofluorescent images show citron kinase 
present in the cytoplasm and nucleus of some (24 +/- 7%; n=946), but not all 
cells.  Nuclear and midbody CitK is present in astrocytomas using methanol 
fixative (bottom panel) Scale bar = 30um.  B) Antibody staining is specific as 
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indicated by absence of signal in the mutant cells (bottom panel).  Nuclei were 
labeled by DAPI (purple). C) Exogenous citron kinase transfected in mutant 
neural progenitor cells is also present in the nucleus. Antibody staining for the 
Myc tag on the protein is specific indicated by the absence of signal in the mock 
transfection (bottom panel).  D) CitK immunostaining in E11 forebrain.  Arrows 
indicate the presence of CitK in midbodies and asterisks indicate nuclear staining 
in neural progenitors.  E)  Nuclear CitK (green) is present in neural progenitors 
cells that express the marker nestin (red).  The cells in this culture system are 
predominantly nestin positive indicating a relatively pure population of neural 
progenitor cells. 
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Figure 2-2: Citron kinase is present in nuclear and cytoplasmic protein 
lysates and interacts with chromatin proteins. A) Nuclear and cytoplasmic 
fractions of neural progenitors were run on SDS/PAGE gel.  Antibodies specific 
for CitK, nuclear marker histone H3 and cytoplasmic marker nestin demonstrate 
CitK’s presence in the nuclear and cytoplasmic fractions.  Relative purity of the 
preparations is indicated by the lack of signal of H3 in the cytoplasmic fraction 
and lack of nestin in the nuclear fraction.  B) Nuclear lysates immunoprecipitated 
for CitK showed interaction with histone proteins H3 and H4.  Co-
immunoprecipitation for H3 and H4 is absent from nuclear lysates 
immunoprecipitated from mutant neural progenitors. 
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Figure 2-3: Citron kinase interacts with histone methyltransferase G9a in 
neural progenitors. A) Representative coomassie gel of proteins 
immunoprecipitated with nuclear citron kinase B) Nuclear preparation of neural 
progenitor cells from both wild-type and mutant were immunoprecipitated for CitK 
and G9a.  G9a co-immunoprecipitates with citron kinase and citron kinase co-
immunoprecipitates with G9a in neural progenitors. In the bottom panel, nuclear 
citron kinase also pulls down H3K9me2.  Absence of co-immunoprecipitation  in 
IgG and mutant neural progenitors lacking citron kinase and immunoprecipitated 
with CitK antibody demonstrates specificity of the interaction. 
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Table 2-1: CitK Interacting Proteins Identified by MS-MS 
ID (GI) Protein Name Mascot Score OMIM Function 
12247526 APEX 7.90E-04 DNA repair enzyme 
62079221 
cleavage and 
polyadenylation specificity 
factor subunit 7 
5.60E-07 pre-mRNA 3-prime end processing 
81295381 
DEAD (Asp-Glu-Ala-Asp) 
box polypeptide 17, isoform 
CRA_a 
1.70E-34 ATP-dependent RNA helicase 
19173790 H/ACA ribonucleoprotein complex subunit 4 8.60E-04 modify residues of rRNA 
47059112 euchromatic histone-lysine N-methyltransferase 2 6.40E-02 histone methyltransferase 
83320094 far upstream element-binding protein 1 1.60E-10 proto-oncogene 
78214356 general transcription factor II-I 3.80E-03 
negatively regulates 
calcium entry 
9588100 heterogeneous nuclear rib nucleoprotein D-like 5.10E-03 
bind to pre-mRNA  in 
splicing and nuclear export 
16758150 interleukin enhancer-binding factor 3 7.50E-12 mRNA elongation 
8393610 importin subunit beta-1 1.30E-11 nuclear pore regulation 
18426824 KH domain-containing, RNA-binding 1.00E-06 
signal transduction 
activator of RNA 
19424312 far upstream element-binding protein 2 4.50E-16 
pre-mRNA splicing and 
localization 
61889073 matrin-3 3.40E-17 binds DNA and RNA 
71153827 Myb-binding protein 1A 1.10E-12 protooncogenic protein 
66730309 H/ACA ribonucleoprotein complex subunit 1 3.20E-04 snoRNP binding protein 
128844 Nucleolin 7.00E-13 transcriptional control of reran 
7242160 nucleophosmin 3.50E-16 nuclear/cytoplasmic shuttle 
71043686 paraspeckle component 1 7.30E-05 paraspeckle to perinucleor cap blockade 
28461167 PC4 and SFRS1-interacting protein 2.90E-07 RNA splicing factor 
6978455 poly [ADP-ribose] polymerase 1 2.80E-02 
compacts and represses 
chromatin 
19705459 polyadenylate-binding protein 1 2.00E-17 
poly-A shortening and 
translational initiation 
266862 
Polypyrimidine tract-
binding protein 
ribonucleoprotein I 
1.90E-15 pre-mRNA splicing 
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61556754 prohibitin-2 8.40E-20 angiogenesis inhibition 
2564007 proteasome p45/SUG 1.50E-07 degradation of nuclear proteins 
16758226 neurabin-2 1.30E-04 antagonizes G-protein-coupled receptors 
58865358 RNA-binding protein with serine-rich domain 1 1.30E-03 RNA-binding protein 
206734 ribosomal protein L5 2.60E-11 inhibits ubiquitination of ribosomes 
74271863 SAP domain-containing ribonucleoprotein 4.40E-11 ssDNA binding 
52783155 SERPINE1 mRNA-binding protein 1 1.00E-10 
may be involved in mRNA-
binding 
15705986 heterogeneous nuclear ribonucleoprotein B0b 3.50E-38 
telomere repeat-binding 
protein 
16124253 M4 protein 8.90E-71 telomere repeat-binding protein 
8393536 high mobility group protein B2 3.90E-11 
non-histone chromatin 
protein 
59891440 
non-POU domain-
containing octamer-binding 
protein 
1.00E-35 transcriptional blockade 
46396568 Su(var)3-9 enhancer of zeste oncogene 9.50E-13 involved in cell proliferation 
20302113 stress-induced-phosphoprotein 1 4.80E-05 
adapter protein 
coordinating HSP70 
729919 Lupus La protein homolog 1.50E-10 mRNA metabolism 
77404395 
staphylococcal nuclease 
domain-containing protein 
1 
3.30E-03 RISC complex formation 
16615753 tetratricopeptide repeat protein 35 2.70E-07 
involved in mitochondrial 
targeting sequence 
6981660 lamina-associated polypeptide 2, isoform beta 8.40E-13 
binding lamina and 
chromosomes to nuclear 
pore 
12018294 DNA topoisomerase 1 1.90E-07 catalyzing the breaking and rejoining of DNA 
1174742 DNA topoisomerase 2-alpha 9.00E-09 
catalyzing the breaking 
and rejoining of DNA 
17865351 transitional endoplasmic reticulum ATPase 1.20E-21 
organelle biogenesis and 
ubiquitin degradation 
203398 Y box binding protein 1 1.60E-05 transcription factor 
Table 2-1: CitK interacting proteins identified by MS-MS. A list of 44 nuclear 
proteins that co-immunoprecipitated with CitK antibodies.  GI number, Protein 
name, calculated Mascot  Score and OMIM Function. 
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Discussion  
Consistent with its well-documented role in cytokinesis, citron kinase has 
been localized repeatedly by immunocytochemistry to the cytoplasm of mitotic 
cells with strongest immunopositivity in both the cytokinesis furrow and midbody 
ring(Di Cunto et al., 1998; Narumiya et al., 1998; Tachibana et al., 2002; Naim et 
al., 2004; Paramasivam et al., 2007).  Transient nuclear localization of citron 
kinase has been reported in two studies, one examining expression and function 
in hepatocytes, where nuclear citron kinase is cell cycle regulated and apparent 
in the nuclei of hepatocytes in G2 phase (Liu et al., 2003; Mattick et al., 2009), 
and in dorsal root ganglion neurons that transiently express citron kinase in the 
nucleus after axotomy(Ahmed et al., 2011). The demonstrated presence of citron 
kinase in the nucleus of some cell types, and the presence of two potential 
nuclear localization sequences (aa 104-110 and 191-212; 
npd.hgu.mrc.ac.uk/user/1NP01026), made us question whether citron kinase was 
present in the nucleus of neural progenitors, and perhaps missed by us and 
others because of epitope masking due to fixation.   
In order to systematically look for citron kinase in the nucleus of neural 
progenitors we established primary neural progenitor (NP) cell cultures from rat 
forebrains at E11 from both wild-type (Citwt/wt), and flathead mutant (Citfh/fh) rat 
embryos. Citfh/fh NPs lack expression of citron kinase because of a spontaneous 
mutation that creates a premature stop codon at the 27th codon of the Cit gene 
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(Sarkisian et al., 2002).  Cells isolated from this early stage in wild-type and 
mutants can be cultured over several passages and frozen down or transfected. 
We found that citron kinase protein is nuclear in ~20% of wild-type neural 
progenitor cells identified by nestin staining.  Nuclear CitK appears in the nuclei 
of E11 forebrain ventricular zone as well (Figure 2-1D).  Interestingly, nuclear 
CitK does not appear to be present at the ventricular wall, where clearly visible 
CitK positive midbodies are present.  This lack of nuclear CitK in regions of 
robust midbody CitK suggests differential roles stemming from the 
compartmentalization of CitK and in later cell divisions.   
As demonstrated by Figure 2-1, light fixation holds the key to revealing 
nuclear CitK.  This is likely due to the tight packaging of proteins and DNA within 
the nucleus, that likely block the necessary epitopes. High concentration fixatives 
would likely cause these abundant proteins  and DNA to bind even more tightly to 
one another and mask the epitope. 
Our tandem mass spectrometry screen (MS-MS) revealed numerous 
nuclear proteins that either bind to or complex with CitK.  In this study we focused 
on CitK interaction with EHMT2(G9a) for several reasons. First, in Drosophila, 
mutation in the CitK homologue sticky alters H3K9 methylation and genetically 
interacts with the methyltransferase Su(var) (Sweeney et al., 2008). Second, the 
histone methyltransferase partner of G9a, EHMT1(GLP), was also identified  in 
our MS-MS screen, though it fell just below our MASCOT cut-off score. Third, 
G9a is responsible for all dimethylation of histone 3 at lysine 9 (H3K9me2) in 
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euchromatic genes in mammalian cells (Tachibana et al., 2002; Fukuda and 
Taga, 2005) and its role in neurogenesis in largely unknown.    
In order to confirm the association of citron kinase with G9a we performed 
reciprocal co-immunoprecipitations and western blot analysis for endogenous 
citron kinase and G9a (Figure 2-3B).  As shown in Figure 2-3B, G9a antibodies 
co-precipitated citron kinase, and similarly citron kinase antibodies co-
precipitated G9a in wild-type NPs.  
The potential association of citron kinase with multiple nuclear proteins 
and G9a lead us to test for co-immunoprecipitation with other chromatin proteins 
including di-methylated histone H3, H3K9me2.  As shown in Figure 2-2B, Histone 
3 and Histone 4 co-immunoprecipitated with citron kinase antibodies in wild-type 
NPs, but failed to immunoprecipitate from mutant NPs. Since G9a catalyzes di-
methylation of lysine 9 on histone 3 (H3K9me2), we also tested for co-
immunoprecipitation of H3K9me2 with citron kinase antibodies, and found that 
H3K9me2 co-immunoprecipitated with citron kinase antibodies in wild-type but 
not in mutant NPs (Figure 2-3B).   
Of note to this dissertation, a recent project in the lab (published in 
Girgenti et. al. 2014) demonstrated that deletion of G9a reduces cortical growth.  
The neocortices of G9aloxp/loxp / Emx1-Cre mice were significantly reduced in 
thickness relative to G9aloxp/wt / Emx1-Cre littermates. Although reduced in 
thickness, we did not observe a difference in the relative position of laminar 
markers, TBR1, Satb2, CTIP2 or Cux1.  Similarly, CitK mutants also show no 
	   33 
signs of laminar disruption in spite of severe cortical thinning. The reduced 
cortical thickness in G9a mutants was apparent in prenatal and postnatal brains 
examined at P21, E19, and E14. Quantification of G9a loxp/loxp / Emx1-Cre and 
G9a loxp/loxp / Emx1-Cre cortical thickness at P2  indicated a significant reduction 
in radial thickness in somatosensory barrel region of cortex by approximately 
20% (601 + 17 µm vs. 497 + 19 µm: two tailed t test p=0.00175).  A similar 
reduction in cortical thickness was evident as early as E14. We did not observe, 
similar to what is found in cortex of CitK mutant embryos and postnatal pups, the 
massive increase in apoptotic condensed nuclei, or appearance of nucleated 
neurons.  This is consistent with G9a, unlike CitK, not having a role in both 
cytokinesis and epigenetic gene regulation.  The results of the conditional 
knockout of G9a are also consistent with a hypothesis that CitK could regulate 
neurogenesis through two paths, one involving cytokinesis and another through 
gene expression changes. 
In sum, the results of chapter two indicate that citron kinase is a nuclear 
kinase in neural progenitors. Nuclear expression of CitK is masked by high 
concentration fixative and is present in approximately 20% of nestin positive 
neural progenitors.  CitK associates with the chromatin of neural progenitors and 
interacts with the H3K9 methyltransferase G9a.   
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CHAPTER 3 
 
CHROMATIN-ASSOCIATED CITRON KINASE REGULATES GENE 
EXPRESSION IN RAT NEURAL PROGENITOR CELLS 
 
 
Abstract 
 
 Recent studies have demonstrated that signaling kinases have a 
surprisingly active role in the nucleus, where they tether to chromatin and 
modulate gene expression programs. The nuclear mechanisms of how signaling 
kinases control transcription of mammalian genes remains elusive.  Here, we 
provide evidence for a hitherto unknown function of citron kinase, which 
physically associates with the chromatin of genes involved in neural 
development.  Chromatin-anchored CitK forms a repressive complex with the 
histone methyltransferase G9a.  ChIP-seq reveals CitK predominantly binds 
proximal to transcription start sites of transcribed genes and that loss of CitK 
results in transcriptional changes of thousands of genes.  A CitK-G9a complex 
forms on promoters during S-phase, setting up H3K9 methylation, which is 
carried through the rest of the cell cycle.   Reintroduction of CitK into mutant 
neural progenitors rescues levels of H3K9 methylation levels.  Remarkably, this 
rescue is dependent on the presence of only the coiled-coil domain of CitK.  Our 
results provide a molecular explanation for the presence of CitK in the nucleus of 
neural progenitor cells and provides evidence of its critical role in 
neurodevelopmental gene expression. 
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Introduction 
Covalent modification of both histones and DNA contribute to the 
specification and maintenance of epigenetic states required for cell identity and 
cell type specific transcription(Seki et al., 2007; Carroll and Schaefer, 2012). 
Repressive modifications are thought to stabilize cell type specific gene 
expression patterns, reducing the likelihood of reactivation of lineage-unrelated 
genes. One important posttranslational modification that regulates transcriptional 
states, genome integrity and cellular identity is histone lysine methylation(Fan 
and Hutnick, 2005; Kouzarides, 2007). H3K9 methylation is involved in both gene 
repression and heterochromatin formation. H3K9 can be mono-, di-, or trim 
ethylated, with each degree of modification associated with different biological 
responses(Bird, 2002; Schuettengruber et al., 2007; Schwartz and Pirrotta, 
2007). In mammals, heterochromatic regions are highly trimethylated on 
H3K9(Kouzarides, 2007; Ausió et al., 2014), whereas silent euchromatin regions 
are enriched for mono- and dimethylated H3K9(Tachibana et al., 2005; 
Kouzarides, 2007; Bannister and Kouzarides, 2011).  H3K9 methylation has 
been linked to de novo gene silencing and DNA methylation, and it can be 
inherited after mitosis in a manner coupled to DNA methylation(Santos-Rosa et 
al., 2002; Epsztejn-Litman et al., 2008).  
It is likely that normal neurogenesis requires coordination of cell cycle and 
epigenetic regulation of gene expression. It remains unknown how these 
processes are coordinated and whether signaling proteins such as kinases linked 
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to cell cycle progression directly regulate chromatin states in neural progenitors.  
Intracellular signaling involves a complex cascade of phosphorylation events to 
enable cells to proliferate and differentiate.  Kinases play a crucial role in these 
pathways and often transiently associate with binding partners or phosphorylate 
target substrates.  This physical association with proteins in the nucleus would 
provide the exquisite control necessary to initiate specific transcriptional 
programs.  Studies in yeast have shown that signal transduction kinases 
translocate to the nucleus and stably associate with the promoter and transcribed 
regions of genes to regulate gene expression(Tachibana et al., 2002; 
PASCUALAHUIR et al., 2006; Pokholok, 2006). 
Chromatin-tethered kinases have been shown to have both a structural 
role as part of transcription complexes, as well as an enzymatic role by 
phosphorylating their targets.  For example PKC-θ, is a component of an 
activating transcriptional complex in human T-cells.  PKC-θ physically associates 
with RNA-polymerase II and localizes to regulator regions of a distinct cluster of 
microRNAs and negatively regulates their transcription(Barski et al., 2007; 
Sutcliffe et al., 2011).   Other members of the PKC family have been shown to 
interact with nuclear proteins such DNA topoisomerase I, lamin B, myogenin, 
nucleophilin, p53 and the vitamin D3 receptor(Martelli et al., 1999; Wen et al., 
2009). 
In this chapter, we performed a differential mRNA expression screen 
comparing citron kinase deficient to wild-type embryonic forebrain by high 
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throughput sequencing to identify genes repressed by citron kinase.  Using 
chromatin immunoprecipitation (ChIP) with massively parallel sequencing (ChIP-
seq) we mapped the genomic binding sites of citron kinase and found that citron 
kinase deficient NPs were lacking H3K9me2 marks near their transcription start 
sites. ChIP experiments further indicated that citron kinase and G9a co-localize 
to the same positions near transcription starts of target genes in S-phase of the 
cell cycle.   
 
Materials and Methods 
Chromatin Immunoprecipitation followed by massively parallel sequencing 
For three wild-type and one mutant NP culture, anti-CitK ChIP was performed 
using DNA from sonicated, digested nuclei. Immunoprecipitated DNA and input 
DNA  was processed for deep sequencing by ligating the Genomic Adaptor Oligo 
Mix (Illumina) to purified fragments.  A small amount of ChIP DNA and Input were 
reserved to confirm pull down of CitK.  This DNA was processed in the same 
manner as described below for individual ChIP-PCRs.  After PCR amplification, 
ligated fragments around 250 bp were gel purified, and CitK ChIP libraries were 
deep sequenced by an Illumina Genome Analyzer (GA II).  Genomic regions 
containing a significantly larger number of reads above input background, peaks, 
were detected with MACs software (Zhang et al 2008).  Mappable tags were 
annotated using the Homer software package.  To determine significance only 
peaks that were detectable in all three wild-type samples above input were 
	   38 
analyzed.  The peaks were uploaded to the University of California Santa Cruz 
(UCSC) genome browser for visual inspection.   
RNA-sequencing 
Forebrains (n=3) of E13 rat embryos were harvested from pregnant 
CitKwt/fh dams that have been timed mated with CitKwt/fh males. All forebrains 
were immediately frozen in liquid nitrogen and stored -80C before RNA 
extraction. Approximately 200mg of forebrain tissue from both a wild-type 
(CitKwt/wt) and mutant (CitKfh/fh) were subjected to RNA extraction by TRIzol © , 
yielding 19-23ug of total RNA. The samples were subsequently treated with 
DNase I (Invitrogen) and 8mg of RNA was sent to the Yale School of Medicine 
Center for Genomic Analysis for mRNA purification and cDNA library construction 
for sequencing using the Illumina/Solexa technology (Illumina Genome Analyzer 
1).  Each individual n generated ~ 40 million reads.  For each genotype, gene 
expression levels achieved a high correlation coefficient (R2=0.94 in wild-type 
and R2=0.882 in mutant). The Illumina pipeline used was the Gerald system to 
map all 32-bp length reads to specific chromosomal locations. The rat genome 
sequence assembly (Rn4) was downloaded from UCSC genome informatics 
portal (http://genome.ucsc.edu/) All reads (over 36 million) from FASTQ files 
were mapped to their unique chromosomal locations and tallied for each 
condition (wild-type and mutant) by scripts developed by our group.  All 
subsequent analyses used uniquely mapped reads and all multi-reads were 
eliminated. Total reads for each gene were normalized by dividing them by the 
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total number of reads in each run. Fold Regulation was calculated by dividing the 
normalized number of reads in wild-type by the normalized number of reads in 
mutant.  Fold Regulation was then plotted against the normalized wild-type read 
number for that gene. Genes were considered up regulated if their fold regulation 
was 1.5 or higher.  Transcripts were considered down regulated if their fold 
regulation was -1.5 or lower. 
Bioinformatics and Gene Ontology Analysis 
For genes identified in the ChIP-seq and RNA-seq screens, we used the DAVID 
Bioinformatics Resource.  We used transcripts that were found to be significantly 
up and down regulated in the RNA-seq (approximately 5000 transcripts).  For GO 
analysis of the CitK ChIP-seq peaks, we used the nearest promoter ID to the 
peak.  Both the RNA-seq and ChIP-seq GO analyses used the rat genome (rn5) 
as background. We used GO:biological processes and GO:molecular processes 
to define enrichments.  Some categories were combined as the gene lists and 
ontologies were too similar to report separately. 
Real-time reverse transcriptase PCR 
For secondary validation of RNA-sequencing results, 1ug of total mRNA 
from Rat forebrain and neural progenitor cell culture was reverse-transcribed to 
make cDNA using oligo-dT primers and reverse transcriptase (Transcritor, 
Roche). RNA was then hydrolyzed, cDNA precipitated and resuspended in 
nuclease free water. Gene specific primers (sequences listed in APPENDIX C) 
were designed and tested for efficiency and specificity by serial dilutions and melt 
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curve analysis. Sybr Green mix (ABI, Life Technologies) was used to amplify 
cDNA. Gapdh was used as an internal normalization control. 
Chromatin Immunoprecipitation 
Chromatin was isolated from 1X106 cultured neural progenitor cells of both 
wild-type and mutant genotypes (n=4-7). Chromatin was sheared by sonication 
into 200 to 500bp fragments using a S220 Focused-Ultrasonicator from Covaris. 
The resulting samples were immunoprecipitated with 5ug of rabbit anti-Cit 
antibody (CT295), 6ug of rabbit anti- KMT1C(G9a) (Abcam Cat# ab31874 
RRID:AB_1269265), 5ug of mouse anti-histone H3 dimethyl K9 (Abcam Cat# 
ab1220 RRID:AB_449854), or 5ug of normal rabbit immunoglobulin G (IgG) 
(Sigma-Aldrich, I8140) for mock IP. A 1% input sample was set aside and 
processed after immunoprecipitation with the other samples.  All ChIP assays 
were performed using the Magna ChIP ™ A chromatin Immunoprecipitation Kit 
(Millipore, Cat No. 17-610).  Promoter tiling primers were designed to target 
sequences identified as enriched for CitK (for sequences see APPENDIX C).  
Quantitative real-time PCR was performed in all conditions and Ct values were 
used for downstream analysis.  To calculate percent of input, all input Ct values 
were adjusted to 100% by subtracting 6.644 cycles.  Average Ct values were 
calculated for all samples (n=6).  Percent input was calculated as 
100*2^(Adjusted input Ct- Ct (IP). For each primer position, mock-IP IgG Ct 
values were obtained to confirm specificity of our pull-down.  In all cases, the 
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mock IP resulted in Ct values greater than 38 with most not amplifying at all, 
adding confidence to our CitK, H3K9me2 and G9a ChIP experiments. 
Neural Progenitor FAC Sorting and Chromatin Immunoprecipitation 
Neural progenitor cultures from both mutant and wild-type genotypes were 
allowed to grow until there were approximately 100,000 cells.  Cells were 
trypsinized and resuspended in PBS for FACs analysis.  Cells were stained for 
DNA content with Propidium Iodide.  Cells for immunoprecipitation, were FAC 
sorted by DNA content directly into a tube of PBS before fixation with 1% 
formaldehyde.  Chromatin immunoprecipitation was then conducted as previously 
above.  Concurrently, cells for each genotype could be counted by cell cycle 
phase and ploidy to determine any cell cycle defects. 
Neural Progenitor Transfection and Chromatin Immunoprecipitation 
 Mutant neural progenitor cells were grown to 50% confluence before 
transfection of truncated CitK constructs.  The constructs used in these 
experiments were a full length CitK (CitK-FL); a C-terminal truncation of citron 
kinase missing the Rho-binding domain (CitK-D1.2); the same C-terminal 
truncation with a single alanine substitution in the catalytic domain sufficient to 
eliminate kinase activity (CitK-KD); a construct containing only the Coiled-coil 
domain (CitK-CC); a construct of the coiled-coil domain missing the HR1 site 
(CitK-CC/ DHR1) and 2 constructs of the HR1 domain and Rho-interacting 
domain (CitK-HR1 and CitK-RID, respectively).  All constructs include a 5’ myc-
tag sequence that served as the epitope during chromatin immunoprecipitation.   
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Cells were transfected using lipofectamine.  36 hours after transfection the cells 
were scraped and fixed in  1% formaldehyde before sonication of the DNA into 
200-500bp fragments.  Immunoprecipitation was performed using 4ug of goat 
ant-Myc tag antibody (Abcam Cat# ab9106).  This followed by quantitative real-
time PCR to measure Ct values and measure immunoprecipitation. 
G9a inhibition and Chromatin immunoprecipitation 
Mutant and wild-type neural progenitors were allowed to grow to 60% 
confluence before transfection with CitK truncation constructs.  Twenty four hours 
after transfection the G9a inhibitors Bix01294 trihydrocholride hydrate (10mM; 
Sigma, B9311) or UNC0638 hydrate (20mM; Sigma, U4885) were added to fresh 
media. DMSO was used as control in wild-type and rescued mutant neural 
progenitors.  Cells were allowed to grow in media for 24 hours after exposure to 
the G9a inhibitors. Following G9a inhibition RNA was isolated using Trizol 
(Invitrogen) and cDNA was synthesized using Superscript III kit (Invitrogen).  
Citron kinase regulated mRNAs were then analyzed using qRT-PCR to detect 
changes transcript expression.  In tandem, separately treated  cultures were 
processed for chromatin immunoprecipitation.  Cells were scraped and fixed in 
1% formaldehyde and sonicated to 200-500bp fragments before 
immunoprecipitation of H3K9me2 protein (5ug of mouse anti-histone H3 dimethyl 
K9 (Abcam Cat# ab1220) and DNA isolation. 
 
Results 
 
Identification of CitK genomic binding sites by ChIP-seq  
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 In order to identify target genomic regions where CitK binds, we mapped 
the genome-wide association of CitK-chromatin interactions using chromatin 
immunoprecipitation and massively parallel sequencing (ChIP-seq). Neural 
progenitor chromatin was sonicated 1, 3, 5 or 8 pulses to determine the optimal  
number necessary to generate DNA fragments of 200-500bp (Figure 3-1A).  We 
reserved ChIP and Input DNA to verify that CitK ChIP was possible.  Using tiling 
promoter primers of genes known to be regulated by loss of CitK we used qRT-
PCR to measure the levels of CitK protein bound to the promoters of Brn2, H2az, 
an Cdkn1a.  CitK protein levels appeared to peak at either -800bp or +200bp 
from the transcription start site (TSS) within these promoters (Fig 3-1B)(RM 
ANOVA, genotype effect F=5.05, P<0.017, Bonferroni corrected post hoc test.  
All Ps<0.05) .  Satisfied with CitK’s ability to be chromatin immunoprecipitated, 
we proceeded with high-throughput sequencing. We obtained positive evidence 
using conservative measures for peak detection for 794 loci significantly enriched 
above input by CitK antibodies. CitK bound loci were broadly distributed within 
50Kb of and centered on transcription start sites (TSS) of 384 genes, with 79% of 
the identified loci within 20Kb of a TSS (Figure 3-2A). The genomic loci included 
6 exon coding regions, 3 un-translated regions, 99 introns, 11 promoter regions, 
and 672 intergenic regions. This CitK-associated gene set, was subjected to 
DAVID GO analysis (Figure 3-2B). The top five biological processes or molecular 
functions identified in the DAVID analysis were for genes in the biological 
processing gene ontologies of neuron differentiation (GO:0030182), neuron 
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development (GO:004866), dendrite development (GO:0016358), and forebrain 
development (GO:0030900).  Many of the genes were in more than one category 
and the entire set of neurodevelopmental genes from GO are shown in Table 3-1.  
The molecular function category that was significantly enriched in the CitK ChIP 
gene set was calcium ion binding and the genes identified in that group are also 
listed in Table 3-1.  Thus, the ChIP-seq experiments revealed that CitK is 
localized near a subset of genes in the genome overrepresented by genes 
involved in neurogenesis and calcium binding processes. 
 
Citron kinase regulates expression of thousands of genes 
 In order to identify gene targets for which CitK regulates expression, 
directly or indirectly, we performed a differential expression screen of mRNA by 
massively parallel sequencing (RNA-seq).  For this screen we compared RNA 
isolated from three E13 CitKwt/wt rat forebrains to RNA isolated from three CitKfh/fh  
forebrains of the same age.  At this age, CitK is expressed in NPs at the 
ventricular zone surface(Sarkisian et al., 2002; Gupta et al., 2010), but there is no 
detectable morphological phenotype in mutant embryos yet.  The RNA-seq 
analysis (Figure 3-3B) indicated expression of 20,298 transcripts in 140 million 
sequences reads in wild-type and mutant cortex. There was excellent transcript 
number overlap within both the wild-type (R2=0.914) and in the mutant 
(R2=0.882) (Figure3-3A) We used averages and standard deviations of total 
normalized reads for each of three technical replicates to determine cut-offs for 
up-regulated and down regulated transcripts, and then used quantitative real-time 
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PCR with Ns of 6 biological replicates to compare 54 up- and 16 down- regulated 
transcripts to validate the results. The Pearson correlation coefficient between 
the fold change in expression in these 70 transcripts between mutant and wild-
type samples as measured in the Raze and in qRT-PCR assays was R2=0.99.  
We compared the fold expression changes in these transcripts in cultured wild-
type and mutant NPs compared to RNA from E13 forebrains of mutant embryos, 
and found a similar agreement in the fold expression change between cultured 
NPs and brain of wild-type and mutant genotypes (R2=0.96) (Figure 3-3E).  
Based on the agreement in fold regulation measured by qRT-PCR and RNA-seq, 
we estimate that 3,370 transcripts are significantly up regulated following loss of 
citron kinase while 1,140 are down-regulated. A gene ontology analysis of all 
regulated genes following loss of CitK indicated that the regulated genes were 
significantly enriched for several GO biological process categories including cell 
cycle control (GO: 0000074), cell proliferation (GO: 0008283), neuronal activity 
(GO: 0048666 ) protein phosphorylation (GO:0006468), chromatin remodeling 
(GO: 0006338), and mitosis (GO:0045840), and molecular functions including 
developmental processes (GO: 0048589), transcription factor (GO:0001134), and 
histone (GO: 0042393) (Figure 3-3D). We also determined the relationship 
between CitK binding positions determined in ChIP-Seq experiments with 
changes in gene expression determined in RNA-seq. A total of 316 of the genes 
containing a CitK binding site within 50Kb were expressed in wild-type and 
mutant embryonic cortex.  A plot of the fold change in expression of these genes 
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relative to the binding position of CitK is shown in Figure 3-C. The most up 
regulated genes that were also present in the ChIP-seq gene set were found to 
have CitK enriched peaks near the TSS (Figure 3-3C), however, not all genes 
with CitK peaks near their TSS were found to be regulated, indicating additional 
co-repressor functions that may supersede CitK function at some loci.  
 
Citron kinase is required for G9a action but not localization to target genes 
Our finding that CitK and G9a interact, and that loss of CitK results 
primarily in derepression, is consistent with a model whereby CitK interaction 
with G9a is required for either G9a to target genomic loci and/or for activating it 
and establishing repression through the addition of H3K9me2 marks. Given that 
G9a is involved in repression of gene expression, we next determined whether 
G9a enrichment at genomic locations would depend upon CitK and whether 
genes repressed by RNA-seq had CitK bound. To asses our ability to ChIP for 
G9a and its target H3K9me2, we designed tiling promoter primers to a known 
G9a bound promoter region in the Ppar gene (RM ANOVA, genotype effect, 
F=65.43, P<0.05), a known H3K9me2 promoter region in the Mage1a gene (RM 
ANOVA, genotype effect, F=53.2, P<0.05), and we used the transcriptionally 
active gene Fezf as a negative control for both G9a (RM ANOVA, genotype 
effect, F=0.24, P<0.45) and H3K9me2 ChIP (RM ANOVA, genotype effect, 
F=.34, P<0.5) (Figure 3-3A, 3-4A).  In all 9 assessed target regions bound by 
CitK and G9a (Figure 3-6A, 3-5B), G9a was found to be bound in both wild-type 
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and mutant neural progenitors.  In fact as a percentage of input G9a at several 
locations was found to increase in CitK mutant progenitors relative to G9a 
progenitors (Figure 3-6C). Because G9a occupancy at these loci was not 
decreased by CitK mutation it appears that CitK is not necessary for G9a to 
occupy or be loaded onto those positions.  To determine whether G9a activity 
was altered at these same 9 loci, we performed ChIP for H3K9me2, the histone 
methylated product of G9a. H3K9me2 did not enrich for the 9 genomic regions in 
CitK mutant NPs (Figure 3-6B).  Thus, although CitK is not necessary for the 
localization and loading of G9a to genomic locations, it is required for G9a to 
establish H3K9me2 marks at these locations.  We next determined whether the 9 
locations co-associated by CitK and G9a were also associated with changes in 
the expression of the nearest gene.  In 4 of 5 genes in which CitK was close to 
the TSS (Cdkn1a, H2az, RBM22, and Pou3f2) loss of CitK resulted in up 
regulation of expression.  In contrast, CamKII, in which CitK was near the TSS  
there was no change in expression (Figure 3-6D), although loss of CitK did result 
in loss of H3K9me2 marks near the TSS of CamKII (Figure 3-6B).  At CitK bound 
loci associated more distally from the TSS (-39Kb_Cdh19, -281_Pard3, -
7Kb_Mcc and 41Kb_VOm2r7), CitK loss resulted in no change in expression, but 
did show a decrease in H3K9me2 at these positions.  Thus, at all genomic 
positions we tested and found both CitK and G9a, we found that CitK loss was 
associated with H3K9me2 loss, but this was not sufficient to result in a change in 
gene expression in all cases. 
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Citron kinase and G9a co-localize to target genomic loci in S-phase 
 To determine whether and when G9a and CitK occupy similar genomic 
regions through the cell cycle, we performed ChIP qRT-PCR for G9a at CitK loci 
in unsorted (Figure 3-7A) and FACs sorted cells. Because we found that nuclear 
immunoreactivity for CitK was evident in 24+/-7% (Figure 2-1A) of nuclei we 
hypothesized that this may represent the S-phase fraction of cells. To test this we 
delivered a 1hour pulse of EdU to cultured NPs to label S-phase cells, fixed 
cultures by methanol, and double labeled for citron kinase and EdU.  As shown in 
Figure 3-7B EdU positive NPs were also positive for citron kinase.  In fact, 93+/-
6% of EdU positive cells were also positive for nuclear citron kinase, and similarly 
76+/-8% of CitK positive nuclei were also EdU positive.  This indicates that CitK 
localizes to the nuclei of NPs in S-phase that likely extends into G2 phase.  The 
pattern of localization also suggested that citron kinase localization to the nucleus 
is dynamic through the cell cycle. To test this possibility we sorted by FACS, NPs 
into G1 and S-phase populations and then performed ChIP experiments on these 
sorted cell populations.  The pattern of H3K9me2, CitK, and G9a enrichment at 
the genes assessed is shown in Figure 3-7C. All eight target loci showed 
enrichment for H3K9me2, CitK, and G9a in the S-phase sorted population; 
however, in G1 cells the H3K9me2 enrichment peak was present but CitK and 
G9a peaks were absent. This suggests a dynamic pattern of CitK and G9a 
association at target genes through the cell cycle, consistent with the localization 
of citron kinase to the nucleus in S-phase. CitK and G9a likely associate with 
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chromatin in S-phase and then dissociate during G1, but the H3K9me2 mark is 
maintained.  This pattern suggests that the CitK/G9a complex may be involved in 
establishing epigenetic repression of a set of genes in each S-phase of the cell 
cycle. 
 
Citron kinase function requires interaction with G9a 
 In order to determine both the domain of CitK that is sufficient for gene 
expression rescue and the domain of citron kinase required for repression of 
target genes, we performed rescue experiments using truncation constructs of 
CitK and two different blockers of G9a methyltransferase (Bix01294 and 
UNC0638).  For these experiments, we transfected mutant neural progenitors 
with one of several different CitK constructs represented in Figure 3-8A. (full 
length citron kinase, CitK-FL; a C-terminal truncation of citron kinase missing the 
Rho binding domains among others, CitKΔ1.2; the same C-terminal truncation 
with a single alanine substitution in the catalytic domain sufficient to eliminate 
kinase activity, CitK−KD; a construct containing only the Coiled-coil domain (CitK-
CC); a construct of the coiled-coil domain missing the HR1 site (CitK-CC/ΔHR1); 
and 2 constructs of the HR1 domain and the Rho-interacting domain (CitK-HR1 
and CitK-RID, respectively).  Neural progenitors of both genotypes were 
transfected by lipofectamine (we achieve 50-70% transfection rates for these 
cells) and three days after transfection eighteen target genes and four intergenic 
loci were assessed for H3K9me2 enrichment peaks by ChIP.  We also measured 
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the gene expression levels of the eighteen genes. We found that both the 
H3K9me2 enrichment peaks (Figure 3-8B) and the gene expression levels 
(Figure 3-8C) of all 18 targets were restored to wild-type progenitor levels by 
transfection of either the full length citron kinase construct, the C-terminal 
construct (CitK-1.2), the coiled-coil construct (CC) and the coiled-coil construct 
lacking HR1 (CC/ΔHR1) (Figure 3-8B).  In fact, we found no consistent 
differences in any of the eighteen genes among these four constructs in gene 
expression or H3K9me2 enrichment.  In contrast, the CitK-HR1 and CitK-RID 
failed to restore gene repression or the H3K9me2 enrichment peak (Figure 3-
8B,C). This result indicates that the coiled-coil domain is sufficient for CitK to 
interact with DNA and promote H3K9 dimethylation at that position.  
 In addition to transfection of these constructs into mutant (Citfh/fh) 
progenitors we also tested all three citron kinase constructs in wild-type (Citwt/wt) 
progenitors. We did this both to test whether any of the constructs could act as a 
dominant negative and whether endogenous citron kinase expression levels were 
limiting for repression at target genes.  We found, that expression levels of 10 of 
10 target genes that we tested were unaffected in wild-type NPs by expression of 
any of the three CitK constructs (Data not shown).  This indicates that 
endogenous expression levels of CitK do not limit repression of these 10 target 
genes.  
Because of G9a’s importance in di-methylation of H3K9, we hypothesized 
that inhibition of G9a would block rescue of H3K9me2 after ectopic expression of 
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CitK in mutant neural progenitors.  To explore this issue, we performed 
experiments in which we treated wild-type and mutant neural progenitors with the 
G9a inhibitors BIX-01294 (10µM) or UNC 0638 (20µM) then assessed seven 
CitK targets H3K9me2 ChIP and RNA expression by qRT-PCR (Figure 3-9A). 
We confirmed for all seven genes tested (Cdkn1a, Rbm22 and H3afz are shown), 
that H3K9me2 enrichment peaks were absent after 1 day of treatment with G9a 
inhibitors (Fig. 3-9A).   
We next compared the fold change in expression for 15 genes in 
BIX01294 or UNC0638 treated and vehicle treated wild-type and mutant NPs 
(Figure 3-9B). The fifteen CitK targets were all up-regulated in mutant NPs 
relative to wild-type NPs by 3 fold or more. These same target genes were up-
regulated in wild-type NPs by G9a inhibitor treatment to a level similar to that in 
mutant NPs. In addition, BIX01294 and UNC0638 treatment of the mutant neural 
progenitors did not significantly increase the expression of these target genes 
beyond their already elevated levels, and did not elevate expression above wild-
type NPs treated with the inhibitors. This result suggests that there is little, if any, 
additional G9a-mediated functional repression of CitK targets that is independent 
of CitK. The results of the response to G9a inhibition treatment indicate that G9a 
mediated repression is maximally affected by loss of CitK at CitK target genes. 
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Figure 3-1: Citron kinase interacts with neural progenitor DNA. A) Neural 
progenitor nuclear lysate was sonicated 1, 3, 5 and 8X.  Crosslinks were 
reversed and DNA purified prior to resolving by electrophoresis and staining with 
ethidium bromide.  Nuclear lysates were resistant to shearing until 8 pulses were 
used and afterward consistently  sheared into 200 to 500 bp fragments.  B)  Real 
time PCR confirmation of identified CitK targets.  Promoter spanning tiling 
primers were designed to confirm enrichment of CitK.  Plotted values are percent 
of input pulled down at each promoter position.  Percent of input equals 100 
times 2^ the adjusted Ct value (Ct-6.644) of the input minus Ct (IP).  Peaks for 
CitK were observed at -800bp and +200bp of the TSS of the target gene. 
*P<0.05 (CitK vs CitKfh/fh and CitK vs IgG), all data are ± SEM. 
	   53 
 
Figure 3-2: Identification of CitK genomic binding sites by massively 
parallel sequencing. A) Genome-wide profile of CitK-bound peaks relative to 
transcription start site (TSS).  Fold enrichment of each individual peak is plotted 
against distance to the TSS.  B)  Gene ontology enrichment analysis of genes 
that are bound by CitK.  Ontologies were combined into like categories and a cut-
off of 0.001 was used to plot significantly enriched ontologies.  The x-axis plots 
the number of genes in each category. 
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Table 3-1: Genes up regulated in progenitors lacking CitK 
Gene Name RNA-seq Distance to TSS (bp) Nearest Promoter ID OMIM Function 
Rbm22 8.12 6 NM_001025676 pre-mRNA splicing 
H2afz 7.77 3 NM_022674 histone h2a variant  involved in embryonic development 
Cdkn1a 7.24 -16 NM_080782 cell cycle progression regulation 
Nebl 3.74 -1848 NM_001191694 actin binding 
Cdh15 3.54 -2343 NM_207613 neuronal cell adhesion proteins 
Mgmt 3.39 1296 NM_012861 cellular defense against O6-methylguanine in DNA 
Pou3f2 3.33 -33 NM_172085 regulates neural differentiation 
Tmem17 2.90 2159 NM_001010961 transmembrane component of primary cilia 
Gucy1a2 2.90 -90434 NM_023956 negative regulator of guanylyl cyclase activity 
Apbb1ip 2.62 577 NM_001100577 signal transduction from Ras to cytoskeletal remodeling 
P2ry6 2.60 -911 NM_057124 extracellular receptor of UDP 
Cntnap5b 2.42 -35538 NM_001047873 CNS and PNS cell adhesion and intercellular communication 
Cntnap5c 2.42 20134 NM_001047866 CNS and PNS cell adhesion and intercellular communication 
Cox7c 2.25 -60014 NM_001134705 cytochrome c oxidase subunit 
Galnt13 2.24 -5304 NM_199106 T- antigen formation in neurons 
Lmo7 2.23 10059 NM_001001515 Lim-domain transcription factor 
Kcne1 2.15 -1439 NM_012973 assembly of beta subunit voltage-gated K+ channel complex 
Arl6ip1 2.08 4674 NM_198737 protein transport and membrane trafficking 
Cct6b 2.07 -2686 NM_001014228 molecular chaperone 
Trem2 2.06 -470 NM_001106884 chemokine and cytokine regulation 
Slc35f5 2.02 -2220 NM_001105950 solute transporter 
Dnai1 2.01 2201 NM_001024342 part of dynein complex of cilia 
Chpt1 1.99 -1975 NM_001007750 formation and maintenance of vesicular membranes 
Stxbp4 1.97 -149 NM_001107038 vesicle transport 
LOC317165 1.91 422 NM_001047892 involved in apoptosis, transcription and nucleosome assembly 
Nrxn1 1.91 25436 NM_021767 neuronal cell surface and adhesion molecule 
Papa 1.90 8535 NM_001107939 metalloproteinase 
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Lrrtm4 1.88 -34295 NM_001134746 regulates synaptic activity, development and maintained 
Olfm3 1.87 -13182 NM_145777 formation of the nodes of Ranvier 
Rpia 1.86 52275 NM_001108632 carbohydrate metabolism 
S100a11 1.86 -7138 NM_001004095 differentiation and conification of keratinocytes 
Fancl 1.83 27168 NM_001191684 ubiquitin ligase protein 
Adra1b 1.80 -416 NM_016991 G-protein coupled receptor 
Fgf14 1.80 -3823 NM_022223 embryonic cell growth, morphogenesis and proliferation 
Kcnip4 1.75 8798 NM_181365 regulatory subunit of Kv4 type voltage-gated channels 
Nsun7 1.75 -8647 NM_001017452 methyltransferase 
Acvr2a 1.72 -10255 NM_031571 receptor ser/thr kinase regulating SMAD 
Vamp3 1.71 13566 NM_057097 vesicular transport from endosomes to Golgi 
Mrpl17 1.71 3782 NM_133539 ribosome constituent and protein binding 
Sec61g 1.69 32646 NM_001135020 protein translocation to endoplasmic reticulum 
Il1rapl1 1.68 -4847 NM_177935 regulates secretion and presynaptic differentiation 
Gpr149 1.67 75 NM_138891 orphan receptor 
Evc2 1.66 4162 NM_001106012 positive regulator of hedgehog signaling pathway 
Crem 1.65 4405 NM_001271248 transcriptional regulator of camp 
Xrcc4 1.63 -4256 NM_001006999 involved in DNA non-homologous end joining 
Josd2 1.63 -477 NM_001106256 deubiquitinating enzyme 
Tmem135 1.61 15197 NM_001013896 proxisome organization 
Erap1 1.60 -50650 NM_030836 peptide trimming 
Ctnna2 1.60 12221 NM_001106598 
linker between cadherin and 
cytoskeleton regulating cell 
adhesion 
Maf 1.60 16605 NM_019318 transcription activation and repression 
Gtf3c3 1.59 2225 NM_001108239 involved in RNA polymerase II mediated transcription 
Mitf 1.58 -9056 NM_001191089 transcription regulation during cell differentiation 
Me1 1.57 1146 NM_012600 regulates glycolytic and citric acid cycles 
Gtf2e2 1.57 1059 NM_001107318 RNA polymerase II initiation complex component 
Aifm2 1.57 1033 NM_001139483 oxioreductase involved in p53/TP53 apoptosis 
Dmd 1.53 23241 NM_001005246 ECM anchor regulating synaptic transmission 
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Slc9a7 1.53 -21772 NM_001108242 electroneutral exchange of protons and Na+ and K+ 
Cetn3 1.53 20449 NM_001191842 microtubule organization, structure and function 
Erbb4 1.53 2457 NM_021687 tyrosine kinase receptor for neuregulins and EGF 
Gcom1 1.53 -798 NM_001014211 NMDA subunit organization 
Tspan2 1.53 -2262 NM_022589 involved in terminal differentiation of oligodendrocytes 
Kcnma1 1.52 -12878 NM_031828 voltage-activated potassium ion channel 
Dnajc15 1.52 23635 NM_001106050 heat shock binding protein 
Cadps 1.51 -2652 NM_013219 
Ca+2 binding, involved in 
exocytosis of 
neurotransmitter/peptide 
Csde1 1.51 -18404 NM_054006 RNA  binding initiator of translation 
Pif1 1.51 -119732 NM_001044253 
DNA helicase, inhibits telomerase 
activity by unwinding DNA/RNA 
duplexes in S1/G2 
Parl 1.51 3568 NM_001035249 control of apoptosis during postnatal growth 
Zmat4 1.51 15867 NM_001134747 DNA damage response 
Ero1lb 1.50 -1537 NM_001191893 reoxidizes protein disulfide isomerases 
Calca 1.50 1655 NM_001033955 reduces serum calcium levels 
 
Table 2-1: Genes up regulated in progenitors lacking CitK.  A list of CitK 
genomic loci with Nearest Promoter Gene Name, Fold Regulation (from RNA-
seq), the Distance to Transcription Start Site (TSS) and the OMIM Function 
 
 
 
 
 
 
 
	   57 
 
Figure 3-3: Citron kinase regulates transcription of thousands of genes. A) 
Gene expression levels were plotted against each for each genotype (wild-type, 
right panel; mutant, left panel).  Transcript expression levels achieved high levels 
of correlation within genotype.  Wild-type R2=0.924 and CitKfh/fh R=0.882.  B) 
RNA-seq analysis of 22,658 genes transcribed in embryonic rat forebrain.  The 
graph shows normalized sequence reads (x) in wild-type forebrain plotted against 
fold change in expression (y).  Fold change was computed as the number of 
normalized reads in mutant relative to normalized reads in wild-type for each 
gene. C)  Fold change in mRNA (RNA-seq) is plotted for each gene with an 
associated CitK Chipset peak (y) versus the position of the peak relative to the 
nearest TSS (x).  Red circles indicate genes that were significantly up-regulated 
in expression in mutants and black circles indicate genes, which were not 
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regulated. D)  Gene ontology enrichment analysis for up and down regulated 
genes in CitK mutants.  Ontologies were considered significantly enriched if they 
were less than a .001 p-value following Benjamini correction.  E)  Quantitative 
RT-PCR was used to verify the regulation of 46 up regulated genes identified in 
RNA-seq.  X-Y graph plots the gene expression changes in the RNA-seq 
compared to measured levels in mutant neural progenitor cells. An R2 of 0.96 
was calculated for correlation. 
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Figure 3-4:  Real time PCR confirmation of neural progenitor G9a targets. 
A)  Neural progenitor DNA was ChIPed for G9a.  Primers were designed to a 
genomic region previously shown to ChIP for G9a (Ppar) and to a non-G9a 
regulated promoter region (Fezf).  G9a enrichment was measured at a peak -800 
bp from the TSS of Ppar and no significant enrichment for G9a was found within 
the promoter of Fezf.  B)  Real time PCR of promoters of transcripts regulated by 
CitK showed enrichment for G9a at -800bp and +200bp, corresponding to peaks 
where CitK had also pulled down.  There is no appreciable enrichment for G9a 
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ChIP anywhere else along these promoter regions. *P<0.05 (CitK vs IgG), all 
data are ± SEM. 
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Figure 3-5:  Real time PCR confirmation of neural progenitor H3K9me2 
targets. A)  Neural progenitor DNA was ChIPed for H3K9me2.  Primers were 
designed to a genomic region previously shown to ChIP for H3K9me2 (Mage2a) 
and to an non-H3K9me2 regulated promoter region (Fezf).  H3K9me2 
enrichment was measured at a peak -800 bp from the TSS of Mage2a and no 
significant enrichment for H3K9me2 was found within the promoter of Fezf.  B)  
Real time PCR of promoters of transcripts regulated by CitK showed enrichment 
for H3K9me2 at -800bp and +200bp, corresponding to peaks where CitK had 
also pulled down.  There is no appreciable enrichment for H3K9me2 ChIP 
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anywhere else along these promoter regions. *P<0.05 (CitK vs IgG), all data are 
± SEM. 
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Figure 3-6: Citron kinase is required for G9a action but not localization to 
target genes. A) Chromatin immunoprecipitation confirms G9a occupancy at 9 
CitK binding genomic loci.  Open green bars indicate ChIP in mutant neural 
progenitors; closed green bars indicate ChIP from wild-type.  G9a occupancy 
occurs in the absence of CitK (indicated by the open bars).  All bars represent 
ChIP percent of input. B) H3K9me2 occupancy of DNA occurs at the same 
genomic loci as CitK. H3K9me2 is absent in mutant neural progenitors (open 
bars).  H3K9me2 bars represent ChIP percent of input. C) The ratio of G9a  ChIP  
in mutant and wild-type progenitors.  Values were calculated as the percent of 
input of G9a in mutant over the percent of input in the wild-type.  D) Transcript 
expression of 9 genes with CitK sites confirmed to be occupied by G9a and 
H3K9me2.  Four genes (Cdkn1a, H2afz, Rbm22 and Pou3f2) were up regulated 
by loss of CitK.  CamKII was not found to be up regulated in either the RNA-seq 
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or by qRT-PCR.  -29Kb_Cadh19, -281_Pard3, -7Kb_Mcc, and 41Kb_Vom2r7 
have intergenic peaks for CitK, G9a, and H3K9me2, but were not found to be 
regulated.  *P<0.05 (CitK vs CitKfh/fh), all data are ± SEM. 
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Figure 3-7: Citron kinase and G9a co-localize to target genomic loci in S-
phase. A) Chromatin immunoprecipitation confirms citron kinase (red) peak 
occupancy at 8 genomic loci. G9a occupancy (green) of DNA occurs at the same 
genomic loci as CitK.  B) Neural progenitor cells with citron kinase localize to the 
nucleus are in S-phase.  EdU was added to cultures 2 hours prior to fixation in 
order to label cells in S-phase (19 +/- 6% of total cells were EdU positive).  93+/- 
6% of EdU positive nuclei were positive for citron kinase.  In contrast 8 +/-3% of 
EdU negative nuclei were positive for citron kinase.  As previously shown, citron 
kinase localizes strongly to the cytokinesis furrow between cells in telophase 
(white arrow, bottom panel).  Scale bar in S-phase panel=12µm, in telophase 
panel =5µm. C) Chromatin immunoprecipitations were performed for H3K9me2 
and G9a in genomic loci where CitK occupies the DNA, in cell populations FACs 
sorted into G1 and S-phase cells, based on DNA content.  Both populations of 
cells show enrichment for H3K9me2, but CitK and G9a enrichment are only 
present in the S-phase population. 
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Figure 3-8:  Citron kinase function in gene repression requires interaction 
with G9a.  A) Schematic representation of citron kinase and deletion mutants.  
All constructs contain an N-terminal Myc epitope tag.  CC, coiled-coil domain; 
RID, rho interacting domain; HR1, homolog region 1; R, rho-binding domain; Zn, 
zinc finger domain; PH, plecstrin homology; SH3, SRC Homology 3 domain; 
PDZ, PDZ binding domain. B) Mutant neural progenitor cells were transfected 
with one of six different constructs.  CitK-FL, CitK1.2, CitK-CC, and CitK-
CCΔHR1 were able to rescue levels of H3K9me2 at genomic loci normally 
occupied by CitK.  Four promoter regions and four intergenic genomic loci were 
plotted individually in A.  Deletion mutants of CitK were Myc tagged and this tag 
served as the epitope for the ChIP experiments. C) Eighteen genes that were up 
regulated, were assessed for gene expression and H3K9me2 following 
transfection of CitK-FL, CitK1.2, CitK-CC and CitK-CC/ΔHR1.  Box plot 
demonstrates that rescue of H3K9me2 (by CitK-FL, CitK1.2, CitK-CC and CitK-
CC/ΔHR1) corresponds to a decrease in transcription of the eighteen genes.  In 
	   67 
contrast, the constructs that were unable to rescue H3K9me2 levels (CitK-HR1, 
CitK-RID and CitK-KD 1.2) showed comparatively high levels of transcription.   
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Figure 3-9: G9a inhibition mimics loss of CitK and blocks rescue of 
H3K9me2 A)  Inhibition of G9a blocks CitK rescue of H3K9me2 histone 
modification.  G9a inhibitors BIX01294 and UNC0638 were bath applied to 
mutant neural progenitor cells transfected with CitK-FL and CitK1.2.  The 
presence of the inhibitor was able to block the constructs ability to rescue 
H3K9me2 levels in three target loci compared to the control (bottom panel).  Bath 
application of both inhibitors was also able to block the re-establishment of H3K9 
di-methylation in wild-type progenitors (right and top panels of C). B)  Transcript 
levels were measured for both control and for rescue with G9a inhibitor for 
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eighteen genes.  In wild-type and mutant rescues (red open symbols), H3K9me2 
levels returned to high levels (y-axis) and showed low levels of gene expression 
change (x-axis).  Addition of the G9a inhibitor (green and blue symbols) blocks 
rescue (square and circle) and reduces H3K9me2 enrichment in wild-type (green 
and blue triangles). 
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Discussion  
The specific mechanisms that control the recruitment of signaling kinases 
to chromatin are not well understood.  There have been numerous models 
proposed to explain which signaling kinases are targeted to DNA.  CitK and G9a  
could be recruited to chromatin by S-phase specific transcription factors.  The 
transcription factor molecular category was one of the highest ranked gene 
ontologies in our RNA-seq screen (Figure 3-2C). We have shown that CitK 
interacts with a number of other nuclear proteins that may be responsible for its 
localization to the DNA (Table 2-1). CitK immunoprecipitated with two S-phase 
specific DNA topoisomerases:  DNA topoisomerase 1 and 2-alpha.   DNA 
topoisomerase 1 knock down in mouse and human neurons impaired 
transcriptional elongation of long coding genes, including nearly all genes that 
are longer than 200kb(Maze et al., 2010; King et al., 2013).  
Massively parallel sequencing of RNA and ChIP DNA has set the standard 
for studying the epigenomes of developing tissues.  We combined an RNA-seq 
screen comparing RNA isolated from E13 Citwt/wt rat forebrains to RNA isolated 
from Citfh/fh forebrains of the same age with a ChIP-seq screen mapping the 
genomic loci CitK bound. We found over 100 up-regulated genes with a CitK 
ChIP peak proximal to its TSS.  Cdkn1a was one of the most highly up-regulated 
genes found by RNA-seq (7.7 fold) and qRT-PCR (6.8 fold).  Cdkn1a is a cell-
cycle inhibitor kinase expressed in neural progenitor cells.  Up-regulation of 
Cdkn1a has been shown to decrease neural stem cell self-renewal and its down 
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regulation is critical for neural stem cell maintenance and multipotency 
(Tschiersch et al., 1994; Fasano et al., 2007).  Cdkn1a is regulated by the 
polycomb protein Bmi-1 and the transcription factor Foxg1(Jones and Gelbart, 
1993; Fasano et al., 2007), both of which are significantly down-regulated in the 
Citfh/fh brain, suggesting a likely pathway affecting progenitor proliferation.  
Further, we found the brain-specific transcription factor Pou3f2 (Brn2) to be 
highly up-regulated (3.33 fold) by RNA-seq and to possess a CitK peak proximal 
to its TSS.  Brn2 is one of four factors required for the direct conversion of 
fibroblasts into functional or induced neurons (iN)(Stassen et al., 1995; 
Vierbuchen et al., 2010).  Also, Brn2  is a co-factor with Sox-2  and binds to 
enhancer regions of Sox-2 regulated genes in neural progenitor cells(Tachibana 
et al., 2002; Lodato et al., 2013).  
The localization of citron kinase in S-phase nuclei, and co-positioning with 
G9a to target promoters in S-phase, is consistent with CitK gating G9a di-
methylation after DNA replication. Selective gene repression by G9a in late S-
phase has been shown in murine ESCs to occur on genes positioned near the 
nuclear periphery (Tachibana et al., 2005; Yokochi et al., 2009). Although we do 
not find citron kinase specifically enriched in the periphery of S-phase nuclei, we 
did not rule out the possibility that CitK target genes in neural progenitors are 
positioned at the nuclear periphery in late S-phase. In addition, primary NPs are 
difficult to synchronize so we are not able to establish with ChIP whether 
G9a/CitK association at target genes occurs specifically in early or late S.  
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Nevertheless, our results suggest that citron kinase target genes would be re-
repressed upon each S-phase of the cell cycle by the co-association of citron 
kinase and G9a. This resetting of G9a repressive marks in each cell cycle is 
consistent with experiments showing that another cell cycle related kinase, Cdk1, 
establishes repressive marks by promoting the action of Ezh2 in G2 (Tachibana 
et al., 2008; Chen et al., 2010; Sharif et al., 2011; Wei et al., 2011).    
In this chapter, I identified that CitK  localized near a subset of genes in 
the genome involved in neurogenesis and calcium binding processes.  
Transcriptome analysis of the Citfh/fh revealed dysreguation of genes critical for 
the proliferation and maintenance of neural progenitor cells.  CitK and G9a 
interact with DNA in S-phase, leaving an H3K9me2 mark that persists through 
the cell cycle.  Ectopic expression of CitK constructs containing the coiled-coil 
domain are capable of rescuing transcription and H3K9me2 levels in mutants, but 
pharmacological inhibition of G9a blocks this effect in mutant progenitors and 
mimics the loss of CitK in wild-type cells. 
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CHAPTER 4 
ASSESSING CITRON KINASE’S ABILITY TO PHOSPHORYLATE G9A IN RAT 
NEURAL PROGENITOR CELLS 
 
Abstract 
 Epigenetic gene regulation in eukaryotes is regulated in part by 
posttranslational modifications of core histone proteins.  While histone 
modification is known to control gene expression states through the recruitment 
of specific effector proteins, it remains unknown whether effector proteins are 
targets for similar modification systems.  Here we examine the possibility that 
citron kinase directly phosphorylates G9a.  We show that bulk levels of 
phosphorylation do not change in mutant neural progenitors and that 
exogenously expressed G9a phosphorylation levels do not change when co-
transfected with CitK into HEK293T.  In vitro kinase analysis followed by tandem 
mass spectrometry revealed a possible phosphorylation of serine 70 on G9a.  
Phosphomimetic constructs replacing serine 70 with an aspartic acid were unable 
to rescue H3K9me2 protein levels without co-transfection with kinase dead CitK 
(CitK-KD) in mutant neural progenitors.  Finally we were unable to identify 
phosphorylation of serine 70  in  vivo  by MS-MS of G9a.  While CitK and G9a 
interact physically, to date, there is no evidence that CitK phosphorylates G9a. 
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Introduction 
Nuclear kinases are well known to modify chromatin states by directly 
phosphorylating histones (Tachibana et al., 2005; Baek, 2011). Histone 
modifying enzymes themselves can also be phosphorylated.  For example, 
Aurora B kinase can phosphorylate G9a and inhibit its methyltransferase 
activity(Tachibana et al., 2002; Sampath et al., 2007). Other effects of direct 
phosphorylation on G9a function have not been characterized. The H3K27 
methyltransferase EZH2 is regulated by phosphorylation by CDK1(Chen et al., 
2010; Kaneko et al., 2010; Sharif et al., 2011; Wei et al., 2011; Katoh et al., 
2012). Phosphorylation at threonine 487 of EZH2 suppresses methylation of 
H3K27 and promotes estrogenic differentiation of mesenchymal stem 
cells(Schaefer et al., 2009; Wei et al., 2011). Phosphorylation of threonine 345 of 
murine Ezh2, also by CDK1, increases binding to ncRNAs XIST and 
HOTAIR(Kaneko et al., 2010; Maze et al., 2010). Similarly, phosphorylation of 
EZH2 at threonine 350 (the homologous threonine to threonine 345 in murine 
cells) diminishes H3K27 trimethylation and reduces proliferation(Feldman et al., 
2006; Ma et al., 2008; Chen et al., 2010). The combined positive and negative 
actions of CDK1 phosphorylation on EZH2 activity underscores the potential for 
diverse epigenetic gene regulation by phosphorylation of histone 
methyltransferases (Tachibana et al., 2002; Sharif et al., 2011). More generally, 
as kinases and phosphatases are upstream of most cell signaling and cell cycle 
events, phosphorylation-dependent gating of histone modifying enzymes is a 
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conceptually attractive general mechanism for dynamically setting and re-setting 
gene repression states(Wang et al., 2001; Baek, 2011). 
In this chapter, we examine the possibility that citron kinase directly 
phosphorylates G9a.  Based on our previous identification of a G9a-CitK 
interaction and their cooperative function in regulating epigenetic states in neural 
progenitors, it seemed likely that CitK could phosphorylate G9a.  We first set out 
to determine if there was a reduction in overall phosphorylation levels of G9a in 
neural progenitors lacking CitK expression.  We then performed an in vitro  
kinase assay to asses direct phosphorylation of G9a by Cit-Kinase-His construct 
and performed tandem mass spectrometry on this phosphorylated protein.  After 
identifying a possible phosphorylation event on serine 70 of G9a, we designed a 
phosphomimetic G9a construct that replaced serine 70 with an aspartic acid, 
mimicking the addition of a phosphate group and attempted to rescue H3K9me2 
levels in mutant neural progenitor cells. Phosphomimetic rescue of H3K9me2 
protein levels only occurred with co-transfection of the dead kinase version of 
CitK.  In addition, we were unable to identify serine 70 phosphorylation in an in 
vivo system, co-expressing G9a and CitK. Combined with our data indicating that 
only the coiled-coil domain was necessary for H3K9me2 rescue (Figure 3-5), 
these results suggest that CitK is unlikely to phosphorylate G9a in vivo. 
 
Materials and Methods 
Phospoho-protein Immunoblotting 
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 Wild-type and mutant neural progenitor cells were allowed to grow to 90-
95% confluence before being homogenized in a hypotonic buffer (NXTRACT; 
Sigma) supplemented with a cocktail of protease and phosphatase inhibitors 
(Roche).  Nuclear proteins were separated from the homogenates using the 
CellLytic NuCLEAR Extraction Kit (Sigma).  Both the nuclear and cytoplasmic 
fractions protein concentrations were calculated using BCA Assay (Thermo 
Scientific, 23227).  Lysates were centrifuged at 13,000rpm for 15 min at 40C and 
the supernatants collected. The protein concentrations were determined using 
BCA Assay kit (Thermo Scientific, 23227).  Samples were subjected to 
SDS/PAGE (10% polyacrylamide). The proteins were transferred onto PVDF 
Immobilon Transfer membrane (Millipore, IPF00010) by western blotting. 
Western blot analysis was performed using specific antibodies to specific 
proteins. The secondary antibodies used were IRDye anti-mouse and anti-rabbit 
antibodies (LI-COR Biosciences). The proteins were detected by LI-COR 
Odyssey Imaging system.  Antibodies used in these experiments included: anti-
KMT1C/G9a (1:000; Abcam Cat# ab31874 RRID:AB_1269265) and the pan-
phosphorylation antibody (pSer/Thr) (1:1000; Abcam Cat # 17464). 
 HEK293 cells were transfected with CitK-FL, CitK1.2 or CitK-KD.  36 
hours after transfection the nuclear fraction was extracted as described 
previously.  Endogenous G9a protein was immunoprecipitated from the nuclear 
extracts using the anti-KMTC/G9a antibody (1:1000; Abcam Cat# ab31874).  
Samples were subjected to SDS/PAGE (10% polyacrylamide). The proteins were 
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transferred onto PVDF Immobilon Transfer membrane (Millipore, IPF00010) by 
western blotting before being  probed with the pan-pSer/Thr antibody (1:1000; 
Abcam Cat # 17464) to measure total phosphorylation levels of G9a.  Identically 
prepared SDS/PAGE gels were also stained using the Pro-Q Diamond 
Phosphorylation Gel Stain (Invitrogen).  SDS/PAGE gels are fixed in 50% 
methanol with 10% Acetic Acid before being washed in ultra pure water and 
stained in the Pro-Q solution.  After 90 minutes the gel is destained using 1M 
sodium acetate, pH 4.0 and ultra pure water.  The phosphorylation bands were 
then visualized on a ChemiDoc MP System (BioRad) using white-light.   
In vitro kinase assay 
The kinases assays were performed in 25mM NaCl, 1mM DTT, 5mM 
MgCl2, 0.1mM ATP, 0.1 EGTA, enzyme and varying amounts of mouse G9a 
recombinant protein.  5’-terminal region of CitK (Kinase-His-CitK) was purified 
from E. coli expressing the pET-32a-NTCITK-HIS plasmid.  Recombinant G9a 
protein was obtained from NEB (M0235S). Varying  amounts of G9a protein was 
added to the kinase mix containing 8ug of His-Cit: (32 ug, 16 ug, 8 ug, 4 ug, 2 
ug,1 ug, 0.5 ug).  For negative control CITK-His protein was added to kinase mix 
containing active CitK-His.    
All kinase reactions were performed at 30oC for 3 minutes and terminated 
by adding 5X SDS sample buffer. For western blot analysis, exactly the same 
amount of G9a protein was taken from each reaction tube and run on a 10% 
SDS-PAGE gel.  After transfer, membranes were incubated in 1% Casein/TBST 
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containing a 1:100 diluted mouse anti-phospho serine/threonine antibody 
(Calbiochem, 525283) and 1:1000 rabbit anti-KMT1C (G9a).  Two-Color 
detection and quantification was performed on a Li-Cor Odyssey Imaging system. 
The ratio of G9a protein to level of phosphor-serine/threonine signal was 
measured. 
Neural Progenitor Transfection and Chromatin Immunoprecipitation 
 Mutant neural progenitor cells were grown to 50% confluence 
before transfection of truncated CitK constructs.  The constructs used in these 
experiments were a C-terminal truncation of citron kinase missing the Rho-
binding domain (CitK-D1.2);  and the same C-terminal truncation with a single 
alanine substitution in the catalytic domain sufficient to eliminate kinase activity 
(CitK-KD). All  CitK constructs include a 5’ myc-tag sequence that served as the 
epitope during chromatin immunoprecipitation.  The G9a  phosphomimetic 
construct has a 3’ HIS tag for exclusive immunoprecipitation of both CitK and 
G9a from the same sample. Cells were transfected using lipofectamine.  36 
hours after transfection the cells were scraped and fixed in 1% formaldehyde 
before sonication of the DNA into 200-500bp fragments.  Immunoprecipitation 
was performed using 4ug of goat anti-Myc tag antibody (Abcam Cat# ab9106) or 
5ug of anti-6X His tag antibody (Abcam Cat# ab18184).  This followed by 
quantitative real-time PCR to measure Ct values and measure 
immunoprecipitation. RNA was isolated using TRIzol (Invitrogen) and cDNA was 
synthesized using Superscript III kit (Invitrogen).  Citron kinase regulated mRNAs 
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were then analyzed using qRT-PCR to detect changes transcript expression 
within the phosphomimetic treated sample. 
 
Results 
G9a phosphorylation levels are normal in mutant neural progenitor cells 
We sought to determine whether G9a was a direct substrate for citron 
kinase.  As described above citron kinase has no identified phosphorylation motif 
and no endogenous substrates have yet to be confirmed by MS-MS.  In order to 
experimentally determine G9a phosphorylation mediated by citron kinase, we first 
compared the overall serine/threonine phosphorylation status of G9a protein 
immunoprecipitated from mutant and wild-type progenitors.  To do this we 
immunoprecipitated G9a from progenitors and then performed western blot 
analysis with both a pan- phospho-serine/threonine antibody and a G9a antibody.  
In addition, we co-transfected full length citron kinase (CitK-FL), the C-terminal 
deletion Citron kinase construct (CitK-1.2) and kinase dead citron kinase (CitK-
KD) with G9a into HEK293T cells and assessed serine/threonine phosphorylation 
of G9a.  As shown in Figure 4-1A, the pan-serine/threonine (pSer/Thr) antibody 
reacted equally with G9a immunoprecipitated from wild-type progenitors 
transfected with a control plasmid expressing eGFP (lane 1 and 3 in Figure 1-
4A), and with G9a immunoprecipitated from mutant neural progenitors (lane 2 
and 4 in Figure 1-4A).  Moreover, full-length CitK, CitK1.2, and CitK-KD co-
expressed in HEK293T did not show any difference in levels of phosphorylation 
	   80 
of immunoprecipitated G9a by either pSer/Thr antibody (Figure 4-1B top panels) 
or the pan-phosphorylation stain ProQ Diamond (Figure 4-1B bottom panels).  
 
Citron kinase phosphorylates G9a in vitro 
 Because citron kinase may only phosphorylate G9a on a single or very 
few residues, a bulk level assessment of total phosphorylation levels may miss a 
difference between mutant and wild-type progenitors. We therefore performed an 
in vitro phosphorylation of G9a in which only recombinant purified mouse G9a 
protein (New England Biolabs) was incubated in a range of concentrations with a 
purified N-terminal domain of citron kinase (Cit-Kinase-His) that contains amino 
acids 1-448 of citron kinase including the catalytically active kinase domain.  We 
found that recombinant G9a could be directly phosphorylated by the N-terminal 
kinase domain of recombinant citron kinase (Figure 4-2A).  Boiled kinase (lane 
1,Figure 4-2A) failed to phosphorylate recombinant G9a. The ability of citron 
kinase to phosphorylate recombinant G9a in vitro presented us with an ideal 
preparation to identify citron kinase phosphorylation sites by MS-MS. We 
phosphorylated G9a and then subjected it to either tryptic digest or Glu-C digest 
and subjected the peptides to HPLC.  After separation by HPLC all peptides were 
run for tandem mass spectrometry (MS-MS) to identify all peptide sequences and 
potential posttranslational modifications. The MS-MS experiments on 
recombinant G9a incubated with Cit-Kinase-His (Appendix E.1, grey highlighting) 
identified one phosphorylated serine (serine 70) and one phosphorylated 
	   81 
threonine (threonine 61) both near the N-terminus of G9a.  The peptides 
recovered in MS-MS included 123 of 150 serines and threonines present in G9a.  
The peptide with the highest confidence score and recovered the most frequently 
in the MS-MS runs was serine 70 (Figure 4-2C).  We further found that a 15 
amino acid peptide that contained serine 70 was specifically phosphorylated by 
purified citron kinase, and substitution of this serine for an alanine eliminated 
phosphorylation (Figure 4-2B).    
 
Phosphomimetic rescue in Citron Kinase Deficient NPs 
If phosphorylation of G9a at serine 70 is sufficient to gate G9a-mediated  
repression of CitK target genes, then we reasoned that expression of a G9a 
phosphomimetic mutant (G9aS70D) (Figure 4-3A), should bypass the need for 
citron kinase and restore repression of CitK targets in neural progenitors lacking 
citron kinase.  To test this possibility, we assessed expression of 7 CitK gene 
targets in Citfh/fh NPs transfected with either a GFP expressing control plasmid 
(green bars in Figure 4-3B), a CitK1.2 expression plasmid that we previously 
demonstrated fully rescues repression of target genes (blue bars; Figure 4-3B), a 
wild-type G9a expression plasmid (brick bars; Figure 4-3B), or either of two 
plasmids expressing phosphomimetic G9a mutants (G9aS70D, G9aS70D/T61D); 
orange bars and light grey bars; Figure 4-3B). The results indicate that addition of 
either wild-type G9a or phosphomimetic mutants is not sufficient to restore 
repression at CitK target genes.   
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 Since citron kinase and G9a interact and co-position at target genes 
(Figure 3-4A), we reasoned that in addition to phosphorylating G9a, perhaps CitK 
must physically interact with G9a or with other proteins in order for G9a to gate 
the activity of G9a in target genes.  
In order to test this possibility, we repeated rescue experiments with G9a 
and G9a phosphomimetic mutants in Citfh/fh mutant progenitors, but added back 
CitK-KD, the kinase dead mutant that localizes to target genes and fails to rescue 
repression or gate G9a methylation on its own.  G9a transfected with the kinase 
dead mutant failed to rescue repression (dark grey bars in Figure 4-3B).  In 
contrast, if either of the two phosphomimetic mutants of G9a were transfected 
along with CitK−KD, then repression of target genes was fully restored (purple 
and cyan bars in Figure 4-3B).  
 We next tested whether the combination of phosphomimetic 
G9a(G9aS70D) and kinase dead citron kinase (CitK−KD) gated dimethylation at 
target positions or promoted loading of phosphomimetic G9a to those target 
positions. Based on the finding described above (Figure 4-3A) that endogenous 
G9a localizes even in mutant progenitors, we hypothesized that phosphomimetic 
G9a would also target correctly in the absence of CitK−KD.  To test this we 
added a -His epitope tag to the 3' terminus of G9aS70D, transfected the -His 
tagged construct with either a control (eGFP) or with CitK−KD expression 
plasmid, and then performed ChIP assays for both the -his tag and H3K9me2.  
The results shown in Figure 4-3C, confirmed our hypodissertation.  In Citfhfh NPs, 
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G9aS70D-His positioned to the same locations in 3 target genes in both the 
absence and presence of CitK−KD.  Moreover, H3K9me2 modification was 
present when CitK−KD was added, but missing without it.  
 
Citron kinase does not phosphorylate G9a NP and HEK Cells 
The in vitro phosphorylation results encouraged us to perform an in vivo 
MS-MS comparison of G9a immunoprecipitated from both wild-type and mutant 
neural progenitors.  As shown in Appendix E.2, peptides in wild-type neural 
progenitors corresponding to the same phosphorylated G9a peptide fragment 
identified in the in vitro phosphorylation experiment (Figure 4-2) were not 
identified.  Interestingly, there were no phosphorylated peptides of G9a identified 
with high confidence in the immunoprecipitated G9a preparation. In order to test 
if S70 was phosphorylated by citron kinase in actual cells, we heterologously 
expressed, in HEK293T cells, full length G9a constructs along with full length 
citron kinase, immunoprecipitated G9a (Figure 4-1B), and assessed 
phosphorylation status of G9a with MS-MS.  As shown in Appendix E.3, we could 
not identify S70 as an in vivo phosphorylation target of CitK. Indeed, this 
experiment yielded no significant phosphorylation event at all on G9a. Overall, 
this evidence indicates that while in an isolated in vitro system, CitK may 
phosphorylate G9a at serine 70, this is unlikely to be occurring in vivo, in cells.  
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Figure 4-1:  G9a phosphorylation level changes are not detectable in NPs 
or HEK293T cells exogenously expressing CitK. A) Wild-type and mutant 
neural progenitors were assessed for G9a phosphorylation levels.  Wild-type and 
mutant G9a phosphorylation levels do not differ as indicated by the pan-
Serine/threonine phosphorylation antibody.  B)  HEK cells co-transfected with 
CitK full length and deletion constructs with G9a demonstrated no changes in 
phosphorylation.  SDS-PAGE gel of IPed G9a-Myc construct co-transfected with 
CitK deletion constructs was stained with pan-phosphorylation solution ProQ-
diamond and showed no detectable change in phosphorylation.  Quantifications 
for all blots were calculated by subtracting the background and dividing 
phosphorylation signal by total G9a.  Error bars indicate SEM, for all conditions, 
n=4.  ProQ Diamond signal was subtracted from the background and is reported 
as a normalized signal.  Error bars indicate SEM, n=3. 
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Figure 4-2: Citron kinase phosphorylates G9a in vitro.  A)  Varying amounts 
of recombinant G9a protein were incubated with CitK-His.  Exactly the same 
amounts of protein were then western blotted for pSer/Thr and G9a to create a 
phosphorylation curve. B)  Peptides of G9a flanking S70 were synthesized.  
G9aS70 and G9aS70A were incubated with CitK-His.  Peptide S70A failed to be 
phosphorylated by CitK-His (lane 1) while 5ng and 10 ng of S70 (lanes 2 and 3) 
show phosphorylation by Citk-His. Peptide S70 was not phosphorylated by boiled 
CitK-His (lane 4).  C)  Schematic representation of the G9a protein indicating the 
position of the serine 70 relative to all relative G9a protein domains.  ANK1-7 
(ankyrin domains), H3K9 (H3K9me2 binding domain), Pre SET (Pre SET 
domain), SET (Su(var)3-9 enhancer of zeste domain- the catalytic domain of 
methylation), Post SET (Post SET domain). 
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Figure 4-3: G9a phosphomimetic restores repression in the presence of  
kinase dead CitK. A)  Schematic representation of G9a phosphomimetic (S70D) 
construct with C-terminal His-tag.  B) Mutant neural progenitors were transfected 
and mRNA was isolated and synthesized cDNA was run for qRT-PCR to 
measure CitK target transcript levels. Horizontal line indicates wild-type transcript 
levels for each transcript. n=6 for each transfection condition.  Error bars indicate 
+/- SEM.  C) Mutant neural progenitors were transfected with either His-
G9aS70D or His-G9a70+CitK-KD.  Chromatin immunoprecipitation was 
performed for the His-tagged G9aS70D and for H3K9me2 in both conditions.   
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Discussion 
 The localization and co-positioning of citron kinase and G9a at promoter 
regions with H3K9me2 prompted us to evaluate CitK’s possible role in 
phosphorylating G9a.  In spite of its importance in cytokinesis, there has been 
only one possible substrate identified for citron kinase.  In vitro phosphorylation 
and heterologous expression has suggested that regulatory light chain of myosin 
II is a likely citron kinase substrate(Yamashiro et al., 2003; Chang et al., 2009). 
No mass spectrometry study has yet confirmed the identity of citron kinase 
substrates. Interestingly, several cytoplasmic proteins that interact with citron 
kinase including Anillin, ASPM, RanBPM, P27kip1 and DLG5, have been 
identified, but none have been identified as citron kinase substrates 
(Paramasivam et al., 2007; Chang et al., 2010a; 2010b; Gai et al., 2011; Serres 
et al., 2012).   
 We used a combination of pan-serine/threonine phosphorylation 
antibodies, pan-phosphorylation staining (ProQ Diamond), tandem mass 
spectrometry and phosphomimetic assays to identify CitK’s role, if any, in 
phosphorylating G9a.  Bulk phosphorylation levels of G9a do no appear to 
change in mutant neural progenitor cells (Figure 4-1A).  Exogenously expressed 
G9a phosphorylation levels also do not appear to change when co-transfected 
with CitK (Figure 4-1B). Secondary validation of this system by using ProQ 
diamond, a fluorescent stain that allows for direct in-gel detection of phosphate 
groups, also did not indicate a change in phosphorylation levels.   
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 Direct phosphorylation of G9a in a kinase assay revealed that in vitro, CitK 
appears to be able to phosphorylate G9a. Identification of phosphorylation sites 
by MS-MS is the gold standard for identifying novel phosphorylated residues.  
However, there are many pitfalls to this analysis.  Of note to this dissertation, is 
the length of peptide being scanned.  This is a function of the endoproteases 
used to cleave the proteins into smaller peptides.  Generally, trypsin and Glu-C 
are the primary proteases used for tandem MS-MS(Swaney et al., 2010).  
Trypsin preferentially cleaves  at arginine and lysine, with higher rates at arginine 
(Olsen, 2004). Glu-C preferentially cleaves after aspartic and glutamic acid 
residues (Breddam and Meldal, 1992).  Unfortunately, the peptide identified by 
our MS-MS containing serine 70 
(AQASWAPQLPAGLTGPPVPCLPSQGEAPAEMGALLLEK) is 38 amino acids 
long and cannot be cut shorter by conventional proteases.  With the majority of 
MS-MS identified phosphorylated peptides falling between 5-12 amino acids 
long(Swaney et al., 2010), this peptide falls well outside of the normal range for 
identification and may explain why we have been unsuccessful in not only 
replicating the phospho-event but also retrieving this peptide (APPENDIX E.2 
and E.3) 
 While initially encouraged by my phosphomimetic rescue assays, it should 
be pointed out that transfection with G9aS70D and CitK-KD is not a true 
phosphomimetic rescue, which would have involved only the G9aS70D construct.  
Based on my previous data in chapter 3 it is more likely that rescue of H3K9me2 
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protein levels is caused by the presence of the coiled-coil domain in the CitK-KD 
construct.  However, it should be noted that CitK-KD, alone, is unable to rescue 
H3K9me2 levels (Figure3-5B).  I hypothesize that the mutation in CitK-KD 
changes the protein confirmation and obstructs the coiled-coil domain, 
structurally preventing methylation of H3K9me2 by G9a. Since neither CitK-KD 
nor G9aS70D can rescue alone, their ability to rescue together remains a 
mystery.  It is possible that the charge caused by the aspartic acid mutation on 
G9a causes the interacting CitK-KD protein folding to change, opening the coiled-
coil domain and allowing rescue. 
 In this chapter, I explored the possibility that CitK directly phosphorylates 
G9a.  Given their direct physical interaction at target promoters and the apparent 
gating of methylation H3K9 by gain of CitK function, it was reasonable to predict 
a phosphorylation event was involved with this function.  While it seems probable 
that CitK-Kinase-His phosphorylates G9a in a kinase assay, our results suggest 
that this system is far more complex in vivo (in cells)- relying more on a structural 
interaction between CitK and G9a than an enzymatic reaction. 
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CHAPTER 5 
SUMMARY AND CONCLUSIONS 
The results of our experiments indicate a model of G9a and citron kinase 
function in neural progenitors. CitK first acts on chromatin in S-phase, when gene 
targets are co-occupied by CitK and G9a. G9a can be loaded onto genomic 
targets in the absence of citron kinase, but when in position, G9a must be in 
association with citron kinase in order for it to add the H3K9me2 modification at 
that location.  The simplest model to explain this action would be that at target 
gene positions the correct orientation of G9a relative to histone 3 is achieved by 
a conformation induced by interacting with the coiled-coil domain of citron kinase. 
Citron kinase protein may also be required to displace proteins that would inhibit 
the action of G9a at target positions and thereby allow G9a to dimethylate H3K9.  
In either case, our studies reveal a novel interaction required for G9a-mediated 
repression of some G9a target genes.   
 Constitutive and conditional genetic deletion of G9a in mice indicate that 
G9a is required for early embryogenesis(Tachibana et al., 2002), for normal 
retinal development(Katoh et al., 2012), for adaptive motor behavior(Schaefer et 
al., 2009), for cocaine withdrawal(Maze et al., 2010), and in embryonic stem cell 
reprogramming and differentiation(Feldman et al., 2006; Ma et al., 2008). A role 
for G9a in neural progenitors and in embryonic cortex has not been established 
previous to this study, but is consistent with recent findings in developing retina 
(Katoh et al 2012). 
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 As the primary H3K9 dimethylase for euchromatic sites in mammalian 
genomes the locus specificity of G9a action in different cell types and tissues is 
likely shaped by interactions with other cell-type specific nuclear factors.  G9a 
has been associated with repression of target genes positioned on the nuclear 
periphery in S-phase(Yokochi et al., 2009), complexes with other lysine 
methyltransferases (Fritsch et al., 2010), associates with NRSF/REST in the 
nucleus (Roopra et al., 2004), and complexes with multiple DNA binding proteins 
that all could differentially localize its function in different cell types(Ogawa et al., 
2002; Duan et al., 2005; Vassen et al., 2006; Epsztejn-Litman et al., 2008; 
Shinkai and Tachibana, 2011).  The localization of citron kinase in S-phase 
nuclei, and co-positioning with G9a to target promoters in S-phase, is consistent 
with CitK gating G9a di-methylation after DNA replication in neural progenitors. 
Our results suggest that citron kinase target genes may be re-repressed upon 
each S-phase of the cell cycle by the co-association of citron kinase and G9a. 
This resetting of G9a established repressive marks in each cell cycle is 
consistent with experiments showing that another cell cycle related kinase, Cdk1, 
establishes repressive marks by promoting the action of Ezh2 in G2(Cha et al., 
2005; Sharif et al., 2011; Wei et al., 2011)  
 Interactions with cell cycle proteins in the cytoplasm would seem a likely 
candidate mechanism to gate the localization of citron kinase to nuclei in S-
phase.  In fact, citron kinase interacts with P27Kip1(Serres et al., 2012), a cyclin 
kinase inhibitor that regulates G1 progression and G1/S entry(Besson et al., 
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2008).  The paper by Serres et al. (2012) found that interaction between a mutant 
of p27 and citron kinase was involved in cytokinesis defects. We hypothesize that 
citron kinase interaction with P27Kip1 in G1/S could also promote the localization 
of citron kinase to the nucleus. Interestingly, reciprocal functional requirements 
for P27Kip1 and citron kinase are observed in neurogenesis in vivo. Genetic 
deletion of P27Kip1results in an over production of neurons in neocortex(Goto et 
al., 2004), while mutation of citron kinase results in significant underproduction of 
neurons in neocortex(Cogswell et al., 1998; Di Cunto et al., 2000; Roberts et al., 
2000; Sarkisian et al., 2002).  The loss of P27Kip in NPs may alter nuclear 
localization of CitK and decrease the repression of genes that would promote exit 
from the cell cycle.   
 The known functional relationship between citron kinase and cellular 
motors during cytokinesis(Yamashiro et al., 2003) could make citron kinase an 
interesting candidate molecule for coordinating changes in chromatin position 
with epigenetic regulation in the nucleus during S-phase. In fact, we found a non-
muscle myosin  in our MS-MS screen of nuclear protein fractions- Mybp1a.  We 
speculate that citron kinase may connect mechanisms of molecular motility with 
epigenetic gene repression in the nucleus. 
 We do not know at this point whether the two identified functions of citron 
kinase, gene repression through G9a and regulation of cytokinesis, are  
completely independent functions operating at different times in the cell cycle, or 
whether they are linked.  Evidence to date suggests two separable functions.  As 
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we show here, and as shown previously in vivo, early neural progenitors (<E13) 
deficient in citron kinase do not fail in cytokinesis or undergo apoptosis at rates 
higher than wild-type neural progenitors.  As we also show here, early NPs do 
show clear deficits in G9a mediated gene repression, and G9a function is not 
required for cytokinesis.  Similarly there are some cell types in Drosophila sticky 
mutants that show changes in HP1 and H3K9me3 immunolocalization, that show 
no defects in cytokinesis(Sweeney et al., 2008). The molecular requirements of 
citron kinase domains in gene repression and cytokinesis appear to differ as well.  
In cytokinesis, the Rho binding domain of citron kinase is essential to its required 
function by shuttling rho to the cytokinesis furrow.  In contrast, as I show in this 
dissertation, gene repression through G9a does not require the rho binding 
domain or the kinase domain. In spite of these differences it remains conceivable 
that citron kinase may coordinate aspects of cytokinesis with gene repression.  
For example, there is evidence that inheritance of the cytokinetic midbody scar, 
which contains citron kinase, has a role in cellular reprogramming and 
tumorigenicity(Kuo et al., 2011). Citron kinase may therefore be one of several 
signaling and chromatin regulating proteins, contained within the midbody that 
could have subsequent effects on epigenetic programs required for efficient 
neural progenitor self-renewal.   
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Final Remarks 
Recent studies have shown evidence in higher eukaryotes that signal 
transduction kinases can exhibit a distinct function in both the cytoplasm and the 
nucleus.  Translocation of kinases to the nucleus could provide an effective 
mechanism whereby cells communicate extracellular signals to the nucleus.   I 
have identified a novel mechanism of action of the kinase, CitK, as a component 
of a repressive, S-phase specific nuclear transcriptional machinery assembled at 
gene control regions within neural progenitors.  Future studies will aim to identify 
the role of other nuclear, CitK interactors in neural progenitors.  While I was 
unable to definitively show that CitK phosphorylates G9a, it remains a likely 
possibility that some of these proteins are direct substrates of CitK.  Further, the 
downstream transcriptional changes themselves are of particular interest.  Many 
of the categories identified by differentially expressed transcripts fall into 
categories of significance to embryonic corticogenesis.  Finally, it remains to be 
determined whether the nuclear role of CitK in regulating gene expression is 
independent or linked to its role in cytokinesis. 
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APPENDIX A 
LIST OF ABBREVIATIONS 
ASPM   Abnormal spindle-like, microcephaly associated 
CC   coiled-coil domain 
Cdk1   Cyclin dependent kinase 1 
Cdkn1a  Cyclin dependent kinase 1a 
ChIP   Chromatin immunoprecipitation 
CitK   Citron kinase 
CNS   Central nervous system 
CP   Cortical plate 
Ctip2   Coup-transcription factor interacting protein 
Cux2   Cut-like homeobox 2 
DLG5   Discs, large homologue 5 
DNMT   DNA methyltransferase 
DRG   Dorsal root ganglion 
E   Embryonic Day 
EdU    5-ethynyl-2 deoxyuridine 
eGFP   Enhanced green fluorescent protein 
Ehmt2   Euchromatic histone methyltransferase 2 
Emx   Empty sparicles homeobox 2 
ESC   Embryonic Stem Cell 
Ezh2   Enhancer of zeste homologue 2 
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FACs   Fluorescent Activated Cell Sorting 
fh/fh   flathead (fh/fh is the genotype) 
GLP   G9a-like protein 
GO   Gene ontology 
GTP   Guanosine triphosphate 
H2AZ   Histone 2A variant z 
H3K9me2  Histone H3 lysine 9 dimethylated 
HDAC   Histone deacetylase 
HEK293T  Human embryonic kidney 
HMT   Histone methyltransferase 
HOTAIR  HOX transcript antisense RNA 
HP1   Heterochromatin protein 1 
HPLC   High performance liquid chromatography 
HR1   Homology Region 1 
IP   Immunoprecipitation 
IZ   Intermediate zone 
KD   Dead Kinasae 
MeCP2  Methyl CpG binding protein 
MS-MS  Tandem mass spectrometry 
ncRNA  Non-coding RNA 
NP   Neural progenitor 
NRSF/REST  RE1-silencing transcription factor 
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P   Post-natal day 
PDZ   PDZ binding domain 
PH   Plecstrin homology domain 
PKC   Protein kinase C 
Pou3f2  POU class 3 homeobox 2 
pSer/Thr  Pan-phosphorylated serine/threonine 
qRT-PCR  Quantitative Real-Time Polymerase Chain Reaction 
R   Rho-binding domain 
RanBPM  RAN binding protein M 
RID   Rho-interacting domain 
Satb2   Special AT-Rich Sequence-Binding Protein 2 
SDS-PAGE  SDS Poly Acrylamide Gel Electrophoresis 
SEM   Standard Error of the Mean 
SET   Su(var), Enhancer of Zeste, Trithorax 
SH3   Src Homology domain 3 
SVZ   Subventricular Zone 
TBR1   T-box brain 1 
TSS   Transcription Start Site 
VZ   Ventricular Zone 
XIST   X-inactive specific transcript 
Zn   Zinc-finger domain 
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APPENDIX B 
PRIMERS 
Table B.1: Exon Spanning Primers used for real time PCR of regulated 
Transcripts 
Gene Name Forward Primer Reverse Primer 
Rbm22  tgttccttctgggtgaaagg catctggatcggtaggcttc 
H2afz cgcagccatcctggagtacc gacaccaccaccagcaatcg 
Chmp1a tgtgcacacatcggtgatgg tccaggccattctcctcagc 
Cdkn1a tgtcgctgtcttgcactctggt atcggcgcttggagtgatagaa 
Brn2/Pou3f2 acagcaacagcagcaacaac agctgggctgcgaatagag 
Gpnmb  aagatgccaacggcaatatc tcttcccagtcctcatcgtc 
Dimt1 ttgccattctttgatgcttg gccaaacgaagagcaaactc 
Tarbp2  gaggaactgagcctgagtgg ctccctggtagtggcagaac 
Igf1 ggcattgtggatgagtgttg gtcttgggcatgtcagtgtg 
Sfrs11 ttgctgcagaccagctattg ttcacgcactctcttcatgg 
Epha6  aggaggaagaagagggcttg aaagaaattcccggacttcg 
Ntng1  tgccaccatgtgtgtgtatg gtcggccctggtaattcttc 
Pard3  atgccagctttgaaaccaag cagaggtgcttgttctggtg 
Cdh19 gaagtggccagagtgagagg ggccttgtggaactatctgc 
 Mcc  ggaggaggtttccagagagg tgccatccttggatttcttc 
Vom2r7  gaacagggcttcagaggttg acgaagcaggtttgagaagg 
Cenpj  agaagacccggaagctcatc tctgttaccctcctggcatc 
Fgfr4 atcggcctctcctaccagtc atatctggcctccgatgttg 
Gcnf  aagccaatcactggagcaac gctggttgctctctgaaacc 
Asf1 tcgagtgcatcgaggacctg ccactgcgtctgcgtctgg 
Smc2 acgctgctgcgaaggtatcc accgctcttccgcttctgtc 
Ezh2 gacgatgatgatgatggagacg gagctgctgctccgtgagttc 
Smarca5 ggaagctctgcgtgtcagtgag tctgtgcctgtgctgcattg 
Chmp2b ggacgcgtggctaccagaag ggtctccaagcacgacctgtg 
Prdx1 tcacttctgtcatctggcatgg acagagcggccaacaggaag 
Sox10 agccaccaggtgtggctctg gcctgcgtggccataatagg 
Hells tcctaactggatggctgagttc caacaggatgaatctgcaacg 
Suv39h2 tgtcctgctgaagctggagttg aggtccacatcggcaccttg 
Pcgf6 aggccgcttcgaggactacg ggttgatcaggcgctcttcc 
Pcgf5 tccaaggtgtggcaaccaag cagctcacgctgaagttcttgc 
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Rnf4 ccgtcagttgtccgatctgc cacggaggcactggctacag 
Cenpn ggcacctggactcactcacg ttgcgtggctctgtggattc 
Asf1a ccgttccagttcgagatcacc cctgcctgcaggaacaggac 
Chd1 cagacacagcagcctcagcag tcttgacatcgctggacgag 
Ino80 atgagcaacagcgccacttg tggtggtgccgtggagattc 
Rsf1 / Hbxap ctccagccaacaggaagacc ttgaccgctcatcagcttcc 
Nr3c1 ggtcgaccagcgttccagag tcacactgcctccgttggtg 
Sap18 caccaccgaatggacgagttc ccttcctgccagacatggtg 
Rbs15 cacctaccgtggcgtggac ttcacgacctccggcttctc 
RbsS2 aatggccacgttggtcttgg aaccagcacagagccacagc 
RbsSA aggagccactccgattgctg cacagagcaatggtggtcagg 
Chd4  agcgacagccggagtacctg aggcgcgctcactaagaagg 
RBL10 ctcctgaggcaccagcttcg cctgcctgctgagaatggtg 
RBL18 gtgcaaccggatgtggagac cacaacctggccgttaaggtg 
RBL26 acctcaggtcgaggccagtg cttggcgtggtcaactgctg 
RBL26 caccatctcacattcggaggaag gccttctctcgctggactcg 
RBLS10 cgaggctacgtgaaggagcag gaatcttgcaggccgctcac 
RBLS14 tccgtatgcagccatgttgg gagcgagcaagagctctgagg 
RBLS16 tggagcctgttctgcttctgg ggtccgatcgtactggatgagg 
Ndpka aggaccggtggttgctatgg ccgcactctccacagaatcg 
Bmp2 gcggaagcgtcttaagtccag tctgcactatggcatggttgg 
Klf4 acctcggcgtcagcttcatc cattgatgtccgccaggttg 
Bmp4 gctggccattgaggtgactc cttcttcctggagcgctgtg 
Ncam1 gtgcatcgctgttaacctgtgc ctcctccgttcggacctctaca 
Cenpf aaggaacaatggcagcagaagc accttccaagtcagtgccaagc 
Tcfap2bn ccagctctccggccttgac cgtgcaatgagaggctgtcg 
Gata3 caaggcacgatccagcacag ggtagagtccgcaggcgttg 
Engrailed ggagaaggcggctccaagac agtcggagctcaccgacagg 
Foxn4 ctgcagcagatggcaagtgg ggtctggctacggagcatgg 
Runx1 tggcatgaccagcctctcag tgtgacaggaggcgagtaggtg 
chd3 ccaaggctggttccatgtcc gtgtcatcggtcgcatcctg 
Tbx1 acagctcctcctggctggtg atgtggccattgtcgtccag 
Foxg1 atggccatcaggcagagtcc cgtagtggcgcggtaccttc 
Bmi1 gcactgacggtgatgcacttg gcggtcagtccatctctctgc 
Mll2 tgcagctgaaggtgctggag ccagctgcttctggatcttgc 
Mll5 gctcgtcctcctccaacacc tcacgtcagtgccgtagctc 
Nova2 tctgcaccaagcgcatcaac tctggagctgcacgatggtc 
Mycn cggtgaacaagcgagagtcg cttgtgctcgccactgttgg 
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Rexo1 ctctggagccagccagtgtg tctcctcctcggccttctcc 
Tcf3 aggagccgagcagcgacag aatagtcgcgcggcttctgg 
Rnf2 tgcgtccacacacagcaatc tgtgcgctgtcgtccttctc 
Gapdh ggcaagttcaacggcacagtc tggtggtgaagacgccagtag 
Tubb2b tggccgctacctgaccgtag cggccgtcttcacattgttg 
Actb ctgaccgagcgtggctacag aggaagaggatgcggcagtg 
Table B.1: Exon Spanning Primers used for real time PCR of regulated 
Transcripts.  Primers used in all real-time PCR experiments in wild-type and 
mutant neural progenitors.  Green highlighted genes represent transcripts that 
were down regulated.  Gapdh, Tubb2b and Actb are housekeeping genes. 
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Table B.2:  Promoter primers used for real-time PCR of CitK target 
Genomic Loci 
Gene Name and     
Primer Position Forward Reverse 
Cdkn1a-1 ggctggatctcttccctttc ggagatctttccctcaactgg 
Cdkn1a-2 aggcctggaatcctccact ttccttggaatttcagggtaagtc 
Cdkn1a-3 cctgcctagcttgttggaag agctggtctccatctgggta 
Cdkn1a-4 acaagctaggcaggcactgt gagccacgcacatctatgaa 
Cdkn1a-5 gggctgagattcccagagg tcacacctctcggctggt 
Cdkn1a-6 ttgtgatatgtaccagccacag gagacagctcgccatgag 
Cdkn1a-7 tgttccacacaggagcaaag acgctcccagacgtagttg 
Cdkn1a-8 tacgtctgggagcgtgttc gagtgcaagacagcgacaag 
Cdkn1a-9 tgtcttgcactctggtgtctc tcagggctttctcttgcag 
Cdkn1a-10 gtccttctcaacccaagctg cccaggtaagaagtggcaag 
Cdkn1a-11 cctaagcgtaccgtccagag agggtctgaggaagggagag 
      
Brn2/Pou3f2-1 actcacgtcagcagggtgt tcacaatcaagcctgtcagc 
Brn2/Pou3f2-2 acgttgccactcttggagat catcttaccggtgtgaccag 
Brn2/Pou3f2-3 ctggtcacaccggtaagatg cagccacacagtccagagag 
Brn2/Pou3f2-4 ggtggtggtggttaggtctc tgaaccattcaacagcttgc 
Brn2/Pou3f2-5 aaaatggaagaaaccattca aaacaaaacaaggcattcat 
Brn2/Pou3f2-6 ttgttcaaatgaaacagtgc aacacatgggtcagaaaaat 
Brn2/Pou3f2-7 agcatcttttgttgtggaat ctctttctctttcctgctga 
Brn2/Pou3f2-8 ccactagcctgacctcatac ctctttccccacctagttct 
Brn2/Pou3f2-9 ttgttactgagaggttggtg atcagtttggagcagttgat 
Brn2/Pou3f2-10 cagcattctgcaaaacataa agcaatcaaagtttcctcaa 
Brn2/Pou3f2-11 tcactgtcttcacacacacc ctcttccagaggtcctgagt 
      
Gpnmb-1 caggacctctggaagagcat cagaggagaaagtgaatgatgg 
Gpnmb-2 ccagttctcctccatgtggt ccatacagcaagcagcaagt 
Gpnmb-3 tccacagagccaagtcgata cgaggtgtcctttcagtcaa 
Gpnmb-4 tgcagggtgtccagattcta ttcctctccaccatctttcc 
Gpnmb-5 ggaaagatggtggagaggaa aagcagtgtggcttggtctt 
Gpnmb-6 tctgactcctggtggatgg ttgttctccctcatgtgatcc 
Gpnmb-7 tcacatgagggagaacaacc gatattggaacccaccaagg 
Gpnmb-8 atttggagctggcttctgac gaccaagtgtgtggaagacg 
Gpnmb-9 acggaagaaatggaacttcg ttcactttggagatgggaatg 
Gpnmb-10 agaagaatgaccggaactcg ggttccattgagcacatacg 
Gpnmb-11 tggcctgtttgtctccaac atgtgggtgaaggcgaag 
      
H2azf-1 atgtggcagaatgtttggtg cacacaggaaacttgggatg 
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H2azf-2 cttggccccactgttgttat cgatggcgtccagtaagaa 
H2azf-3 ttcttactggacgccatcg accacgtgagcttccctcta 
H2azf-4 ccccaccactctacttctcg gattcaaactgcgccttctc 
H2azf-5 tttctctgccttgcttgc tcaggtgtcgatgaatacgg 
H2azf-6  cctgaaatctaggacaacaagc agcaagttgcaagtgacgag 
H2azf-7 ttgagttggcaggaaatgc atttgtggatgtgtgggatg 
H2azf-8 ctggtggtggtgtcatcc gatacagtccactggaatcacc 
H2azf-9 tccagtgttggtgattccag ccaccacttcagattcaatagc 
H2azf-10 ttaattagctttccaaccaacc cccaccacttcagattcaatag 
H2azf-11 tgtggcttcaaagaagctattg tccaccagagtggaaataatg 
      
RBM22-1 aaattaaacccagttgccagag catgaggcatggtgattgtc 
RBM22-2 gaagcttctgcctaatgacg cttgcagcagcagtacacg 
RBM22-3 aatgtctctggcctctgtagg gtgttcaccaccaccatttg 
RBM22-4 caaggccagcctgatctaag ccattacggtaaggatgttgg 
RBM22-5 tgtctggttaaatgtgatttcg acccagtagggtccaaacg 
RBM22-6 cctaggcgcgcagattatac gttggaacccagagaagtcg 
RBM22-7 tgggttccaacacttacaacag accctagggcaaggcttc 
RBM22-8 tgactgagggaacagggtct agggttttctccaagacacg 
RBM22-9 tgccctacctatttcctctcc ctcgcctgtcaacagaccta 
RBM22-10 gcgacaggcatcaatgatta actctcctgtgctggttggt 
RBM22-11 agatggcatatccacatcctaa caccactcatggctggttta 
      
Cenpj-1 caactggagaggggaagatg ttgtgagctaccgtgtaggg 
Cenpj-2 ccaggcacctactaacattcg cagaccaggtttgaacaaca 
Cenpj-3 ccctctggtggcaatacaa tggcttcacaaagtgtattcat 
Cenpj-4 tctcccaaacctgtcgtctt tgaaatcaacccattgagacc 
Cenpj-5 cccctagcaacgtttatggt tccaatgactcctgggaaat 
Cenpj-6 ccgcctgtttcctgagag aagaacaaagcgggcttaaa 
Cenpj-7 ccaaaagctttgttgctttg gcactggaggagaaggaaga 
Cenpj-8 gggaattgttgatgattttcac atgcatgaaaccaacgcata 
Cenpj-9 ccactttgagccatctctcc agtccgggtacacagcaagt 
Cenpj-10 ccagtaagaaccagccccta ctacccaggcttctctgcat 
Cenpj-11 cctgcttaggagaggcattg gaccctcacctgaggaactg 
      
Chmp1a-1 aagtgaaatcggcagcaact gcacaaagttgggagagctt 
Chmp1a-2 tacacaagatgccctcgaaa ttgggtcccatgtgtaagaa 
Chmp1a-3 tgcttggtctccttctccat  ctcgggctgtaggtctaacg 
Chmp1a-4 cgtctcacaaaacccacact tccggggttgttactgtttc 
Chmp1a-5 gacggtaaggggctgtcat caggcccagggatagagtc 
Chmp1a-6 ccgattcttgactccagacc ctggctagaaggacctggtg 
Chmp1a-7 gctcctggagataggcgtta cgttctttgggagtttcgag 
Chmp1a-8 gctggcctggaacttacatc gggatggcacagacctttag 
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Chmp1a-9 aagagtcccttggggagaag tctggggaaccctaaagtga 
Chmp1a-10  aggtgattttagcccagcag tcacgcttgaatcctgaaaa 
Chmp1a-11 tgcgaatgagtggctaattg gcgctctaccactgagctaaa 
      
Fgfr4-1 gctcaggcaaagaagaggtc tacaacctgcgaggtgtgac 
Fgfr4-2 cacgcctctcagatcagaac gaatgtccctgcaactacagc 
Fgfr4-3 accctctaactctgggcaag gatttaccgtcccctccac 
Fgfr4-4 taagagcactgtcgcctttg agttgtcctgcactcacacg 
Fgfr4-5 cgtgggagtgggaataaaac cggcaaaagactcctaccac 
Fgfr4-6 cactggcgtttaaaatgaagg  actaaagttggccaggcaga 
Fgfr4-7 agcagggtcctaagggaaag gaccaggaaaccagtggagt 
Fgfr4-8 gcacactcagtatggggaca aaggttgcttcagggacaaa 
Fgfr4-9 tggatgtggaaatgccaata ttcattgctgaaggctcaaa 
Fgfr4-10 tccagtctctgccctgctat gcactggtcccattctttgt 
Fgfr4-11 tcaggagacaccagccttct ctccagctctactcagccaga 
      
Dimt1-1 cgagacattatactggcaggaa aatttcaaaagcctgttaatgg 
Dimt1-2 gtacagcattccacctgcat gagttcaattcccagcaacc 
Dimt1-3 catcccagtgatggaactca cgtgtctcttcgttgtggaa 
Dimt1-4 gcagggaaacaggaaagaga atttcccagaggacatgcac 
Dimt1-5 cggaggaactcaccaaagac cagcaggctagagctcagtg 
Dimt1-6 ctcttgccctagggactcct agtcccaagcttcctccac 
Dimt1-7 caggagggatggatggact acagcagcaggatggacag 
Dimt1-8 catgttcaacacagggatcg atgacacacaaacgctctgc 
Dimt1-9 ttaagagttgcccagggattt tggggatttagctcagtggt 
Dimt1-10 ggttccttcactccactttcc tttctggggacattttggac 
Dimt1-11 gccgaaattattgccaatgt catgtcctaacctaggggaat 
      
Tarbp2-1 tgtattttgccaaggctgtg ccttgacaaaggagaaatctga 
Tarbp2-2 gggttcctgaattgcattgt ctgaaggcaagtggagaagg 
Tarbp2-3 ctccccagcatagagcaaat gtcgtacacgggcttctttc 
Tarbp2-4 gacaccagctgcactgactc  catctccatgggagagttcc 
Tarbp2-5 tccataaagctggcaaagtg accaatggaaaaatggcttg 
Tarbp2-6 tctagggtctttgggctctg cccactcaggctcagttca 
Tarbp2-7 gtcactgtggttctgccact tgggtgctatttgctactgg 
Tarbp2-8 gagactgaggaaggcacagg cgaattccaatttcccttca 
Tarbp2-9 aaggagccatgaaccacaa tttattctggactccaatcgaa 
Tarbp2-10 caaaacttaaatttaggaaaag tttcaattgttctcatcaaaaa 
Tarbp2-11 caaacaaacaaacaaaaacaa tctccaaaataaagacaatca 
      
Sfrs11-1 gaatcaaggcacacatacct cggaatgattgatagttgatg 
Sfrs11-2 gtgcactattagaagtggaaga tatgtttggttggagaggac 
Sfrs11-3 taaatgtgtgcttgttggtc gttgagaaaaatcccaatga 
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Sfrs11-4 caaatcaaatacttgcctatca aggactgtggcatgacttac 
Sfrs11-5 ctctgtccttgctctctgtg gcggggttatctagctgt 
Sfrs11-6 ttagtaatccgggccttg aaaaagtttctcctcagtgc 
Sfrs11-7 gtcggttgtcttgagttgat agctgctcgtaatacaccac 
Sfrs11-8 atggacaatccaatcttacg tgcagtgattaaagatgtgc 
Sfrs11-9 ttcctgcttagtttttcctg cacgttaggaacctacatcc 
Sfrs11-10 gagaacaacttgagcgagac acctctgactgagttggcta 
Sfrs11-11 cattggaggtctaattttgc taggacaaaaaggcaaacac 
      
Ntng1-1 tgaacacatcctgagacaga cttggcagagaccctaaaat 
Ntng1-2 ggctctgagagagctgttta ttgatgggaaagatctgact 
Ntng1-3 gccaacttgctttctatcat gcaaccttttggaaacaata 
Ntng1-4 cagacacaggaccatagaca acatccgataatcctgagtg 
Ntng1-5 tgttctacgaggagaagagg acagattgggaatattgtgc 
Ntng1-6 aaagacacgtatagaggcaca catgaatcgacaggaatctt 
Ntng1-7 cagatttacacggaagaagg taatatccggaggatccag 
Ntng1-8 acaaatggcattgtatctca caagcttccactaaaaagga 
Ntng1-9 ataaaccaaggcaggtgata aaccattaatgtagctttttga 
Ntng1-10 aaactggaatgtttggtcag ttggtctacagggtgagttc 
Ntng1-11 gaggtgggttatgtgaaaga caggagatttcagcagctat 
      
Epha6-1 gaggatggcactcagaca acctttcccttcaagacatt 
Epha6-2 gttttgggggactaaggtag agcctcttgactgtgtgg 
Epha6-3 cctttggaccacttgagat cagatcagaggaggcaca 
Epha6-4 agaactgcaccttcactacc agctcaggctgtagtttgg 
Epha6-5 gaggaagaggaggaggag ctcctccttaaaaagaagtg 
Epha6-6 aagtccgggaatttctttt gtttgtcccttaccttggtt 
Epha6-7 gaacttcttccctgggttag gttatgagcttcggaaagaa 
Epha6-8 gcagcttaaaagaaaggtca cgaggaagtgaatggtagag 
Epha6-9 atcagtgggtagtggtaacg atctcatggaaggatgagtg 
Epha6-10 acagccataaaagttttcca gtctgcgtagagagtccttg 
Epha6-11 ctttgtgcaggataggtagg gaggaatgtctgaatgctgt 
      
Gcnf-1 cacattttagtgtctgtgtgg acattgatttctggccttta 
Gcnf-2 acatgtacagacaaacccact ttctctttcttcagcctcca 
Gcnf-3 tgtttaacttcgcaagtctg ataacaactggtgccaagtc 
Gcnf-4 tgaaacaagagccagaattt ttgcaaaccttaagagcaat 
Gcnf-5 ccagaaattgtggttttgtc gttacacacagcatgcaaga 
Gcnf-6 gtggcacatggttgtaatc catgtagctgagacaaactcc 
Gcnf-7 aaaaacccagaaacaaaaca taagcttcaccaagaagagc 
Gcnf-8 tcatggcaaaggttacttct ctctgccacttgttagctct 
Gcnf-9 aaatgttcccttcctttctc aggatttggtgaagagctac 
Gcnf-10 ctcttattcttgggacatgg cagaacctgaactcggtatt 
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Gcnf-11 gttatgtgcttgtggtgatg agaataatgagggcaatgaa 
      
Igf1-1 tggatcaacaaaagatcaga ccagggttatgatgtcattc 
Igf1-2 ccagctggtattatttggaa tttgtgtaagtgggacacag 
Igf1-3 atagtgtgtgcctcccatac tctgggacagtctgaaaaat 
Igf1-4 caaagcatgatacagtgtcc gattgaaagccagttttctg 
Igf1-5 tttcccccaaattttgtatt gctcgaaggtacacttgtct 
Igf1-6 ttaacgtctgctaaccctgt ttctggcaaagttatcgagt 
Igf1-7 ctaaatccctcttctgcttg tcacatttcaattttgagga 
Igf1-8 caccaattcatttccagact ccttcaagaagtcacagagg 
Igf1-9 ctgcctgcagtcattatattc tttttaacagctcccacaga 
Igf1-10 tgctaaaccctccacttcta cgtttatatccatgcttcct 
Igf1-11 atgtgtgtgatttgtcagga agtgcaaagaactcccaat 
      
Cdh19-1 cgtttttcctgttctgtgat ctccttatttgggaaggact 
Cdh19-2 tggtagggtagcatcttgac aatgacaggtggttgaaaag 
Cdh19-3 gtgagaaaaaggaccctacc  attcttgtactgtggcctgt 
      
Pard3-1 cccaaaagccttcttagag aataaaaggaactcgcaaaa 
Pard3-2 aaaaaccctaagaaaacaac  cttctcactggggaattgt 
Pard3-3 aaatcactcctgttttccaa gtgagagggaaaaatctgc 
      
Mcc-1 tctgttacctggacaagtgc  ccagggtttttctaacatga 
Mcc-2 atgccttgctagcttaggag agcagaaccttcctcatctt 
Mcc-3 caaagctaagccaagaacac ctggtagctcatatgccttg 
      
Vom2r7-1 aacctataccacaagcatcg gggcatttgatattttgcta 
Vom2r7-2 gcttcagcagaaacatcttc ttaagtccctgaagtggaaa 
Vom2r7-3 tgcatgcaagacttttaatg ctttctctggtgtcttggag 
Table B.2:  Promoter primers used for real-time PCR of CitK target 
Genomic Loci.  Promoter spanning primers used in all real-time PCR 
experiments of ChIP DNA for Citron kinase, G9a and H3K9me2.  Primers were 
designed to amplify 200bp increments +1Kb to -1Kb of the TSS of the gene.  
Thus primer 1 is +1Kb-+800bp, primer 2 is +800bp to +600bp, etc. 
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Table C.1: CitK Genomic Occupancy in the Neural Progenitors  
Nearest PromoterID Gene Name ChIP_ Enrichment 
Distance to 
TSS 
NM_053677 Chek2 36.09 -204584 
NM_001025755 MGC116197 39.12 -121104 
NM_001044253 Pif1 52.98 -119732 
NM_001107516 Tubgcp5 37.98 -99268 
NM_023956 Gucy1a2 50.43 -90434 
NM_023956 Gucy1a2 36.69 -87599 
NM_001004446 Smarca2 24.87 -81124 
NM_001044253 Pif1 41.91 -73795 
NM_001044253 Pif1 79.47 -73171 
NR_046246 Rn28s 16.29 -70471 
NM_020088 Tenm2 34.11 -68753 
NM_001109010 Nudt12 32.88 -67867 
NM_022799 Nucks1 35.07 -67044 
NM_001099659 Vom2r78 14.94 -62394 
NM_001099659 Vom2r78 51.78 -62120 
NR_046239 Rn45s 15.33 -61241 
NM_001134705 Cox7c 37.98 -60014 
NM_001107180 Ipo9 37.98 -58559 
NM_031572 Cyp2c12 32.01 -51506 
NM_030836 Erap1 43.83 -50650 
NM_001106930 Efcab1 13.74 -49783 
NM_001106930 Efcab1 64.35 -49627 
NM_001106930 Efcab1 52.98 -49539 
NM_001106930 Efcab1 79.47 -49514 
NM_001106930 Efcab1 15.99 -49463 
NM_001106930 Efcab1 13.2 -49418 
NM_001106930 Efcab1 12.39 -49383 
NM_001106930 Efcab1 11.85 -49244 
NM_001106930 Efcab1 14.25 -49175 
NM_001106930 Efcab1 14.1 -49064 
NM_053706 Dmrt1 19.8 -48973 
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NM_001099659 Vom2r78 25.83 -48033 
NR_045198 Hmox2-ps1 31.65 -47419 
NM_001106020 Abca13 26.58 -46555 
NM_080895 Faim 34.29 -43420 
NM_030836 Erap1 37.98 -41672 
NM_030836 Erap1 27.27 -41532 
NM_001099659 Vom2r78 34.32 -41434 
NM_001099659 Vom2r78 73.35 -41399 
NM_001099659 Vom2r78 50.01 -41095 
NM_001009448 Cdh19 31.17 -40028 
NM_001009448 Cdh19 28.05 -39911 
NM_001009448 Cdh19 30.69 -39745 
NM_001009448 Cdh19 18.21 -39476 
NM_001009448 Cdh19 17.4 -39447 
NM_001009448 Cdh19 21.03 -39413 
NM_001009448 Cdh19 30.06 -39327 
NM_001009448 Cdh19 19.05 -39255 
NM_001009448 Cdh19 25.41 -39172 
NM_001009448 Cdh19 16.47 -39131 
NM_001009448 Cdh19 50.1 -39096 
NM_001009448 Cdh19 34.5 -38931 
NM_001009448 Cdh19 29.22 -38797 
NM_001009448 Cdh19 35.07 -38706 
NM_001009448 Cdh19 31.56 -38604 
NM_001009448 Cdh19 37.98 -38176 
NM_001009448 Cdh19 29.22 -37782 
NM_001014074 Fam228a 17.91 -37436 
NM_001009448 Cdh19 31.65 -37435 
NM_001009448 Cdh19 37.59 -36805 
NM_001009448 Cdh19 20.88 -36746 
NM_001009448 Cdh19 37.77 -36525 
NM_001009448 Cdh19 44.31 -36504 
NM_001009448 Cdh19 37.2 -36479 
NM_001047873 Cntnap5b 44.31 -35538 
NM_001107278 Fndc3a 40.92 -35195 
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NM_001134746 Lrrtm4 37.98 -34295 
NM_001044253 Pif1 79.47 -32764 
NM_001271306 LOC686295 19.74 -30057 
NM_001134416 Ints10 37.98 -28334 
NM_012583 Hprt1 55.47 -26853 
NM_001107464 Dact2 14.13 -25338 
NM_199118 Gaa 48.9 -25059 
NM_001007558 Emr4 30.57 -24006 
NR_031818 Mir17-1 34.71 -23911 
NM_001009538 Zfp868 20.04 -22817 
NM_001108058 Spaca5 92.7 -22683 
NM_022686 Hist1h4b 35.07 -22432 
NM_022686 Hist1h4b 37.98 -22313 
NM_022686 Hist1h4b 35.07 -22264 
NM_031819 Fat1 30.69 -22142 
NM_053379 Dcx 55.02 -22140 
NM_001271306 LOC686295 46.68 -22025 
NM_001108242 Slc9a7 46.68 -21772 
NM_022686 Hist1h4b 37.2 -21007 
NM_001107585 Uhrf2 79.47 -20929 
NM_001135756 Galntl6 44.31 -20247 
NM_021762 Tsn 30.06 -20095 
NM_001006990 Igsf5 13.11 -20085 
NM_001135084 Zfp322a 31.32 -19714 
NM_021762 Tsn 38.97 -19546 
NM_022686 Hist1h4b 35.07 -19461 
NM_022686 Hist1h4b 58.47 -19411 
NM_021762 Tsn 32.31 -19268 
NM_021762 Tsn 35.76 -19246 
NM_001108547 Ect2 37.2 -19200 
NM_021762 Tsn 40.92 -19108 
NM_021762 Tsn 30.24 -19011 
NM_054006 Csde1 12.45 -18404 
NM_021762 Tsn 32.67 -18320 
NM_001044253 Pif1 64.17 -18235 
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NM_021762 Tsn 37.98 -18199 
NM_021762 Tsn 50.67 -18135 
NM_021762 Tsn 29.22 -17879 
NM_023956 Gucy1a2 66.21 -17814 
NM_021762 Tsn 37.98 -17799 
NM_021762 Tsn 47.82 -17561 
NR_046246 Rn28s 15.21 -15891 
NM_001014146 RGD1308114 37.98 -15569 
NM_001110366 Pabpc5 27.09 -15397 
NM_001106883 Apobec2 44.31 -15026 
NM_001013033 Tspyl1 50.67 -14375 
NM_001277057 Ascc3 29.22 -13408 
NM_001109414 Dazl 31.65 -13375 
NM_145777 Olfm3 40.92 -13182 
NM_001135030 Tctex1d1 35.55 -12981 
NM_031828 Kcnma1 56.76 -12878 
NM_001037216 Nxf7 44.19 -12578 
NM_031070 Nell2 20.76 -11997 
NM_199412 Micu1 11.1 -11631 
NM_001109500 Lce1m 13.53 -10282 
NM_031571 Acvr2a 24.18 -10255 
NM_001113787 RGD1559804 36.63 -10251 
NM_031007 Adcy2 33.63 -10240 
NM_001191810 Tns1 38.37 -10144 
NM_031563 Ybx1 37.98 -9653 
NM_001271306 LOC686295 39.57 -9471 
NM_001013033 Tspyl1 35.07 -9238 
NM_001191089 Mitf 43.08 -9056 
NM_001170534 Mcc 37.98 -8893 
NM_001170534 Mcc 31.65 -8793 
NM_001170534 Mcc 46.77 -8758 
NM_001170534 Mcc 37.98 -8676 
NM_001017452 Nsun7 12.57 -8647 
NM_001170534 Mcc 40.92 -8554 
NM_001170534 Mcc 44.31 -8397 
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NM_001109010 Nudt12 32.88 -8375 
NM_001170534 Mcc 37.98 -8300 
NM_001170534 Mcc 30.3 -8242 
NM_001170534 Mcc 31.65 -8149 
NM_022204 Exoc5 21.66 -7986 
NM_001107363 Pitrm1 27.45 -7885 
NM_147146 Rwdd1 37.98 -7848 
NM_001170534 Mcc 37.98 -7775 
NM_021672 Gdf9 37.98 -7735 
NM_001170534 Mcc 44.31 -7684 
NM_001109259 RGD1564053 37.98 -7647 
NM_147146 Rwdd1 33.93 -7636 
NM_001170534 Mcc 43.83 -7628 
NM_001109312 Vwc2 59.16 -7417 
NM_001170534 Mcc 37.98 -7405 
NM_001271306 LOC686295 20.16 -7370 
NM_021762 Tsn 35.07 -7350 
NM_001170534 Mcc 31.98 -7325 
NM_001170534 Mcc 34.5 -7242 
NM_001013033 Tspyl1 37.98 -7219 
NM_001170534 Mcc 34.59 -7183 
NM_022284 Guca2b 46.41 -7161 
NM_001109460 Stx19 29.34 -7147 
NM_001004095 S100a11 17.88 -7138 
NM_001170534 Mcc 33.18 -7122 
NM_001013033 Tspyl1 43.08 -7019 
NM_001044245 Asap1 27.81 -6962 
NM_001106930 Efcab1 26.4 -6950 
NM_001107095 Nfkbiz 44.01 -6943 
NM_001191691 Trpc7 50.67 -6926 
NM_001013033 Tspyl1 37.68 -6888 
NM_001170534 Mcc 26.97 -6876 
NM_001013033 Tspyl1 42.03 -6805 
NM_001170534 Mcc 45.09 -6706 
NM_001170534 Mcc 32.31 -6600 
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NM_001170534 Mcc 44.31 -6519 
NR_046238 Rn5-8s 48.9 -6291 
NM_001126289 Dennd1c 52.98 -6246 
NM_001170534 Mcc 33.93 -6138 
NM_001126289 Dennd1c 47.31 -6113 
NM_001100860 Slc25a16 40.92 -6055 
NM_001170534 Mcc 37.98 -6010 
NM_001170534 Mcc 30.06 -5890 
NM_001271306 LOC686295 50.94 -5885 
NM_173310 Chst15 26.31 -5867 
NM_001170534 Mcc 35.07 -5775 
NM_017018 Hrh1 37.98 -5691 
NM_001170534 Mcc 42.51 -5690 
NM_001170534 Mcc 54.42 -5657 
NM_001170534 Mcc 44.31 -5622 
NM_021762 Tsn 20.7 -5592 
NM_001106061 Arhgef3 69.66 -5575 
NM_001170534 Mcc 39.6 -5549 
NM_012957 Gabrb2 22.89 -5421 
NM_001170534 Mcc 37.2 -5418 
NM_001271306 LOC686295 47.31 -5335 
NM_001100973 Pard6g 12 -5318 
NM_199106 Galnt13 35.07 -5304 
NM_001271306 LOC686295 52.98 -5273 
NM_001271306 LOC686295 104.79 -5247 
NM_001170534 Mcc 45.27 -5220 
NM_001170534 Mcc 43.47 -5170 
NM_001009629 Rfc3 126.63 -5098 
NM_001106398 Mcu 29.94 -5048 
NM_175595 Cacna2d3 50.67 -4987 
NM_177935 Il1rapl1 29.34 -4847 
NM_001271306 LOC686295 45.84 -4841 
NM_001271306 LOC686295 61.14 -4827 
NM_001271306 LOC686295 41.91 -4800 
NM_001039699 Lrfn2 37.98 -4740 
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NM_001012464 Terf1 31.65 -4723 
NM_001044253 Pif1 62.49 -4695 
NM_001271306 LOC686295 45.84 -4650 
NM_001271306 LOC686295 22.92 -4622 
NM_001271306 LOC686295 42.78 -4556 
NM_001271306 LOC686295 61.14 -4547 
NM_017354 Ntm 33.63 -4547 
NM_001271306 LOC686295 43.14 -4525 
NM_001009629 Rfc3 139.32 -4510 
NM_001006999 Xrcc4 50.67 -4256 
NM_001271306 LOC686295 48.9 -4177 
NM_001006999 Xrcc4 41.61 -4173 
NM_021261 Tmsb10 35.07 -4170 
NM_001005539 Smpdl3a 37.98 -4106 
NM_080405 Gli3 32.37 -3977 
NM_001107137 Tyw1 46.77 -3954 
NM_001277210 Smim15 30.06 -3938 
NM_001271306 LOC686295 52.98 -3871 
NM_145088 Rmt1 37.98 -3841 
NM_001100528 Rag2 28.29 -3834 
NM_001110366 Pabpc5 57.15 -3828 
NM_022223 Fgf14 31.65 -3823 
NM_024152 Arf6 41.76 -3794 
NM_023956 Gucy1a2 119.19 -3732 
NM_024159 Dab2 35.07 -3695 
NM_012959 Gfra1 61.14 -3676 
NM_019171 Spt1 12.54 -3637 
NM_001109312 Vwc2 45.15 -3614 
NM_001107331 Irx1 70.98 -3587 
NM_001271306 LOC686295 64.35 -3542 
NM_001271306 LOC686295 49.44 -3482 
NM_001106387 Lrrtm3 30.06 -3471 
NM_031542 Brca2 38.37 -3432 
NM_001108415 Elmo1 40.92 -3431 
NM_001004282 Tmem178a 29.22 -3335 
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NM_001142758 Zfp958 42.09 -3314 
NM_012750 Gfra2 36.27 -3286 
NM_001099465 Vom2r9 37.98 -3280 
NM_001037216 Nxf7 36.69 -3200 
NM_001108420 Asb13 35.07 -3134 
NM_001109460 Stx19 27.57 -3112 
NM_001191846 Foxo1 42.51 -3107 
NM_001142758 Zfp958 46.77 -3105 
NM_001191663 Gsx1 35.67 -2983 
NM_144758 Slc15a4 23.64 -2971 
NM_001191663 Gsx1 34.5 -2952 
NM_001024365 Cesl1 44.25 -2930 
NM_001135174 Tomm7 20.61 -2861 
NM_031542 Brca2 24.54 -2848 
NM_001191626 Mex3b 43.83 -2841 
NM_001191663 Gsx1 50.91 -2814 
NM_001106844 Fam46a 29.22 -2710 
NM_001014228 Cct6b 36.27 -2686 
NM_001191663 Gsx1 40.92 -2673 
NM_013219 Cadps 37.44 -2652 
NM_001037216 Nxf7 31.44 -2652 
NM_001271306 LOC686295 32.1 -2641 
NM_001191663 Gsx1 63.24 -2620 
NM_001037216 Nxf7 35.97 -2606 
NM_001191663 Gsx1 32.88 -2561 
NM_031542 Brca2 44.31 -2534 
NM_001191663 Gsx1 34.5 -2532 
NM_001134979 Ezh2 69.66 -2526 
NM_001107748 Slc35c1 37.59 -2503 
NM_001037216 Nxf7 44.01 -2501 
NM_001106968 RGD1561230 27 -2466 
NM_001191873 Gsc 50.67 -2442 
NM_001134979 Ezh2 37.98 -2429 
NM_001163168 Ntrk2 25.68 -2423 
NM_001191663 Gsx1 44.31 -2419 
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NM_001107813 Zfp217 75.99 -2417 
NM_001271306 LOC686295 26.97 -2406 
NM_207613 Cdh15 35.07 -2343 
NM_001126289 Dennd1c 59.7 -2332 
NR_031934 Mir221 56.34 -2332 
NM_031542 Brca2 44.31 -2273 
NM_022589 Tspan2 29.64 -2262 
NM_001105950 Slc35f5 35.07 -2220 
NM_001048215 Kirrel3 24.36 -2144 
NM_001025133 Capn13 24.24 -2140 
NM_001270711 Gucy1b2 32.31 -2137 
NM_001011938 Scyl1 44.31 -2137 
NM_001126289 Dennd1c 62.88 -2097 
NM_053324 Syt9 37.98 -2080 
NM_001012116 Spag1 31.17 -2032 
NM_133589 Ppp6c 35.07 -1996 
NM_001017467 Ly6e 21.03 -1987 
NM_001007750 Chpt1 28.05 -1975 
NM_001191694 Nebl 35.07 -1848 
NM_053849 Pdia4 44.31 -1840 
NM_001077681 RGD1564345 44.31 -1676 
NM_001191893 Ero1lb 36.27 -1537 
NM_001006990 Igsf5 31.65 -1507 
NM_001108669 Ptplad2 33.18 -1484 
NM_001107626 Ado 40.92 -1463 
NM_012973 Kcne1 31.26 -1439 
NM_001037287 Hnrnpf 28.29 -1409 
NM_176074 C6 35.07 -1345 
NM_001000970 Olr1635 31.17 -1288 
NM_021837 Mycs 61.14 -1245 
NR_046246 Rn28s 62.88 -1175 
NM_001024365 Cesl1 48.9 -1141 
NM_001024365 Cesl1 45.84 -1104 
NR_046239 Rn45s 17.49 -1097 
NM_001014048 Ctdspl2 37.59 -1085 
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NR_046246 Rn28s 40.74 -1015 
NM_012670 Tcp1 18.9 -991 
NR_046239 Rn45s 16.8 -950 
NM_053415 Cxcr3 24.39 -931 
NM_057124 P2ry6 37.98 -911 
NM_017018 Hrh1 17.55 -878 
NM_020098 Pclo 62.22 -860 
NR_031902 Mir184 32.73 -835 
NM_001014211 Gcom1 61.38 -798 
NM_001106400 Ankrd32 37.98 -797 
NR_031902 Mir184 44.31 -738 
NR_031902 Mir184 57 -718 
NM_130746 Slc5a6 48.39 -690 
NM_001191586 Bcor 52.98 -688 
NM_001193275 LOC100360933 30.69 -683 
NM_138854 Slc38a5 61.14 -656 
NR_046239 Rn45s 37.44 -653 
NM_001009711 RGD1304567 18.78 -634 
NM_001170593 Chat 37.98 -633 
NM_001047942 LOC499541 31.65 -575 
NM_181375 Robo4 33.06 -567 
NM_001191078 Grxcr2 35.07 -561 
NM_001106473 Bdh2 43.77 -553 
NM_001271190 Smarca1 57.06 -551 
NM_053924 Abcc5 37.98 -543 
NM_138547 Akr1c14 57 -513 
NM_001106256 Josd2 39.6 -477 
NM_022860 B4galnt1 24.54 -475 
NM_001106884 Trem2 37.98 -470 
NM_001013142 Cmtm2a 17.55 -461 
NM_001170343 Sec61a2 57 -460 
NR_046238 Rn5-8s 14.7 -452 
NM_001190372 Ankrd29 36.45 -428 
NM_016991 Adra1b 48.9 -416 
NM_001198796 LOC691849 43.83 -387 
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NM_001024763 Nif3l1 29.22 -373 
NR_046246 Rn28s 17.52 -366 
NM_001109259 RGD1564053 38.97 -365 
NR_046239 Rn45s 62.88 -359 
NM_031235 Pard3 37.59 -281 
NM_001108692 Arhgef19 31.05 -280 
NM_001191692 Lrrc16a 50.67 -280 
NM_031502 Amy2a3 37.59 -267 
NM_001002827 Notch4 37.98 -265 
NM_001100634 Tph1 29.76 -262 
NR_046238 Rn5-8s 39.6 -188 
NM_001099659 Vom2r78 53.94 -180 
NM_001107038 Stxbp4 37.98 -149 
NM_001002853 P2ry13 38.55 -135 
NM_001025002 LOC310926 31.17 -102 
NM_172085 Pou3f2 31.65 -33 
NM_012920 Camk2a 31.65 -21 
NR_046239 Rn45s 52.98 -19 
NM_080782 Cdkn1a 32.73 -16 
NM_012920 Camk2a 37.98 -4 
NR_046239 Rn45s 44.31 -3 
NM_022674 H2afz 28.74 3 
NM_001025676 Rbm22 50.67 6 
NM_001271271 Prr9 17.58 21 
NM_134453 Lbr 38.58 27 
NR_046239 Rn45s 55.02 46 
NM_138891 Gpr149 22.32 75 
NM_173328 Lgr4 50.67 99 
NR_046238 Rn5-8s 14.25 113 
NM_001099465 Vom2r9 56.58 185 
NM_199412 Micu1 13.26 196 
NM_001108950 Gnat2 33.39 251 
NM_080907 Ppp4r1 40.08 267 
NM_001127504 Gas2 28.5 277 
NM_001108537 Gtf3c6 44.31 288 
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NM_001013047 Mtm1 14.79 291 
NM_001109509 Gpr84 10.35 315 
NR_046238 Rn5-8s 17.04 326 
NM_017311 Atp5g1 39.15 331 
NM_001108058 Spaca5 41.25 340 
NM_001106910 Ercc5 38.37 352 
NM_001104528 Ephb1 45.09 361 
NM_001107896 Ppfibp1 22.05 377 
NM_001191579 Elmod1 47.82 402 
NM_001170471 Zc3h13 21.72 414 
NM_001047892 LOC317165 37.59 422 
NM_001246357 Stab2 21.54 453 
NM_022629 Bbox1 37.98 458 
NR_046239 Rn45s 31.2 470 
NM_001114392 Gpr39 35.07 487 
NR_046246 Rn28s 16.2 526 
NM_001108622 Hipk2 37.2 546 
NM_030827 Lrp2 31.65 564 
NM_001100577 Apbb1ip 35.07 577 
NM_183334 Ldhal6b 40.26 648 
NM_053307 Msra 44.31 669 
NM_138854 Slc38a5 52.98 671 
NM_053307 Msra 23.91 695 
NM_057156 St8sia2 37.98 708 
NR_046246 Rn28s 15.81 734 
NM_017018 Hrh1 37.2 737 
NM_001108456 Afg3l1 45.87 746 
NM_001013989 G3bp2 31.17 769 
NR_031902 Mir184 64.29 796 
NM_001107038 Stxbp4 20.46 802 
NM_001126296 Tra2a 32.88 809 
NR_046239 Rn45s 9.54 826 
NR_031902 Mir184 40.92 860 
NR_046246 Rn28s 14.85 870 
NM_001107038 Stxbp4 44.31 874 
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NM_001106108 Irf4 26.31 953 
NM_053612 Hspb8 10.74 964 
NM_012550 Ednra 31.65 971 
NM_001190369 LOC100365112 52.98 1002 
NM_145880 Lhx1 32.88 1006 
NM_001139483 Aifm2 37.98 1033 
NM_001107318 Gtf2e2 50.67 1059 
NM_001012467 Rnase10 35.07 1062 
NR_046246 Rn28s 53.67 1075 
NM_001135992 LOC498276 23.37 1101 
NM_012600 Me1 35.07 1146 
NM_017333 Ednrb 39 1161 
NM_001039006 Klhl25 44.31 1252 
NR_046246 Rn28s 58.41 1257 
NM_001107312 Mtmr7 18.09 1292 
NM_012861 Mgmt 37.59 1296 
NM_001025133 Capn13 31.65 1364 
NM_001013203 Trim44 44.31 1393 
NM_031976 Prkab1 33.39 1503 
NM_001108453 Cbfa2t3 36.63 1532 
NM_207612 Ostn 31.65 1546 
NR_046246 Rn28s 32.16 1551 
NM_001107931 Murc 35.07 1574 
NM_001006990 Igsf5 18.18 1589 
NM_017070 Srd5a1 26.97 1614 
NM_053849 Pdia4 28.35 1623 
NM_001033955 Calca 31.65 1655 
NM_001006990 Igsf5 16.86 1667 
NM_001271111 LOC100910318 48.9 1669 
NR_046246 Rn28s 28.5 1672 
NM_024152 Arf6 25.5 1680 
NM_001106060 Slmap 35.07 1693 
NM_001006990 Igsf5 30.81 1701 
NM_024152 Arf6 20.94 1714 
NM_001014235 Phf11b 35.07 1749 
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NM_001009629 Rfc3 88.65 1766 
NM_031976 Prkab1 42.33 1777 
NM_001014271 LOC367515 14.58 1801 
NM_001009629 Rfc3 82.32 1811 
NM_001100502 Gbe1 44.31 1863 
NM_001130098 Kdm1a 19.98 1878 
NM_020088 Tenm2 25.89 1977 
NM_053849 Pdia4 24.54 2017 
NM_031324 Prep 37.98 2028 
NM_001009629 Rfc3 126.63 2048 
NM_001009629 Rfc3 31.65 2092 
NM_021762 Tsn 31.65 2096 
NM_001108423 Riok3 28.71 2097 
NM_001270711 Gucy1b2 31.89 2113 
NM_031542 Brca2 69.66 2124 
NM_053849 Pdia4 36.27 2132 
NM_031976 Prkab1 35.07 2154 
NM_001010961 Tmem17 35.07 2159 
NM_001109087 Shisa3 14.49 2161 
NM_001024342 Dnai1 39.66 2201 
NM_053849 Pdia4 36.27 2207 
NM_001108239 Gtf3c3 35.07 2225 
NM_001024342 Dnai1 43.83 2233 
NM_001191080 Golga4 37.98 2253 
NM_001024342 Dnai1 36.69 2265 
NM_001170398 Fry 35.07 2274 
NM_001191663 Gsx1 31.65 2294 
NM_001191663 Gsx1 31.65 2340 
NM_013123 Il1r1 30.06 2367 
NM_001191663 Gsx1 50.67 2411 
NM_001191784 Srgap1 28.05 2425 
NM_001191663 Gsx1 31.65 2430 
NM_021687 Erbb4 38.58 2457 
NM_017116 Capn2 29.82 2459 
NM_001191663 Gsx1 35.07 2471 
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NM_001191663 Gsx1 31.65 2499 
NM_001126289 Dennd1c 48.9 2538 
NM_147146 Rwdd1 37.98 2564 
NM_001191663 Gsx1 30.93 2570 
NM_001191663 Gsx1 23.07 2589 
NM_001191663 Gsx1 17.22 2606 
NM_001134979 Ezh2 37.98 2628 
NM_001126289 Dennd1c 73.35 2646 
NM_001191663 Gsx1 61.53 2656 
NM_001006995 Acat2 44.31 2660 
NM_001106879 Efhb 28.05 2676 
NM_001191663 Gsx1 37.77 2680 
NM_001191663 Gsx1 32.4 2697 
NM_001013249 Dhx30 35.07 2721 
NM_001024350 Efcab11 26.31 2725 
NM_001191663 Gsx1 41.25 2733 
NM_001134979 Ezh2 37.98 2743 
NM_001191663 Gsx1 31.65 2756 
NM_001169129 Pcdh19 27.21 2795 
NM_001005539 Smpdl3a 31.65 2798 
NM_001191663 Gsx1 30.78 2802 
NM_001134416 Ints10 455.91 2826 
NM_001271306 LOC686295 61.14 2848 
NM_031976 Prkab1 38.37 2853 
NM_001191663 Gsx1 41.25 2855 
NM_001191663 Gsx1 46.77 2884 
NM_001005539 Smpdl3a 23.37 2903 
NM_001191663 Gsx1 35.22 2912 
NM_001191663 Gsx1 50.67 3003 
NM_001005539 Smpdl3a 39.45 3004 
NM_001191663 Gsx1 32.64 3019 
NM_001024365 Cesl1 36.69 3031 
NM_001191663 Gsx1 37.98 3054 
NM_001005539 Smpdl3a 30.69 3093 
NM_133528 Mob4 45.54 3103 
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NM_001142758 Zfp958 44.31 3138 
NM_031542 Brca2 40.32 3194 
NM_001142758 Zfp958 63.33 3237 
NM_001170475 Tmem260 46.77 3244 
NM_001142758 Zfp958 40.92 3290 
NM_001013963 Cpped1 34.29 3391 
NM_001004072 Pdha1 41.91 3417 
NM_001108214 Npas2 27.39 3452 
NM_001271306 LOC686295 45.96 3458 
NM_001142758 Zfp958 44.31 3487 
NM_001142758 Zfp958 44.31 3549 
NM_001035249 Parl 37.98 3568 
NM_001126289 Dennd1c 60.3 3589 
NM_001109012 Rp2 89.22 3646 
NM_001109312 Vwc2 32.58 3670 
NM_001109312 Vwc2 75.51 3727 
NM_031542 Brca2 29.64 3770 
NM_133539 Mrpl17 31.65 3782 
NM_207587 Adipor1 44.55 3934 
NM_001271306 LOC686295 52.98 4010 
NM_001191663 Gsx1 27.81 4030 
NM_021766 Pgrmc1 79.47 4047 
NM_001006999 Xrcc4 31.65 4060 
NM_001006999 Xrcc4 44.31 4088 
NM_001006999 Xrcc4 38.37 4121 
NM_001106012 Evc2 33.15 4162 
NM_001005539 Smpdl3a 30.24 4174 
NM_001191586 Bcor 61.14 4192 
NM_001006999 Xrcc4 36.93 4230 
NM_001005539 Smpdl3a 32.37 4272 
NM_001271306 LOC686295 62.16 4314 
NM_001011969 Strap 42.51 4388 
NM_001271248 Crem 26.52 4405 
NM_001024870 Ctnnbl1 35.07 4421 
NM_017354 Ntm 36.27 4597 
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NM_001009629 Rfc3 75.99 4624 
NM_198737 Arl6ip1 31.17 4674 
NM_001009629 Rfc3 132.96 4681 
NM_001107199 Kctd3 37.98 4688 
NM_198737 Arl6ip1 21.66 4701 
NM_001107199 Kctd3 44.31 4701 
NM_001271306 LOC686295 42.09 4767 
NM_133601 Cblb 25.68 4767 
NM_001009629 Rfc3 107.64 4841 
NM_001017499 Scfd2 43.83 4852 
NM_001271306 LOC686295 59.49 4941 
NM_001009629 Rfc3 63.33 4992 
NM_001009629 Rfc3 126.63 5072 
NM_001109092 Hus1 46.77 5084 
NM_138854 Slc38a5 66.21 5091 
NM_001142758 Zfp958 37.98 5150 
NM_001271306 LOC686295 52.41 5186 
NM_001014061 Ccdc91 30.06 5233 
NM_001170534 Mcc 27.84 5287 
NM_001271306 LOC686295 52.98 5362 
NM_001170534 Mcc 37.98 5501 
NM_022669 Scg2 20.58 5562 
NM_001106398 Mcu 35.97 5584 
NM_053724 Glra3 28.71 5605 
NM_017018 Hrh1 31.65 5734 
NM_017018 Hrh1 47.82 5823 
NM_001271306 LOC686295 26.67 5823 
NM_001170534 Mcc 31.65 5845 
NM_053724 Glra3 36.93 5939 
NM_001271306 LOC686295 66.21 5949 
NM_139091 Nupl1 31.65 5951 
NM_001106372 Rnf153 14.04 5956 
NM_001271306 LOC686295 60.12 6006 
NM_001191687 Kcnrg 31.65 6009 
NM_001271306 LOC686295 51.48 6066 
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NM_001271306 LOC686295 40.2 6290 
NM_001271306 LOC686295 52.98 6367 
NM_001170534 Mcc 24.63 6375 
NM_001170534 Mcc 31.32 6450 
NM_017018 Hrh1 27.87 6532 
NM_001109010 Nudt12 40.08 6675 
NM_001170534 Mcc 40.86 6770 
NM_001191691 Trpc7 29.22 6898 
NM_001134861 Cerk 41.61 6928 
NM_013028 Shox2 33.93 6929 
NM_031040 Grm7 30.06 6956 
NM_001170534 Mcc 35.07 7006 
NM_001106217 Lrp11 50.67 7029 
NM_022384 Ascl1 29.76 7058 
NM_001109460 Stx19 35.25 7105 
NM_001013033 Tspyl1 36.27 7320 
NM_001012097 Atg7 30.96 7348 
NM_001170534 Mcc 31.47 7557 
NM_001191936 Shisa2 40.77 7571 
NM_001134574 LOC361646 31.32 7654 
NM_001170534 Mcc 38.85 7843 
NM_001170534 Mcc 35.07 7980 
NM_001271306 LOC686295 12.33 7985 
NM_001170534 Mcc 44.31 8350 
NM_001271306 LOC686295 17.43 8399 
NM_031117 Snrpn 44.31 8452 
NM_001170534 Mcc 59.67 8465 
NM_001009538 Zfp868 38.37 8466 
NM_001107939 Pappa 32.64 8535 
NM_181365 Kcnip4 30.72 8798 
NM_001271306 LOC686295 10.65 8887 
NM_001170534 Mcc 15.39 8927 
NM_147146 Rwdd1 31.17 9712 
NM_001001515 Lmo7 82.32 10059 
NM_001109500 Lce1m 15.36 10220 
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NM_001024892 Rlim 26.64 10325 
NM_013128 Cpe 35.07 10348 
NM_001134416 Ints10 33.18 10429 
NM_031007 Adcy2 43.08 10503 
NM_001106136 Ftmt 37.98 10572 
NM_031542 Brca2 36.42 10702 
NM_001024365 Cesl1 44.46 11062 
NM_001025762 Smyd3 29.73 11308 
NM_001037216 Nxf7 42.51 11367 
NM_019378 Srcin1 34.56 11785 
NM_001109110 Anxa10 40.92 11926 
NM_021762 Tsn 29.22 12126 
NM_001106598 Ctnna2 36.63 12221 
NM_001106896 Tfap2b 23.7 12382 
NM_023956 Gucy1a2 39.72 12941 
NM_022211 Fgf5 13.89 13260 
NM_001135084 Zfp322a 37.98 13358 
NM_057097 Vamp3 62.64 13566 
NM_001013033 Tspyl1 26.31 13681 
NM_001135084 Zfp322a 38.97 14088 
NM_147146 Rwdd1 49.23 14113 
NM_001135084 Zfp322a 38.97 14300 
NM_001109127 Cbln1 35.07 14439 
NM_001004448 Dear 37.89 14449 
NM_012603 Myc 11.94 14485 
NM_012585 Htr1a 37.59 14503 
NM_001135084 Zfp322a 38.97 14733 
NM_023956 Gucy1a2 52.98 14928 
NM_001191688 Pcdh9 35.07 15121 
NM_001013896 Tmem135 50.1 15197 
NM_001013155 Shoc2 32.61 15317 
NM_001104613 Hnrnpa2b1 31.17 15560 
NM_022686 Hist1h4b 37.98 15784 
NM_001134747 Zmat4 36.09 15867 
NM_023956 Gucy1a2 78.6 16417 
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NM_001108030 Daam1 28.44 16538 
NM_019318 Maf 37.59 16605 
NM_130822 Lphn3 43.83 16811 
NM_022198 Clcn4 58.98 17082 
NM_001191939 Msr1 26.31 17409 
NM_021762 Tsn 50.82 17412 
NM_021762 Tsn 50.67 17481 
NM_001134416 Ints10 42.33 17482 
NM_021762 Tsn 31.65 17601 
NM_021762 Tsn 44.31 17673 
NM_021762 Tsn 31.65 17690 
NM_021762 Tsn 44.31 17734 
NM_021762 Tsn 31.17 17768 
NM_021762 Tsn 31.65 17842 
NM_021762 Tsn 34.5 17999 
NM_021762 Tsn 37.59 18025 
NM_021762 Tsn 38.31 18102 
NR_046246 Rn28s 42.78 18186 
NR_046246 Rn28s 13.56 18212 
NM_021762 Tsn 50.67 18222 
NM_021762 Tsn 35.07 18256 
NM_021762 Tsn 50.67 18275 
NM_021762 Tsn 44.19 18398 
NM_023956 Gucy1a2 45.84 18549 
NM_001134416 Ints10 31.65 18613 
NM_021762 Tsn 42.09 18658 
NM_021762 Tsn 28.8 18711 
NM_001163156 Etv1 47.85 18769 
NM_021762 Tsn 46.77 18792 
NM_021762 Tsn 34.92 18832 
NM_021762 Tsn 31.65 19039 
NM_021762 Tsn 37.98 19128 
NM_021762 Tsn 37.2 19185 
NM_021762 Tsn 37.98 19224 
NM_021762 Tsn 28.35 19413 
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NM_021762 Tsn 44.31 19443 
NM_021762 Tsn 48.39 19515 
NM_021762 Tsn 33.93 19624 
NM_021762 Tsn 34.5 19670 
NM_021762 Tsn 31.89 19860 
NM_021762 Tsn 33.93 19931 
NM_021762 Tsn 57 19985 
NM_001047866 Cntnap5c 25.05 20134 
NM_001191842 Cetn3 40.92 20449 
NM_001271306 LOC686295 13.71 20738 
NM_022686 Hist1h4b 30.51 21061 
NM_022686 Hist1h4b 36.93 22079 
NM_001005246 Dmd 41.91 23241 
NM_001106050 Dnajc15 35.07 23635 
NM_001106050 Dnajc15 18.45 23695 
NM_021767 Nrxn1 44.31 25436 
NM_001191636 Myof 16.74 25592 
NM_145098 Nrp1 35.07 25911 
NM_001191684 Fancl 38.37 27168 
NM_001099659 Vom2r78 40.2 29063 
NM_001044253 Pif1 77.22 29337 
NM_001108058 Spaca5 51.09 29423 
NM_001013993 LOC305806 48.09 29533 
NM_001271306 LOC686295 18.45 30201 
NM_001014074 Fam228a 28.11 30342 
NM_001135020 Sec61g 24.93 32646 
NM_001044253 Pif1 73.44 32793 
NM_001107283 Slitrk1 41.4 33735 
NM_133418 Slc25a10 25.47 34253 
NM_030836 Erap1 37.68 35797 
NM_001009448 Cdh19 37.98 36017 
NM_001134622 Ccser1 37.59 36578 
NM_001009448 Cdh19 40.92 36849 
NM_001106398 Mcu 20.34 36931 
NM_001009448 Cdh19 30.78 38528 
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NM_001009448 Cdh19 50.1 38559 
NM_001009448 Cdh19 37.98 38838 
NM_001009448 Cdh19 35.07 38978 
NM_001009448 Cdh19 25.17 39353 
NM_001009448 Cdh19 36.93 39562 
NM_001009448 Cdh19 24.6 39639 
NM_031114 S100a10 37.98 40741 
NM_001099659 Vom2r78 66.03 41116 
NM_001099659 Vom2r78 37.05 41146 
NM_001099659 Vom2r78 45.15 41309 
NM_001099659 Vom2r78 36.69 41526 
NM_001099659 Vom2r78 39.66 41598 
NM_001108991 Trhde 26.31 41702 
NM_001099659 Vom2r78 35.49 41715 
NM_031730 Kcnd2 37.98 41734 
NM_001106386 Reep3 30.06 42011 
NM_001100860 Slc25a16 17.55 44537 
NM_138910 Dad1 37.98 46357 
NM_001106020 Abca13 36.09 46581 
NM_022799 Nucks1 41.01 46666 
NM_001107464 Dact2 19.5 48895 
NM_001106930 Efcab1 13.11 49026 
NM_001106930 Efcab1 12.81 49091 
NM_001106930 Efcab1 66.69 49490 
NM_001107516 Tubgcp5 31.89 49593 
NM_001106930 Efcab1 52.41 49675 
NM_001106930 Efcab1 15.72 49758 
NM_001014033 Septin10 13.35 51479 
NM_001107464 Dact2 21.48 51989 
NM_001108632 Rpia 30.06 52275 
NM_012494 Agtr2 66.21 57536 
NM_199118 Gaa 34.92 57653 
NM_001135020 Sec61g 40.92 60904 
NM_031572 Cyp2c12 19.98 61264 
NM_001099659 Vom2r78 52.98 61526 
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 Table C.1: CitK Genomic Occupancy in the Neural Progenitors.  ChIP-seq 
peaks for CitK are annotated for nearest promoter ID, the name of the gene, the 
raw read count, ChIP enrichment and the peak’s distance to the TSS. 
 
 
 
 
 
NM_001099659 Vom2r78 39.12 61634 
NM_001099659 Vom2r78 52.98 61762 
NM_001099659 Vom2r78 52.41 61889 
NM_001099659 Vom2r78 66.21 62020 
NM_001099659 Vom2r78 40.02 62265 
NM_001107464 Dact2 24.6 64645 
NM_001044253 Pif1 49.56 70310 
NM_001044253 Pif1 30.57 70376 
NM_001113749 Hif1an 34.65 71940 
NM_001025755 MGC116197 48.27 71971 
NM_001044253 Pif1 63.24 72740 
NM_001044253 Pif1 52.41 72822 
NM_001044253 Pif1 33.96 73454 
NM_001099461 Vom2r1 55.02 74268 
NM_001009448 Cdh19 20.49 79237 
NM_001106930 Efcab1 39.03 81327 
NM_001014074 Fam228a 18.57 84093 
NM_001014074 Fam228a 33.69 85348 
NM_001014074 Fam228a 22.53 90509 
NM_133421 Marf1 21.9 95362 
NM_001168631 Cdh10 37.98 95891 
NM_001047873 Cntnap5b 27.12 114486 
NM_001044253 Pif1 52.41 119338 
NM_001044253 Pif1 38.13 119540 
NM_001025755 MGC116197 33.87 133738 
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Appendix D 
 
MASS SPECTROMETRY PHOSPHO-PEPTIDES 
 
G9a peptides  
 
D.1: In vitro Kinase Assay Phospho-peptides 
PEPTIDE SEQUENCE 
.ACASTGVIMSVNNSLYLGPILKFGSAQQK.  3 Phospho (ST);  
.AENSALSMSLRTLQGDLVK.  2 Phospho (ST) 
.AEPLSVQR. + Phospho (ST) 
.ALQGQSGGLR. + Phospho (ST) 
.ALTRSGCFLPSASPAASFGGWLHMVWVVLLSLLCYLVLFLCR. + 4 Phospho (ST);  
.ANTDVLWCVLLLIVMCLTGALGHGIWLSR.  2 Phospho (ST);  
.APGISARFSGSLIGDK. + 2 Phospho (ST) 
R.AQASWAPQLPAGLTGPPVPCLPSQGEAPAEMGALLLEK.E + Phospho (ST) 
R.AQASWAPQLPAGLTGPPVPCLPSQGEAPAEMGALLLEKEPR.G + Phospho (ST) 
.AQDLLRTGSR. + Phospho (ST) 
.AQVATELPKK. + Phospho (ST) 
.ARLAFSSALELNSK. + Phospho (ST) 
.ARLAFSSALELNSK. + Phospho (ST) 
.AVESLTCGK. + Phospho (ST) 
.AVIKHALSCGSFLWM. + Phospho (ST);  
-.CARTPDYYGSSFYAMDYWGQGTSVTVSS.- + 6 Phospho (ST); 3 Phospho (Y);  
.CCRSPR. + Phospho (ST); 2  
.CISQLELAQLIGTGVK. + Phospho (ST);  
.CSAGQKVLASLIIR. + Phospho (ST) 
.CVQLQESGGGLVQPGGSMK. + Phospho (ST);  
K.DINSTAQDVMFYDMGSGSTVCTIVTYQTVK.T  Phospho (ST);  
.DIQMAETSPEGTKPERR.  Phospho (ST) 
.DSIGSPEAGVIGCCELPEVVAENDTLDFYKK. + Phospho (ST); Phospho (Y) 
.EAEEAAKGLPDMDSSILIHHNGGIPANK. + 2 Phospho (ST) 
.EAEGSGLGFLVQVTPMAGDLEQELILTTK. + 3 Phospho (ST) 
.EIGADTFSQLGSLQALDLSWNAIRAIHPEAFSTLR. + 4 Phospho (ST) 
.EIMSSEKVFVDVLK.  Phospho (ST) 
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.EKTIVYLDSMGHK. + Phospho (ST) 
.ELCNSQTLWLLPGGTPTPLGSSSPVKVECLEAELVVTVSR. + 4 Phospho (ST); 2  
.ELLSLYTVNSNTR. + Phospho (ST) 
.EMTTTKCAISVATGK. + Phospho (ST);  
.EPVPKEPLHTTSKPK. + Phospho (ST) 
.ESLDRMADGAR. + Phospho (ST) 
.ESSGMPSLLDTREALVQYITMVIFTCSAK. + 2 Oxidation (M); Phospho (ST) 
.ESSGMPSLLDTREALVQYITMVIFTCSAK. + 2 Oxidation (M); Phospho (ST) 
.ETGRVYVYMVGQQNLLMLQGTLQPDR.  Phospho (ST) 
.FTGSGSGTDFTLTISSVQAEDLAVYYCQHDHSYPPLTFGKGTK. + Phospho (ST);  
.GALLLALRCLGFSSR. + 2 Phospho (ST) 
.GALPSPGSR. + Phospho (ST) 
.GESQLLAPGASLGTR. + 2 Phospho (ST) 
.GLEWLWVIWAGGSTNYNSALMSRLSISK.  3 Phospho (ST); Phospho (Y) 
.GMQTASPWGK. + Phospho (ST) 
.GVTGEPFSMR. + Phospho (ST) 
.HFCNLLCILMFCHQQTVCDPPLQNNAASISMVQAASAGPPSLR. + 2 Phospho (ST)  
.HFGMLSR. + Phospho (ST) 
.HITVFRMQLHTR.  Phospho (ST) 
.IDTGTYFFR. + Phospho (Y) 
.IEDSQPFSLCVFKTAQLPTAVLWQNGPLLWIHPNVSPAK. + 4 Phospho (ST) 
.IGPATWAMATSKPDIMIILLSK. + 2 Oxidation (M); Phospho (ST) 
.IIISGVPSRK. + Phospho (ST) 
.IMAMTDPAFGSSGRPMLVLSCISQADVKR. + 3 Oxidation (M); Phospho (ST) 
.ISRVEADDLGVYFCSHSTHVPYTFGGGTK. + Phospho (ST); Phospho (Y) 
.ISSLHPDDVATYYCQNVLSTPYTFGSGTKL. + 2 Phospho (ST); Phospho (Y) 
.ITIVSCLK. + Phospho (ST);  
.ITSGESSSGGNPK. + Phospho (ST) 
.KALPSASLVGR. + Phospho (ST) 
.KGDSCLGINPK. + Phospho (ST) 
.KLLQNTANLTQLTLEK. + 2 Phospho (ST) 
.KPYSSRLEK. + Phospho (Y) 
.KVGLFPTDFLEEI. + Phospho (ST) 
.LAAINAMFSDISDLSGGMREENR.  Phospho (ST) 
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.LALKTGSVSR. + Phospho (ST) 
.LDSEGICLHITVPQKIEPR. + Phospho (ST);  
.LELALSMIK. + Phospho (ST) 
.LFLHNNRITHLIPGTFSQLESMK.  2 Phospho (ST) 
.LIEDSTLSKSVK. + Phospho (ST) 
.LKESAPSR. + Phospho (ST) 
.LLGLPQGNLGAAVSPTSIHTDK. + Phospho (ST) 
.LLIENGRHGPSNTLYHLVR. + Phospho (ST) 
.LNSLSYCQFTR. + Phospho (ST) 
.LPVPSKILAFLSYR. + Phospho (ST) 
.LQEILSRMSLLR. + Phospho (ST) 
.LRTMVLTQ.  Phospho (ST) 
.LSIIRNTSK. + Phospho (ST) 
.LSINTPNSR. + Phospho (ST) 
.LTLLPTVVMHLK.  Phospho (ST) 
.MAVSEMLGK. + Phospho (ST) 
.MDRDEEPLSARPALETESLR.  Phospho (ST) 
.MFPTMMLCFLNSGFRSHLCPLGATLGFK. + 2 Oxidation (M); Phospho (ST);  
.MNITVDQDTDYAELVLSVGEITLGEKTR.  Phospho (ST); Phospho (Y) 
.MNMRPTTCSVLVLLLMLR.  2 Phospho (ST) 
.MSGEPNTAGK. + Phospho (ST) 
.MSSSSRGPGAGAR.  Phospho (ST) 
.MTMSPSSLSASLGDTITITCR. + 2 Oxidation (M); Phospho (ST) 
.NPWITFGAGTKLE. + Phospho (ST) 
.QEGHEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYK. + Phospho (ST);  
.QENFSLILELASLSQTAVYFCASSDPGNTLYFGAGTR. + Phospho (ST); Phospho 
(Y) 
.QEVSLVCVKLTK. + Phospho (ST);  
.QLEEDLYDGQVLQKLLEK. + Phospho (Y) 
.QPTNAAKKPAAESVGMTSSNSSSSK.  Phospho (ST) 
.QSGSVLVRPGASVK. + 3 Phospho (ST) 
.QTDPSCTAFGTFNSLGGHLIIPNSGVSLLIPAGAIPQGR. + 2 Phospho (ST);  
.RALENSSIMK. + Phospho (ST) 
K.REAPAISSSK.N + Phospho (ST) 
 132 
K.REAPAISSSK.N + Phospho (ST) 
.RGGFTTVFAYWGQGTTVTVSS. + 4 Phospho (ST) 
.RGIVQYLQK. + Phospho (Y) 
.RPADLTPTKK. + Phospho (ST) 
R.RPLAAAHAGGGGSSCLCLR.G + Phospho (ST);  
.RTFSSILCR. + Phospho (ST) 
.RVGMGSQTLQILR. + Phospho (ST) 
.RVGMGSQTLQILR.  Phospho (ST) 
.RVGMGSQTLQILR.  Phospho (ST) 
.SAASFRPVR. + Phospho (ST) 
.SARLSPMPVTFTLELK. + Phospho (ST) 
.SCPLTVQIDITIR. + Phospho (ST) 
.SDFCFFVLYATEGFSLQLSLK. + Phospho (ST) 
.SEDTATYFCMRYSSYWYFAVWGAGTTVTVSS.  2 Phospho (ST); Phospho (Y);  
.SEVEGVGIHLFSYPQLQMGK.  Phospho (Y) 
.SFLPVPRSK. + Phospho (ST) 
.SGLDPKLLAK. + Phospho (ST) 
.SGSVLTSP. + Phospho (ST) 
.SIELGTLTIR. + 2 Phospho (ST) 
.SKYVLLSAR. + Phospho (ST); Phospho (Y) 
.SLIISSLTLNTITSVLAATASIMGVVSVAVGSQFPFR.  4 Phospho (ST) 
.SLYAVGMKPLMYSQLDATIYNIGWRR. + 2 Phospho (ST); Phospho (Y) 
.SMYRCMGK.  Phospho (Y) 
.SNLPTDCTLR. + Phospho (ST);  
.SPEEMLLAMSSSFQVLCCLTEACMRLVK.  Phospho (ST);  
.SRLGSSMSSLR.  Phospho (ST) 
.SRVDLEPISPR. + Phospho (ST) 
.SSFSIRSMCPSIK.  Phospho (ST);  
.SSGVALSIAVGLLECTFPNTGARIMMFIGGPATQGPGMVVGDELK.  2 Phospho 
(ST) 
.SSILLDVKPWDDETDMAQLETCVRSIQLDGLVWGASK. + 4 Phospho (ST);  
.SSTTAYMQLSSLTSEDSAVYYCTLR. + 5 Phospho (ST); Phospho (Y);  
.STVSTAPQEVLIGKLSK. + Phospho (ST) 
.SVTPEVKSR. + Phospho (ST) 
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.TAGLTPEQLVIGIPDK. + Phospho (ST) 
R.TASSRAAAVTAAILR.L + Phospho (ST) 
R.TASSRAAAVTAAILR.L + Phospho (ST) 
R.TASSRAAAVTAAILR.L + Phospho (ST) 
.TCTLDDLR. + Phospho (ST) 
.TEDGTTPLMLAARLAVEDLVEELIAAR.  2 Phospho (ST) 
.TEHQGFHATLKK. + Phospho (ST) 
.TLLSIYHTTRLLEK. + Phospho (ST); Phospho (Y) 
.TLRGAQESVAATVR. + Phospho (ST) 
.TPLSLSQLCRVSLR. + 2 Phospho (ST) 
.TSAVKTGDTK. + Phospho (ST) 
.TTHQLLFVR. + Phospho (ST) 
.TVPAMLGTPRLFR. + Phospho (ST) 
.VEPPTIPEGYAMSVAFHCLLDLVR. + Phospho (ST); Phospho (Y);  
.VFSRSVHLTQHQR. + 2 Phospho (ST) 
.WSSKELLLQPVTISR. + 2 Phospho (ST) 
.YQCVVLTEIKLTLQK. + Phospho (ST); Phospho (Y);  
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D.2: Wild-type Neural Progenitor Phospho-Peptides co-immunoprecipitated 
with G9a 
 
PEPTIDE SEQUENCE 
.ADIEVVCKTVK. + Phospho (ST) 
K.AGTHLK.G + Phospho (ST) 
R.AKTPVTLKQR.R + 2 Phospho (ST) 
R.APTAAPSPEPR.D + Phospho (ST) 
.DIPGQTKR. + Phospho (ST) 
K.EPEVITVTLKK.Q + Phospho (ST) 
R.FNIDLVSKLLYSR.G + Phospho (ST) 
R.FNIDLVSKLLYSR.G + Phospho (Y) 
R.FNIDLVSKLLYSR.G + Phospho (ST) 
K.GHSLLKSAR.E + Phospho (ST) 
K.GLFSRAEIEIAVSR.V + Phospho (ST) 
.GSLSSNGRTSRK. + Phospho (ST) 
R.ILSIKSTTLR.V + Phospho (ST) 
K.KAASPSPQSVR.R + Phospho (ST) 
K.KANSTTTASR.Q + Phospho (ST) 
K.KDISQNKR.A + Phospho (ST) 
K.KENPAPPKSCK.S + Phospho (ST);  
.KFDELLQLASR. + Phospho (ST) 
.KIILSDEGK. + Phospho (ST) 
.KKKVEQSHTGGYLPK. + Phospho (ST) 
K.KKTTIKK.N + Phospho (ST) 
R.KLELQVESMR.S + Oxidation (M); Phospho (ST) 
R.KLLAKGTSQLR.D + Phospho (ST) 
.KLSLQTFQTFK. + 2 Phospho (ST) 
R.KVKSAAEK.F + Phospho (ST) 
.KYLDVISNKNIK. + Phospho (Y) 
R.LIKSMESVMVK.Y + Oxidation (M); Phospho (ST) 
.LLGTLAVSR. + Phospho (ST) 
K.LTAQKLTESEQASR.V + Phospho (ST) 
K.MIGIKKVQGGALEESR.L + Oxidation (M); Phospho 
(ST) 
K.NETITK.F + Phospho (ST) 
.NFMSVAKTILK. + Oxidation (M); Phospho (ST) 
R.NQLQSVAAACK.V + Phospho (ST);  
.QDGSTVHPK. + Phospho (ST) 
R.QHTLK.H + Phospho (ST) 
.QLYPLPTPR. + Phospho (Y) 
K.QSRCVNIEWHR.F + Phospho (ST) 
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.RSSPRTISFRMSLK. + Oxidation (M); Phospho (ST) 
.SLLGHSENAVR. + Phospho (ST) 
R.SPSPAPPPPPPPPPR.R + Phospho (ST) 
.SRHQRSFSVPK. + Phospho (ST) 
R.SSSPYSKSPVSK.R + Phospho (ST) 
.TAQPYRPK. + Phospho (Y) 
R.TASPPPPPKR.R + Phospho (ST) 
.TEVIEIMTDR. + Oxidation (M); Phospho (ST) 
K.TGSESSVDRLMK.Q + Oxidation (M); Phospho (ST) 
.TRQNQLTR. + Phospho (ST) 
K.TVAVKPEVGHSK.T + Phospho (ST) 
.VGKTPPK. + Phospho (ST) 
.VSAVPIEAPDVSK. + Phospho (ST) 
.YTSRYYLK. + Phospho (ST) 
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D.3: HEK293 Phospho-Peptides co-immunoprecipitated with G9a 
 
PEPTIDE SEQUENCE 
.AAPFFTVYVGADSK. + Phospho (ST) 
.ACGKGSYGR. + Phospho (ST) 
.AKTQLMSMLMMNLESRPVIFEDVGRQVLATHSRK. 2 Phospho (ST) 
.AQQLSLLGCMSTSASKSLVQLEGSMEVQKLRLLVSR. 3 Phospho (ST) 
.ARHLVLAGGSKPRDVTNLTVGGFTPMSPR. 3 Phospho (ST) 
.ARIVCSGDAATSQVTDIAEENESKEMGFLR. 2 Phospho (ST);  
.AWIRGFSGNLEGEGYILTR. + Phospho (Y) 
.CILAGDHKQLPPTTVSHKAALAGLSRSLMER. 2 Phospho (ST) 
.CTIKPSGTTISVTASVTISLAPPTMPEVELSKMIMEGRLSAK. 3 Phospho (ST) 
.DCNTICGTMFDFFTHMHNKKHTQGQSQKSSHFPK. 2 Phospho (ST) 
.DKPSSCR. + Phospho (ST);  
.DQCPKYQGSRCSSDANMLGEMMFGSVAMSYK.  2 Phospho (ST);  Phospho 
(Y);  
.EAKRSESGSPR. + Phospho (ST) 
.EISLWERLEFVNGWYILLVTSDVLTISGTIMK.  2 Phospho (ST) 
.EMNCSETETQIQKDLSHFPTVDSEKIAAEFPK.   5 Phospho (ST);  
.FCYHETPGPR. + Phospho (ST);  
R.FNIDLVSKLLYSR.G + Phospho (Y) 
.GHRYLGWITSTHPRECEDSKAAQVHLHR.  2 Phospho (ST) 
.HEISVNSITHKLCSNSCFNEYRLTNGLIMNCCEQCSKYMPK. 2 Phospho (ST); 
Phospho (Y);  
.HFGMLSR. Phospho (ST) 
.IAYSNDGK. Phospho (Y) 
K.IEDVGSDEEDDSGKDKK.K +Phospho (ST) 
K.IEDVGSDEEDDSGKDKK.K  Phospho (ST) 
.ILKSQEEGQCSLR.  Phospho (ST) 
.ILPCPNISK. Phospho (ST) 
.ILQIAQSYLVVSDK.  2 Phospho (ST) 
.IVTTQK. + Phospho (ST) 
.IYPSSYRVDSSNYNPQPFWNAGCQMVALNYQSEGRMLQLNR. 3 Phospho 
(ST); 4 Phospho (Y);  
.KALSTCASHVTVVVLFLVPCSYLYLRPMTSFPTNKAVTVFCTLVT.  5 Phospho 
(ST); 2 Phospho (Y);  
.KDVLTR. + Phospho (ST) 
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.KPNTWVLLEFSNMGILGKLLHSK. + 3 Phospho (ST) 
.KRAFSTCSSHMIVVSITYGSCIFIYVKPSAK. + Phospho (ST); 2 Phospho (Y) 
.KRDSLQEYMDRQHMSDYCHVEDDAVK. + ; Phospho (ST); Phospho (Y);  
R.KTKPVKCVLNHINSSTK.K + 2 Phospho (ST) 
.KVILESKPACCFDCTPCPENEISNETGMDQCFKCPETHYTSAEKK. 3 
Phospho (ST);   
.KVRPSASR. + Phospho (ST) 
.LACADITVNILYGLYVVLSTVGVDSSLIVMSYSLILYTVMGLASPR. 4 Phospho 
(ST); 2 Phospho (Y);  
R.LALLCLSK.L + Phospho (ST);  
.LFPKGTVFTGKCETSGFQCPEMLSNKPWNYQVDYYGVAASIYCMLFGTYMK.  
3 Phospho (ST); 4 Phospho (Y);  
.LKDMNSSVSELELKSLISMSVVEK. 2 Phospho (ST) 
.LKMYKHSNNKAMTTGAIAAMLSTILYSR. 4 Phospho (ST); Phospho (Y) 
.LPSLPVKSWGYVNSR.  2 Phospho (ST) 
.LSQSKASKELVER. + Phospho (ST) 
.LSSGPVCLLCFQEPGDPEKLGEFLQKDNLCVHYFCLILSSKLPQK.  Phospho 
(ST) 
.LTCLLSIYLSIYRQSLTC.  Phospho (ST);  
.MAASVQAAAAPSGVLGTCGLEQILEALK.  Phospho (ST);  
-.MALTVRFEEATAAK.E Phospho (ST) 
.MAPITTSR. + Phospho (ST) 
.MATCSRQFTSSSSMKSSCGIGGGSSRMSSVLAGGSCR. 6 Phospho (ST);  
.MEAMSPQQDALGAQPGRSSSLTGMSRIAGGPGTKK.  4 Phospho (ST) 
.MEPSLSSETIERLEVSSLAQTSSAVASSTDGSIHTESVDGIPDPQRTK.  6 
Phospho (ST) 
.MGFFSLLTVQSALFALRYNVLTLVRMLSLK.  3 Phospho (ST); Phospho (Y) 
.MGSSVGLCLGK. + Phospho (ST);  
.MKVCQTGQPRLFSDCGKAPSPGTTLK.  Phospho (ST) 
.MLIYCSK. Phospho (ST) 
.MLLDGEIETKGLMGPFSK. Phospho (ST) 
.MPPSASAVDFFQLFVPDNVLKNMVVQTNMYAR. 2 Phospho (ST); Phospho 
(Y) 
.MSACFCLAKIANSMVSTWTGPPAMKSLFTR. 5 Phospho (ST);  
.NKATLTADTSSNTAYLKLSSLTSEDTATYFCTTH. 2 Phospho (ST) 
.NKLMIHEKPSCTEYVTQSHYITAPLSQEEVEFPLAYVMVIHHNFDTFARLFR. + 
2 Phospho (ST) 
.NLRAQAACMIITAAYPPGHSILLIITHHKLKAK. Phospho (ST); Phospho (Y) 
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.QLETVAARLSVSLLRHTQLLPADKAFYEAGTAAK. 3 Phospho (ST) 
.QSTVSLIKLK. + Phospho (ST) 
.QTLKGKALAFEGAGQQHTLITGLASTSTATALK. 6 Phospho (ST) 
.RATTRETPPCFLFSTTMLPLTGPTCQRK. 8 Phospho (ST); 2  
.RESAIR. + Phospho (ST) 
.RMQAVANMSIGAMFIMYGLTATFGYLTFYSTVK. 3 ; Phospho (ST); 2 
Phospho (Y) 
.RSDVEILGYCMLRWLCGKLPWETNLENPVAVQTTAG. 2 Phospho (ST); 
Phospho (Y) 
.RSRAELGSGSSTGSSGPAATTCR. + 5 Phospho (ST);  
.RSYSSICTTSSDEPDLDPVQELTYDLRSQCDAIRVTK. 3 Phospho (ST) 
.SKFSGFGK. + Phospho (ST) 
.SLQYLERYIYLILFNAYLRLEKASSWQRPFSTWMR. + Phospho (ST); 2 
Phospho (Y) 
.SLSGCPLADKSLRNLMAAHSADLKCPTPGCDGSGHITGNYASHR. ; 4 
Phospho (ST) 
.SPPRSPQSPSSGAEAADEDSNDSPTSSSSSRPLKVRIK.  3 Phospho (ST) 
.TGKMIHSMVAHLDAVTSLAVDPNGIYLMSGSHDCSIRLWNLDSK.  2 Phospho 
(ST);  
.TIPSQILEVMGDQSLVPYASDLLETMFK. + ; 2 Phospho (ST) 
.TNGVAMGMVAGTTMAMSAGTLLTTPQHTAIGAHPVSMPTYR. 2 Phospho 
(ST); Phospho (Y) 
.TSRPVTLGIDLGTTSVKAALLEAAPGHPSGFVVLASCAR. 2 Phospho (ST);  
.VLDIGPITKK. + Phospho (ST) 
.VLRYKPPPSECNPALDDPTPDYMNLLGMIFSMCGLMLKALNLR. 3 ; Phospho 
(ST) 
.VRVSPQDANSLMANGTLTRRHQNGR. + Phospho (ST) 
.VTSAAFPSPIEKTISKPEGRTQVPHVYTMSPTKEEMIQNEVSITCMVK. 2 
Phospho (ST) 
.WALGVCQACFSGDLSNQPLVAEGLWAIGRNTESTYVTCGPSR. 2 Phospho 
(ST); Phospho (Y); 2  
.YARSRKAWQR. + Phospho (ST) 
.YIKEGKIVPVEITISLLK. + 2 Phospho (ST); Phospho (Y) 
.YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR. 2 Phospho (ST);  
.YNSETVDKKIEEFLSSFEEKIENLTEDAFNTQVTALIK. 3 Phospho (ST) 
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